Sentence,class,file
Int J Obes (Lond) 2012; 36:1072-77;PMID:22024641; http://dx.doi.org/10.1038/ijo.,OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
"As aÂ© Lena M Kranz, Matthias Birtel, Christina Krienke, Christian Grunwitz, Jutta Petschenka, Kerstin C Reuter, Niels van de Roemer, Fulvia Vascotto, MathiasVormehr, Sebastian Kreiter, and Mustafa Diken *Correspondence to: Lena M Kranz; Email: kranzl@uni-mainz.de Submitted: 06/19/2015; Accepted: 06/29/2015http://dx.doi.org/10.1080/21645515.2015.1068485 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nat Med 2006; 12:246-51; PMID:16462803; http://dx.doi.org/10.1038/nm1360 2.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Clin Oncol 2013; 31:e439-42; PMID:24043743; http://dx.doi.org/10.1200/ JCO.2012.47.7521 3.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nat Med 2015; 21:1-7; PMID:25569538; http://dx.doi.org/10.1038/ nm.3785 4.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cancer Res 2012; 72:1081-91; PMID:22237626; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3722 6.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Sci Rep 2014;4:4743; PMID:24752137; http://dx.doi.org/10.1038/ srep04743 8.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Immunol 2008; 180:309-18; PMID:18097032; http://dx.doi.org/ 10.4049/jimmunol.180.1.309 10.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
GeneTher 2010; 17:961-71; PMID:20410931; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cancer Res 2010; 70:9031-40; PMID:21045153; http://dx.doi.org/10.1158/0008-5472.CAN-10-0699 12.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nature 2015;520:692-6; PMID:25901682; http://dx.doi.org/ 10.1038/nature14426 13.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Proc Natl Acad Sci U S A 1996; 93:5008-13; PMID:8643520; http://dx.doi.org/ 10.1073/pnas.93.10.5008 14.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cancer Res 2006;66:10995-1004; PMID:17108138; http://dx.doi.org/ 10.1158/0008-5472.CAN-06-0160 16.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Vis Exp 2013; e50070; PMID:23407473; http://dx.doi.org/10.3791/50070 17.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Immunother 2003; 26:332-42;PMID:12843795; http://dx.doi.org/10.1097/ 00002371-200307000-00005 18.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Clin Cancer Res 2011; 17:4550-7; PMID:21498393;http://dx.doi.org/10.1158/1078-0432.CCR-11-0116 19.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Curr Opin Immunol 2009; 21:233-40; PMID:19304471; http://dx.doi.org/10.1016/j.coi.2009.03.002 20.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Br J Cancer 2015; 112:1510-8; PMID:25867267; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nat Med 2013; 19:747-52;PMID:23644516; http://dx.doi.org/10.1038/nm.3161 22.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nat Protoc 2006; 1:1120-32; PMID:17406393; http://dx.doi.org/10.1038/nprot.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Science 2014; 344:641-5; PMID:24812403; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Exp Med 1996; 184:923-30; PMID:9064352; http://dx.doi.org/ 10.1084/jem.184.3.923 25.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nature 1998; 393:480-3; PMID:9624005; http://dx.doi.org/ 10.1038/31002 26.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nat Immunol 2011; 12:908- 13; PMID:21804558; http://dx.doi.org/10.1038/ni.2079 27.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nat Commun 2012; 3:948; PMID:22781761; http://dx.doi.org/10.1038/ncomms1948 28.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Exp Med 2005; 202:1691-701; PMID:16365148;http://dx.doi.org/10.1084/jem.20050915 29.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nat Med 2007; 13:1050-9; PMID:17704786; http://dx.doi.org/10.1038/nm1622 30.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
2011; 334:1573-7; PMID:22174255; http://dx.doi.org/10.1126/science.1208347 31.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nat Med 2007; 13:54-61; PMID:17187072; http://dx.doi.org/10.1038/nm152332.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Annu Rev Immunol 2013; 31:51-72; PMID:23157435; http://dx.doi.org/10.1146/annurev-immunol-032712-100008 34.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Autophagy 2014; 10:529-31; PMID:24413089; http://dx.doi.org/ 10.4161/auto.27643 35.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Gastroenterology 2014; 147:502- 26; PMID:25043945; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Gastroenter- ology 2008; 134:988-97; PMID:18395080; http://dx.doi.org/10.1053/j.gastro.2008.01.015 38.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cancer Immu- nol Immunother 2015; 64(7):831-42;PMID:25863943; http://dx.doi.org/10.1007/s00262- 015-1688-2 40.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Science 2014; 344:1396-401; PMID:24925914; http://dx.doi.org/10.1126/science.1254257 42.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Acta Neuropathol 2009; 118:469-74; PMID:19554337; http://dx.doi.org/10.1007/s00401- 009-0561-9 43.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cancer Discov 2013; 3:730-41;PMID:23796461; http://dx.doi.org/10.1158/2159- 8290.CD-13-0083 44.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nat Genet 2015; 47:458-68; PMID:25848751; http://dx.doi.org/10.1038/ng.3273 45.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nature 2014; 512:324-7; PMID:25043048; http://dx.doi.org/10.1038/nature13387 46.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cell 2010; 141:52-67; PMID:20371345; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Exp Med 2005; 202:61-72; PMID:15998788; http://dx.doi.org/ 10.1084/jem.20042138 48.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cancer Cell 2011; 19:333-46; PMID:21397857; http://dx.doi.org/10.1016/j.ccr.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cell Rep 2014; 9:1856-70; PMID:25466255; http://dx.doi.org/ 10.1016/j.celrep.2014.10.067 51.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cancer Immunol Res 2014; 2:410-22; PMID:24795354; http://dx.doi.org/10.1158/2326-6066.CIR-13-0171 52.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cancer Immu- nol Res 2014; PMID:24801836; http://dx.doi.org/ 10.1158/2326-6066.CIR-14-0024 53.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cancer Cell 2014; 25:846-59; PMID:24898549; http://dx.doi.org/10.1016/j.ccr.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer.BMC Cancer 2011; 11:134; http://dx.doi.org/ 10.1186/1471-2407-11-134 56.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Clin Invest 2014; 125:739-51; PMID:25562322; http://dx.doi.org/10.1172/JCI74894 57.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
"Oncoimmunology 2014; 3, e955687; PMID:25941620; http://dx.doi.org/10.4161/216240 11.2014.955687 61.",Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
N Engl J Med 2015; http://dx.doi.org/10.1056/NEJMoa1504030 62.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Hum Vaccin Immunother 2013; 9:2025-32;PMID:23877042; http://dx.doi.org/10.4161/hv.25768 63.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Clin Invest 2012; 122:1066-75; PMID:22326955; http://dx.doi.org/10.1172/JCI61226 65.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
1997; 3:682-5; PMID:9176498; http://dx.doi.org/10.1038/nm0697-682 66.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cancer Immunol Res 2014; 2:351-60; PMID:24764582; http://dx.doi.org/10.1158/2326- 6066.CIR-13-0181 67.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Clin Cancer Res 2015; 21:1639-51; PMID:25589619; http://dx.doi.org/ 10.1158/1078-0432.CCR-14-2339 68.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nature 2014; 515:577-81; PMID:25428507; http://dx.doi.org/10.1038/nature1398869.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
ClinCancer Res 2015; 21:781-94; PMID:25501579; http://dx.doi.org/10.1158/1078-0432.CCR-14-2142 71.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Cancer Immunol Res 2015; PMID:25888578; http://dx.doi.org/10.1158/2326-6066.CIR-15-0052 72.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Lancet 2014; 383:816-27; PMID:24054424;http://dx.doi.org/10.1016/S0140-6736(13)60802-8 73.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Lancet 2012; 380:358-65; PMID:22735384; http://dx.doi.org/10.1016/S0140-6736(12)60868-X 75.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
NEngl J Med 2014; http://dx.doi.org/10.1056/ NEJMoa1412690 76.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Nature 2012; 483:100-3; PMID:22281684; http://dx.doi.org/10.1038/nature10868 78.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;http://dx.doi.org/10.1056/NEJMoa1003466 79.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Clin Oncol [Epub ahead of print] 2015; 33(17):1889-94; PMID:25667295; http://dx.doi.org/10.1200/JCO.2014.56.2736 80.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
N Engl J Med 150419053123009 2015;372(26):2521-32; http://dx.doi.org/10.1056/ NEJMoa1503093 81.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Lancet Oncol2015; 16(5):522-30; http://dx.doi.org/10.1016/S1470- 2045(15)70122-1 82.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Eur J Cancer 2012; 48:218-25;PMID:22056637; http://dx.doi.org/10.1016/j.ejca.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Clin Oncol 2014; 32:1020-30; PMID:24590637; http://dx.doi.org/10.1200/JCO.2013.53.0105 84.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
N Engl J Med 2014; 372:320-30; PMID:25399552; http://dx.doi.org/10.1056/NEJMoa1412082 85.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
N Engl J Med 2015;372:2018-28; PMID:25891174; http://dx.doi.org/ 10.1056/NEJMoa1501824 86.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
N Engl J Med 2015; 372:311-9; PMID:25482239; http://dx.doi.org/10.1056/NEJMoa1411087 87.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
J Clin Oncol 2015; 33 (18):2013-20; http://dx.doi.org/10.1200/JCO.2014.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
N Engl J Med 2013; 369:122-33;PMID:23724867; http://dx.doi.org/10.1056/ NEJMoa1302369 90.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
N Engl J Med 2015; 372:2006-17; PMID:25891304; http://dx.doi.org/10.1056/NEJMoa1414428 91.,OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
Semin Oncol 2015; 42:429-35; PMID:25965361; http://dx.doi.org/ 10.1053/j.seminoncol.2015.02.010 www.tandfonline.com 221 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/92/b6/khvi-12-01-1068485.PMC4962731.pdf
"This option seems to be comparable in terms Â© Fernando Carlos, Jorge Alberto G /C19omez, Pablo Anaya, and Luis Romano-Mazzotti *Correspondence to: Fernando Carlos; Email: Fernando.Carlos@Racsalud.ComSubmitted: 03/11/2015; Revised: 05/30/2015; Accepted: 06/18/2015 http://dx.doi.org/10.1080/21645515.2015.1065362 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Vac- cine 2010; 28:6653-7; PMID:20723630; http://dx.doi.org/10.1016/j.vaccine.2010.08.037 4.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Salud Publica Mex 2007;49:S377-85; http://dx.doi.org/10.1590/S0036- 36342007000900009 6.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Value Health 2009; 12:A516; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
JAMA 2005; 294:202-10; PMID:16014594; http://dx.doi.org/ 10.1001/jama.294.2.202 9.,OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
J Viral Hepat 2008; 15 Suppl 2:62-5; PMID:18837837; http://dx.doi.org/10.1111/j.1365-2893.2008.01032.x 10.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
J Viral Hepat 2008; 15(Suppl 2):47- 50; PMID:18837834; http://dx.doi.org/10.1111/ j.1365-2893.2008.01029.x 11.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Hum Vaccin Immunother 2012; 8:1099-108; PMID:22854667; http://dx.doi.org/ 10.4161/hv.20549 12.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Available from: http://www.csg.gob.mx/contenidos/ CB2013/medicamentos/med2013 13. International Monetary Fund.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
2013 Available from: http://www.imf.org/external/pubs/ft/weo/2013/02/weodata/weorept.aspx?sy D2011&ey D2013&scsm D1&ssdD 1&sortDcountry&ds D.&brD1&cD273&sDNGDPPC &grpD0&aD&pr.xD40&pr.y D1514.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Pediatr Infect Dis J 2003; 22:904-14; PMID:14551492; http://dx.doi.org/ 10.1097/01.inf.0000091295.53969.6a 15.,OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Pediatrics 2007; 119:e12- e21; PMID:17200237; http://dx.doi.org/10.1542/peds.2006-1573 16.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Vaccine 2005; 23:4110-9; PMID:15964479; http://dx.doi.org/ 10.1016/j.vaccine.2005.03.021 17.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Rev Panam Salud Pub- lica 2008; 23:303-12; PMID:18510790; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Braz J Infect Dis 2009; 13:257-61;PMID:20231986; http://dx.doi.org/10.1590/S1413- 86702009000400003 19.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.Rev Panam Salud Publica 2007; 21:345-56; PMID:17761046; http://dx.doi.org/10.1590/S1020- 49892007000500002 20.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
J Med Virol 2011; 83:1885-91; PMID:21915861; http://dx.doi.org/10.1002/jmv.22200 21.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Hum Vaccin Immunother 2012; 8:323-7; PMID:22327499; http://dx.doi.org/10.4161/hv.18617 22.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Available from: http://www.dgepi.salud.gob.mx/ anuario/html/anuarios.html 25.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Vaccine 2000; 18(Suppl 1):S71-4; PMID:10683554; http://dx.doi.org/10.1016/S0264- 410X(99)00470-3 26.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Int J Infect Dis2013; 17:e939-44; PMID:23791857; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Pediatr Infect Dis J 2014; 33:84-8; PMID:24352191; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Med Decis Making 2012; 32:167-75; PMID:21393559; http://dx.doi.org/10.1177/0272989X11398489 29.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Pediatrics 2002; 109:839-45; PMID:11986444; http://dx.doi.org/ 10.1542/peds.109.5.839 30.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Int J Infect Dis 2008; 12:270-7; PMID:17988917; http://dx.doi.org/10.1016/j.ijid.2007.08.006 31.,OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Available from: http://www.medicines.org.uk/emc/medicine/2040/SPC/ 34.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Available from: http://www.sinais.salud.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Availablefrom: http://compras.imss.gob.mx/ 37.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Value Health 2011; 14:S65-S70; PMID:21839902; http://dx.doi.org/ 10.1016/j.jval.2011.05.025 38.,OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Available from: http://www.imss.gob.mx/profesionales/ Documents/GRD_IMSS.pdf 40.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
2012 Available from: http://www.inegi.org.mx/sistemas/olap/ proyectos/bd/consulta.asp?p D27608&c D27221&s Dest &clD4# 42.,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Value Health2011; 14:282-90; PMID:21296602; http://dx.doi.org/ 10.1016/j.jval.2010.10.004 43.,OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
Avail- able from: http://www.banxico.org.mx/portal-mer cado-cambiario/index.html www.tandfonline.com 63 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/7c/1d/khvi-12-01-1065362.PMC4962732.pdf
"However, 3D regimens of Â© Barbara Romanowski, Tino F Schwarz, Linda Ferguson, Klaus Peters, Marc Dionne, Ulrich Behre, Karin Schulze, Peter Hillemanns, Pemmaraju Suryakir an, Florence Thomas, and Frank Struyf*Correspondence to: Barbara Romanowski; Email: broman@docromanowski.comSubmitted: 03/18/2015; Revised: 06/01/2015; Accepted: 06/18/2015 http://dx.doi.org/10.1080/21645515.2015.1065363 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Lancet 2007;369: 2161-70; PMID:17602732; http://dx.doi.org/ 10.1016/S0140-6736(07)60946-5 2.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Lancet 2009; 374: 301-14; PMID:19586656; http://dx.doi.org/10.1016/ S0140-6736(09)61248-4 3.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Lancet Oncol 2012; 13: 89-99; PMID:22075171; http://dx.doi.org/10.1016/S1470-2045(11)70286-8 4.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Lancet Oncol 2012; 13: 100-10; PMID:22075170; http://dx.doi.org/10.1016/S1470-2045(11)70287-X 5.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Vaccine 2008; 26: 6630-8;PMID:18845199; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Hum Vaccin 2009; 5: 332-40; PMID:19221517; http://dx.doi.org/10.4161/hv.5.5.7211 7.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
"Angelo MG, David MP, Zima J, Baril L, Dubin G, Arellano F, Struyf F. Pooled analysis of large and long- term safety data from the human papillomavirus-16/ 18-AS04-adjuvanted vaccine clinical trial programme.Pharmacoepidemiol Drug Saf 2014; 23: 466-79; PMID:24644063; http://dx.doi.org/10.1002/pds.3554 8.",Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
N Engl J Med 2005; 353: 2158-68; PMID:16291985; http://dx.doi.org/10.1056/ NEJMsa044278 9.,OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Hum Vaccin Immunother 2013; 9: 1706-11; http://dx.doi.org/10.4161/hv.24904 10.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
J Adolesc Health 2007; 40: 564-71; PMID:17531764; http://dx.doi.org/10.1016/j.jadohealth.2007.02.015 14.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Pediatrics 2006; 118:2135-45; PMID:17079588; http://dx.doi.org/ 10.1542/peds.2006-0461 15.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Lancet 2004; 364: 1757- 65; PMID:15541448; http://dx.doi.org/10.1016/S0140-6736(04)17398-4 16.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Lancet 2006; 367: 1247-55; PMID:16631880; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
J Infect Dis 2007; 196: 1438-46; PMID:18008221;http://dx.doi.org/10.1086/522864 18.,OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Lancet 2007; 369: 1861-8; PMID:17544766; http://dx.doi.org/ 10.1016/S0140-6736(07)60852-6 19.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Hum Vaccin 2011; 7: 1374-86; PMID:22048171; http://dx.doi.org/10.4161/hv.7.12.18322 20.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Lancet 2009; 374: 1975-85; PMID:19962185; http://dx.doi.org/10.1016/S0140- 6736(09)61567-1 22.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Int J Cancer 2011;129: 2147-57; PMID:21190190; http://dx.doi.org/ 10.1002/ijc.25887 23.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
J Adolesc Health 2012; 50: 187-94; PMID:22265115;http://dx.doi.org/10.1016/j.jadohealth.2011.11.004 24.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Hum Vaccin Immunother 2014; 10: 2147-62; PMID:25424918;http://dx.doi.org/10.4161/hv.29532 25.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Vaccine 2006; 24: 5937-49; PMID:16828940; http://dx.doi.org/10.1016/j.vaccine.2006.06.005 26.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Available at: http://espid.meetingxpert.net/espid_945/poster_95279/pro gram.aspx.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Available at: http://www.eurogin.com/2013/images/pdf/EURO GIN-2013-Abstracts-Part-2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Vaccine 2009; 27: 581-7; PMID:19022320; http://dx.doi.org/ 10.1016/j.vaccine.2008.10.088 29.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Gynecol Oncol 2009; 115: S1-S6; PMID:19217149; http://dx.doi.org/10.1016/j.ygyno.2009.01.011 28 Volume 12 Issue 1 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Vaccine 2007; 25: 4324-33; PMID:17445955; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
J Natl Cancer Inst 2011; 103:1444-51; PMID:21908768; http://dx.doi.org/ 10.1093/jnci/djr31932.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Cancer Prev Res (Phila) 2013; 6: 1242-50; PMID:24189371; http://dx.doi.org/10.1158/1940- 6207.CAPR-13-0203 33.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Hum Vaccin 2008; 4: 425- 34; PMID:18948732; http://dx.doi.org/10.4161/ hv.4.6.6912 34.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Hum Vaccin 2009; 5: 705-19; PMID:19684472; http://dx.doi.org/10.4161/ hv.5.10.9518 35.,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
Biometrics 2001; 57: 120-5; PMID:11252586; http://dx.doi.org/10.1111/j.0006- 341X.2001.00120.x www.tandfonline.com 29 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/2c/c1/khvi-12-01-1065363.PMC4962738.pdf
"ï¬ Submitted: 01/27/2015; Revised: 05/15/2015; Accepted: 05/30/2015 http://dx.doi.org/10.1080/21645515.2015.1058457 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
N Engl J Med 2001; 344:1378-88; PMID:11333996; http://dx.doi.org/10.1056/NEJM200105033441807 2.,OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Vaccine 2009; 27 (Suppl 2):B51-63; PMID:19477562; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Available from: http://ecdc.europa.eu/en/publications/Publica tions/1111_SUR_Annual_Epidemiological_Report_on_ Communicable_Diseases_in_Europe.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Clin Infect Dis 2010; 50:184-91; PMID:20001736; http://dx.doi.org/10.1086/649209 5.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Vaccine 2001; 20 (Suppl 1):S58- 67; PMID:11587814; http://dx.doi.org/10.1016/S0264-410X(01)00299-7 6.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
FEMS Microbiol Rev 2007; 31:27- 36; PMID:17168995; http://dx.doi.org/10.1111/ j.1574-6976.2006.00060.x 7.,OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
European Medicines Agency 2013 [cited 2013 Dec 28]; Available from:http://www.ema.europa.eu/ema/index.jsp?curl Dpages/ medicines/human/medicines/002333/human_med_ 001614.jsp&mid DWC0b01ac058001d124 9.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Scand J Infect Dis 1977; 9:105-10; PMID:408918; http://dx.doi.org/10.3109/inf.1977.9.,OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Scand J Infect Dis 2000; 32:527-31; PMID:11055659; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
J Infect Dis 2006;194:1745-52; PMID:17109348; http://dx.doi.org/ 10.1086/509619 12.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Pediatrics 2011; 128:1213-8; PMID:22123893; http://dx.doi.org/10.1542/peds.2011â2380 13.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Hum Vaccin 2010; 6:881- 7; PMID:21339701; http://dx.doi.org/10.4161/hv.6.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
J Infect Dis 2006; 193:821-8; PMID:16479517; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Vaccine 2012; 30:2831-8; PMID:22394992; http://dx.doi.org/10.1016/j.vaccine.2012.02.046 16.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Pediatr Infect Dis J 2013; 32(4):e170â7; http://dx.doi.org/10.1097/ INF.0b013e318279ac3822.,OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Hum VaccinImmunother 2012; 8:866-72; PMID:22485049; http://dx.doi.org/10.4161/hv.20229 23.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Pediatr Infect Dis J 2006; 25:995-1000; PMID:17072120; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Avail- able from: http://neisseria.org/ipnc/2012/IPNC_2012_ abstracts.pdf 27.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
Vaccine 2005; 23:2222-7; PMID:15755600; http://dx.doi.org/10.1016/j.vaccine.2005.01.051 30.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
J Exp Med 1969; 129:1307-26; PMID:4977280; http://dx.doi.org/10.1084/jem.129.,Non-OADS,/arxiv_data1/oa_pdf/5e/a5/khvi-12-01-1058457.PMC4962747.pdf
"Kleinbaum et al7distinguish 3 major sources of error in epidemiologicalresearch: information bias (the mainKeywords: epidemiological bias, H1N1, inï¬uenza, narcolepsy, vaccine Â© Thomas Verstraeten, Catherine Cohet, Ga â¬el Dos Santos, Germano LC Ferreira, Kaatje Bollaerts,Vincent Bauchau, and Vivek Shinde *Correspondence to: Thomas Verstraeten; Email: Thomas.Verstraeten@P-95.com Submitted: 06/08/2015Accepted: 06/27/2015 http://dx.doi.org/10.1080/21645515.2015.1068486 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Available at http://www.ecdc.europa.eu/en/publica tions/Publications/Vaesco%20report%20FINAL%20with%20cover.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Available at: http://www.lakemedelsver ket.se/english/All-news/ NYHETER-2010/The-MPA-inves tigates-reports-of-narcolepsy-in-patients-vaccinated-with-Pandemrix/ 5.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Available at http://www.lake medelsverket.se/upload/nyheter/2011/Fallinventeringsrapport_pandermrix_110630.pdf 6.,OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Available at http://www.ecdc.europa.eu/en/ activities/sciadvice/_layouts/forms/Review_DispForm.aspx?List Da3216f4c-f040-4f51-9f77-a96046dbfd72& ID=4577.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Neurology 2013; 80:1315-21; PMID:23486871; http://dx.doi.org/10.1212/ WNL.0b013e31828ab26f 12.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Sleep Med 2014; 15:262-5;PMID:24468101; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Brain 2013; 136:2486-96; PMID:23884811; http://dx.doi.org/10.1093/brain/awt187 14.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
L â¬akemedelsverket 2013; Available at: http://www.lakemedelsverket.se/ upload/nyheter/2013/PDX%20Rapport%20SV%20-%20registerstudie %207%20landsting%20regioner%202013-03-26.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Arch Dis Child 2002; 87:493-4; PMID:12456546; http://dx.doi.org/10.1136/adc.87.6.493 16.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
BMJ2011; 343:d5956; PMID:21994316; http://dx.doi.org/ 10.1136/bmj.d5956 17.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Ann Neurol 2011; 70:410-7; PMID:21866560; http://dx.doi.org/10.1002/ ana.22587 18.,OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
PloS One 2013; 8:e68402; PMID:23950869; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
2013; 8:e68402; PMID:23950869; http://dx.doi.org/ 10.1371/journal.pone.0068402 20.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Vaccine 2013; 31:3104-9; PMID:23624093; http://dx.doi.org/ 10.1016/j.vaccine.2013.04.02623.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Lancet Infect Dis 2014; 14:227-38; PMID:24360892; http://dx.doi.org/10.1016/S1473-3099(13)70238-X 24.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
PloS One 2012; 7: e33536; PMID:22470453; http://dx.doi.org/10.1371/ journal.pone.0033536 25.,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
Sleep Med2013; 14:867-71; PMID:23773727; http://dx.doi.org/ 10.1016/j.sleep.2013.03.020 www.tandfonline.com 193 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/c6/e4/khvi-12-01-1068486.PMC4962758.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e0/c3/ijn-11-2995.PMC4962759.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2995â3007International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2995OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10503 5 Increased cutaneous wound healing effect  of biodegradable liposomes containing  madecassoside: preparation optimization, in vitro  dermal permeation, and in vivo bioevaluation Zehao li1 Meifeng liu1 huijuan Wang1 song Du2 1school of chemistry and chemical  engineering, guangdong Provincial  Key laboratory for green chemical  Product Technology, south china  University of T echnology, guangzhou,   2guangdong Jiabao Pharmaceutical  co., ltd., Qingyuan, Peopleâs  republic of chinaAbstract:  Madecassoside (MA) is highly potent in treating skin disorders such as wounds and  psoriasis.",Non-OADS,/arxiv_data1/oa_pdf/e0/c3/ijn-11-2995.PMC4962759.pdf
"If the wound healing time is prolonged, the continuing inflammatory cascade may  result in increasing tissue destruction and necrosis rather than healing.3 Scarring is the  inevitable process product of human wound healing; it may cause pain, itching, and  movement inflexibility.4 In addition to interfering with normal tissue function, serious correspondence: Meifeng liu school of chemistry and chemical  engineering, guangdong Provincial Key  laboratory for green chemical Product  Technology, south china University  of Technology, guangzhou 51640,  Peopleâs republic of china Tel +86 20 8711 0234 email liumf@scut.edu.c n  song Du guangdong Jiabo Pharmaceutical co.,  ltd., Qingyuan, 511517, Peopleâs  republic of china email dusong75@aliyun.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Li et al Running head recto: Liposomes in vitro permeation and in vivo bioevaluation DOI: http://dx.doi.org/10.2147/IJN.S105035",Non-OADS,/arxiv_data1/oa_pdf/e0/c3/ijn-11-2995.PMC4962759.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e0/c3/ijn-11-2995.PMC4962759.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/c3/ijn-11-2995.PMC4962759.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/4d/07/amep-7-357.PMC4962760.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4d/07/amep-7-357.PMC4962760.pdf
"php and incorporate the Creative Commons Attribution â Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4d/07/amep-7-357.PMC4962760.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 357â370Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 357 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S102000 An evidence-based laparoscopic simulation  curriculum shortens the clinical learning curve  and reduces surgical adverse events Gunter De Win1,2  Siska Van Bruwaene3,4  Jyotsna Kulkarni5  Ben Van Calster6  Rajesh Aggarwal7,8  Christopher Allen9  Ann Lissens4  Dirk De Ridder3  Marc Miserez4,10 1Department of Urology,  Antwerp  University Hospital, 2Faculty of  Health Sciences, University of  Antwerp, Antwerp, 3Department  of Urology, University Hospitals of KU Leuven,  4Centre for Surgical  T echnologies, KU Leuven, Leuven,  Belgium;  5Kulkarni Endo Surgery  Institute, Pune, India; 6Department of  Development and Regeneration, KU Leuven, Leuven, Belgium;  7Department  of Surgery, Faculty of Medicine,   8Steinberg Centre for Simulation  and Interactive Learning, Faculty of Medicine, McGill University, Montreal,  QC, Canada;  9School of Arts and  Sciences, University of Pennsylvania,  Philadelphia, PA, USA;  10Department  of Abdominal Surgery, University Hospitals Leuven, Leuven, BelgiumBackground: Surgical simulation is becoming increasingly important in surgical education.",Non-OADS,/arxiv_data1/oa_pdf/4d/07/amep-7-357.PMC4962760.pdf
"3 In addition, a week of simulation training seemed to have a  positive clinical impact on the transition from student to intern.4Correspondence: Gunter De Win   Department of Urology, Antwerp  University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium Tel +32 3 821 5586   Fax +32 3 821 4479   Email gunter.dewin@uza.beJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: De Win et alRunning head recto: Clinical impact of laparoscopic simulationDOI: http://dx.doi.org/10.2147/AMEP .S102000",Non-OADS,/arxiv_data1/oa_pdf/4d/07/amep-7-357.PMC4962760.pdf
Available from: http://www.websurg.com/doi-vd01en1608e.htm.,Non-OADS,/arxiv_data1/oa_pdf/4d/07/amep-7-357.PMC4962760.pdf
Available from: http://www.websurg.com/doi-ot02en011.htm.,Non-OADS,/arxiv_data1/oa_pdf/4d/07/amep-7-357.PMC4962760.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/4d/07/amep-7-357.PMC4962760.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 370 De Win et al  37. van Dongen KW , van der Wal WA, Rinkes IH, Schijven MP , Broeders  IA.",Non-OADS,/arxiv_data1/oa_pdf/4d/07/amep-7-357.PMC4962760.pdf
"7, 656 â669 http://dx.doi.org/10.1080/15476286.2016.1191728",Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Nat Struct Biol 2001; 8:746-50; PMID:11524674; http://dx.doi.org/10.1038/nsb0901-746 2.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Nature 2002; 418:244-51; PMID:12110901; http://dx.doi.org/10.1038/418244a 3.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Proc Natl Acad Sci U S A 2000; 97:4985-90; PMID:10781109; http://dx.doi.org/ 10.1073/pnas.060034297 4.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Nature 1998; 391:806-11; PMID:9486653;http://dx.doi.org/10.1038/35888 5.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Nature 2000; 404:293-6; PMID:10749213; http://dx.doi.org/10.1038/35005107 6 .,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Dev Biol 2000; 217:394- 405; PMID:10625563; http://dx.doi.org/10.1006/dbio.1999.9540 7.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Nat Rev Mol Cell Biol 2014; 15:366-7; PMID:24854784; http://dx.doi.org/ 10.1038/nrm3813 8.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Cell 2000; 101:25-33; PMID:10778853; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
J Biol Chem 2009; 284:17897-901; PMID:19342379; http://dx.doi.org/10.1074/jbc.R900012200 10.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Nat Rev Genetics 2013; 14:447-59; PMID:23732335; http://dx.doi.org/ 10.1038/nrg3462 11.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Cold Spring Harbor Perspectives Biol 2010; 2:a003640; http://dx.doi.org/10.1101/cshperspect.a003640 12.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Nat Biotechnol 2007;25:1322-6; PMID:17982443; http://dx.doi.org/10.1038/nbt1359 13.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Curr Opin Biotechnol 2004; 15:139-43; PMID:15081052; http://dx.doi.org/10.1016/j.copbio.2004.02.004 14.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
GM crops 2010; 1:207-13; PMID:21844675; http://dx.doi.org/ 10.4161/gmcr.1.4.13344 15.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
J Insect Physiol 2010; 56:227-35; PMID:19837076; http://dx.doi.org/10.1016/j.jinsphys.2009.10.004 16.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Applied Biochem Biotechnol 2013; 171:847-73; http://dx.doi.org/10.1007/s12010-013-0399-4 17.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Insect Sci 2013; 20:15-30; PMID:23955822; http://dx.doi.org/10.1111/j.1744-7917.2012.01513.xRNA BIOLOGY 667,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Nat Chem Biol2006; 2:711-9; PMID:17108989; http://dx.doi.org/10.1038/nchembio839 19.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
J Biol 2008; 7:34; PMID:19014674; http://dx.doi.org/10.1186/jbiol97 20.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
J Insect Physiol 2013; 59:1212-21; PMID:24041495;http://dx.doi.org/10.1016/j.jinsphys.2013.08.014 21.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Pest Management Sci 2011; 67:175-82; http://dx.doi.org/10.1002/ps.2048 22.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Curr Opin InsectSci 2014; 6:1-8; PMID:26705514; http://dx.doi.org/10.1016/j.cois.2014.09.011 23.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Cold Spring Harbor Symposia Quantitative Biol 2006; 71:95-100; http://dx.doi.org/10.1101/sqb.2006.71.060 24.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
PloS One 2012; 7:e47431; PMID:23133513; http://dx.doi.org/10.1371/journal.pone.0047431 25.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Genome Biol 2008; 9:R10; PMID:18201385; http://dx.doi.org/10.1186/gb-2008-9-1-r10 26.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
J Insect Sci 2010; 10:162; PMID:21067417; http://dx.doi.org/10.1673/031.010.14122 27.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
J InsectPhysiol 2011; 57:231-45; PMID:21078327; http://dx.doi.org/10.1016/j.jinsphys.2010.11.006 28.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Ann Rev Entomol 2010; 55:111-28; http://dx.doi.org/10.1146/annurev-ento-112408-085301 29.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Peptides 2014; 53:307-14; PMID:24394433; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Insect Biochem Mol Biol 2012; 42:148-54; PMID:22178129; http://dx.doi.org/10.1016/j.ibmb.2011.11.007 32.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
PloS One2011; 6:e20250; PMID:21637842; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
"Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/ 10.1006/meth.2001.1262 35. t Hoen PA, de Kort F, van Ommen GJ, den Dunnen JT.",OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Nucleic Acids Res 2003; 31:e20; PMID:12595569; http://dx.doi.org/10.1093/nar/gng020 36.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Scienti ï¬c Reports 2014; 4:6840; PMID:25354547; http://dx.doi.org/10.1038/ srep06840 37.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Applied Microbiol Biotechnol 2013; 97:5921-31; http://dx.doi.org/10.1007/s00253-013-4785-1 38.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Methods Mol Biol 1994; 32:9-15; PMID:7951753; http://dx.doi.org/10.1385/0- 89603-268-X:9 41.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
EMBO J 2011; 30:3481-500; PMID:21878991; http://dx.doi.org/10.1038/emboj.2011.286 42.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Dev Dynamics 2008; 237:861-82; http://dx.doi.org/10.1002/dvdy.21484 43.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Oncogene 2004; 23:8401-9; PMID:15517022; http://dx.doi.org/10.1038/sj.onc.1208176 44.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Immunol Cell Biol 2005; 83:217-23;PMID:15877598; http://dx.doi.org/10.1111/j.1440-1711.2005.01332.x 45.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Planta 2014; 239:543-64; PMID:24402564; http://dx.doi.org/10.1007/s00425-013-2019-5 46.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Int J Biol Sci 2014; 10:1150-8; PMID:25332689; http://dx.doi.org/10.7150/ijbs.10452 48.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Hum Genetics 2011; 130:583-605; http://dx.doi.org/ 10.1007/s00439-011-0995-8 49.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Int Rev Cell Mol Biol 2014; 312:139-67; PMID:25262241; http://dx.doi.org/10.1016/ B978-0-12-800178-3.00005-1 50.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
PLoS One 2012; 7:e47534; PMID:23071820; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Insect Mol Biol 2013; 22:574-83; PMID:23869949; http://dx.doi.org/10.1111/imb.12046 53.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
J Biotechnol 2012; 160:97-104;PMID:22575788; http://dx.doi.org/10.1016/j.jbiotec.2012.04.011 5 6 .,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Insect Biochem Mol Biol 2015; 60:68-77; PMID:25863352; http://dx.doi.org/10.1016/j.ibmb.2015.03.009 57.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
Nat Cell Biol 2006; 8:793-802;PMID:16862146; http://dx.doi.org/10.1038/ncb1439 58.,OADS,/arxiv_data1/oa_pdf/9b/01/krnb-13-07-1191728.PMC4962799.pdf
"5, 486 â499 http://dx.doi.org/10.1080/15476286.2015.1110673",Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Proteins wereidenti ï¬ed by MASCOT peptide mass ï¬ngerprint search (Mas- cot 2.4.1; http://www.matrixscience.com) using a Uniprot data-base for bacteria (20150624 11624423 sequences; 3649040132 residues).,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Quorum sensing controls exopolysaccharide production in Sinorhizobium meliloti .J Bacteriol 2003; 185:325 â31; PMID:12486070; http://dx.doi.org/ 10.1128/JB.185.1.325-331.2003 4.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
J Bacteriol 2002; 184:5686 â 95; PMID:12270827; http://dx.doi.org/10.1128/JB.184.20.5686- 5695.2002 5.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
J Bacteriol 2004; 186:5460 â 72; PMID:15292148; http://dx.doi.org/10.1128/JB.186.16.5460-5472.2004 6.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Mol Microbiol 2009; 74:1238 â56; PMID:19889097; http://dx.doi.org/10.1111/j.1365-2958.2009.06930.x 7.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Cell 2004; 118:69 â 82; PMID:15242645; http://dx.doi.org/10.1016/j.cell.2004.06.009 8.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Mol Microbiol 2012; 84:807 â15; PMID:22515735; http://dx.doi.org/10.1111/j.1365-2958.2012.08037.x 9.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
RNA Biol 2014; 11:563 â79; PMID: 24786641; http://dx.doi.org/10.4161/rna.28239 11.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
J Bacteriol 2014; 196:1435 â 47; PMID:24488310; http://dx.doi.org/10.1128/JB.01471-13 12.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Genes Dev 2005; 19:2176 â86; PMID:16166379; http://dx.doi.org/10.1101/gad.1330405 13.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
J Bac- teriol 2013; 195:5051 â63; PMID:23995643; http://dx.doi.org/10.1128/ JB.00751-13 15.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Mol Microbiol 2004; 51:973 â85; PMID:14763974; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
J Bacteriol 2009; 191:461 â76; PMID:18978044; http://dx.doi.org/ 10.1128/JB.01157-08 17.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Global analysis of quorum sensing targets in the intracellular pathogen Brucella melitensis 16 M. J Proteome Res 2010; 9:3200 â17; PMID:20387905; http://dx.doi.org/10.1021/pr100068p18.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Int J Med Microbiol 2006; 296:73 â81; PMID:16476569; http://dx.doi.org/10.1016/j.ijmm.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
J Bacteriol 2003; 185:2080 â 95; PMID:12644477; http://dx.doi.org/10.1128/JB.185.7.2080- 2095.2003 20.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
BMC Genomics 2010; 11:245; PMID:20398411; http://dx.doi.org/10.1186/1471-2164-11-245 21.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Nucleic Acids Res 2008; 36(Web Server issue): W109 â113; PMID:18477632; http://dx.doi.org/10.1093/nar/gkn264 22.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
J. Bacteriol 2008; 190:5308 â17; PMID:18515420; http://dx.doi.org/10.1128/JB.00063-08 23.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Mol Plant Microbe Interact 2008; 21:1498 â509; PMID:18842098; http://dx.doi.org/10.1094/MPMI-21-11-1498 24.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
BMC Genomics 2007; 8:467; http://dx.doi.org/10.1186/1471-2164-8-467 25.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Biochem Biophys Res Commun 2009; 390:331 â6; PMID:19800865; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
2015; 11:e1005153; PMID:25923724; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Mol Microbiol 2003; 48:855 â61; PMID:12753181; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Nucleic Acids Res 2010; 38(Web Server issue):W373 â7; PMID:20444875; http://dx.doi.org/10.1093/nar/gkq316 31.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
RNA 2003; 9:1308 â14; PMID:14561880; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Cell 1994;76:889 â900; PMID:7510217; http://dx.doi.org/ 10.1016/0092-8674(94)90363-8 33.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
2001; 29:4581 â8; http://dx.doi.org/10.1093/nar/ 29.22.4581498 K. BAUMGARDT ET AL.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
2009;41:719 â30; PMID: 19727520; http://dx.doi.org/10.1093/abbs/gmp060 35.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
The seed region of a small RNA drives the controlled destruction of the targetmRNA by the endoribonuclease RNase E. Mol Cell 2012;47:943 â53; PMID:22902561; http://dx.doi.org/10.1016/j.molcel.2012.07.015 37.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
J Bac- teriol 2004; 186:4492 â501; PMID:15231781; http://dx.doi.org/ 10.1128/JB.186.14.4492-4501.2004 40.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
PLoS One 2012; 7:e50768; PMID:23226379; http://dx.doi.org/10.1371/journal.pone.0050768 41.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Nucleic Acids Res 2014; 42:4847 â58; PMID:24510101; http://dx.doi.org/10.1093/nar/gku119 42.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Mol Microbiol 2012; 84:17 â35; PMID:22289118; http://dx.doi.org/10.1111/j.1365-2958.2012.07965.x 43.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Charac- terization of the role of ribonucleases in Salmonella small RNA decay.Nucleic Acids Res 2007; 35:7651 â64; PMID:17982174; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Genes Dev 2011; 25:385 â96; http://dx.doi.org/ 10.1101/gad.2001711 45.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
J Gen Microbiol 1974; 84:188 â98; PMID:4612098; http://dx.doi.org/10.1099/ 00221287-84-1-188 47.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Biotechnology 1982; 1:784 â91; http://dx.doi.org/10.1038/ nbt1183-784 49.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Mol Plant Microbe Interact 1998; 11:1119 â29; PMID:9805399; http://dx.doi.org/10.1094/MPMI.1998.11.11.1119 50.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
FEBS Lett 2009; 583:2339 â42; PMID:19540834; http://dx.doi.org/ 10.1016/j.febslet.2009.06.026 51.,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Micro-biology 2005; 151:1927 â38; PMID:15942000; http://dx.doi.org/ 10.1099/mic.0.27789-0 52.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
Nucleic Acids Res 2001; 29:e45; PMID:11328886; http://dx.doi.org/10.1093/nar/29.9.e45 53.,Non-OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
J Mol Biol 1990; 215:403 â10; PMID:2231712; http://dx.doi.org/10.1016/S0022-2836(05)80360-2RNA BIOLOGY 499,OADS,/arxiv_data1/oa_pdf/fb/d3/krnb-13-05-1110673.PMC4962803.pdf
"Published with license by Taylor & Francis Group, LLC Â© Kuan-Chieh Leu, Ming-Hsiun Hsieh, Huei-Jing Wang, Hsu-Liang Hsieh, and Guang-Yuh Jauh This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
"6, 593 â604 http://dx.doi.org/10.1080/15476286.2016.1184384",Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Similar results were obtained using TargetP prediction software(http://www.cbs.dtu.dk/services/TargetP/ ).,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
"Additionally,aPPRove software ( http://www.cs.colostate.edu/cstop/index.php) was used to analyze the conserved combination code for PPME, but none was detected.",OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
ORCID Guang-Yuh Jauh http://orcid.org/0000-0003-3459-1331 References 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Science 1999; 283: 1476-81; PMID:10066161; http://dx.doi.org/10.1126/science.283.5407.1476 3.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Bio- chim Biophys Acta 2014; 1840: 1233-45; PMID:24080405; http://dx.doi.org/10.1016/j.bbagen.2013.09.026 5.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
J Plant Physiol 2011; 168: 1345-60; PMID:21316793; http://dx.doi.org/10.1016/j.jplph.2011.01.005 6.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Philos Trans R Soc Lond B Biol Sci 2003; 358: 181-8; discussion 8-9; PMID:12594926; http://dx.doi.org/10.1098/rstb.2002.1179 7.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
"Trends Plant Sci 2014; 19: 380-9; PMID:24462302; http://dx.doi.org/ 10.1016/j.tplants.2013.12.008 8. de Longevialle AF, Small ID, Lurin C. Nuclearly encoded splicing fac- tors implicated in RNA splicing in higher plant organelles.",OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Mol Plant 2010; 3: 691-705; PMID:20603383; http://dx.doi.org/10.1093/mp/ssq025 9.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant Cell 2012; 24: 3349-65; PMID:22942382;http://dx.doi.org/10.1105/tpc.112.101006 10.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
PLoS One 2014; 9:e112360; PMID:25402171; http://dx.doi.org/10.1371/journal.pone.0112360 11.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Biochimie 2015; 113: 93-9; PMID:25882680; http://dx.doi.org/10.1016/j.biochi.2015.04.004 12.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant Cell 2004; 16: 2089-103; PMID:15269332; http://dx.doi.org/10.1105/tpc.104.022236 13.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Trends Biochem Sci 2000; 25: 46-7; PMID:10664580; http://dx.doi.org/10.1016/S0968-0004(99)01520-0 1 4 .,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Proc Natl Acad Sci U S A 2007; 104: 8178-83; PMID:17483454; http://dx.doi.org/10.1073/ pnas.0700865104 15.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant Cell 2009; 21: 146-56; PMID:19182104; http://dx.doi.org/10.1105/tpc.108.064667 16.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant J 2013; 74: 935-45; PMID:23521509; http://dx.doi.org/10.1111/ tpj.12180 17.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
RNA Biol 2013; 10: 1549-56; PMID:23899506; http://dx.doi.org/10.4161/rna.25755 18.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Annu Rev Plant Biol 2014; 65: 415-42; PMID:24471833; http://dx.doi.org/ 10.1146/annurev-arplant-050213-040159 19.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant Cell 2007; 19: 3256-65; PMID:17965268; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
RNA 2012; 18: 1197-209; PMID:22495966; http://dx.doi.org/10.1261/rna.032623.112 22.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant Cell 2006; 18: 2650-63; PMID:17041147; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant Physiol 2015; 168: 490-501; PMID:25888618; http://dx.doi.org/10.1104/pp.15.00354 24.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Mol Cell Biol 2008; 28: 5337-47; PMID:18591259; http://dx.doi.org/10.1128/MCB.00563-08 25.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
RNA 2008; 14: 1930-41; PMID:18669444; http://dx.doi.org/10.1261/rna.1077708 26.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
RNA Biol 2013; 10: 1419-25; PMID:23669716; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
RNA Biol 2014; 7: 213-9; PMID:20473038; http://dx.doi.org/10.4161/rna.7.2.11343 28.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Annu Rev Genet 2013; 47: 335-52; PMID:24274753; http://dx.doi.org/10.1146/annurev-genet-111212-133519 29.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
J Biol Chem 1995; 270: 18227-33; PMID:7629140; http://dx.doi.org/10.1074/jbc.270.31.18227 30.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
PLoS Genet 2013; 9: e1003584; PMID:23818871; http://dx.doi.org/10.1371/journal.pgen.1003584 31.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
FEBS Lett 2013; 587: 1429-33;PMID:23523919; http://dx.doi.org/10.1016/j.febslet.2013.03.022 32.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant Cell 2012; 24: 3684-94; PMID:23001034; http://dx.doi.org/10.1105/tpc.112.099507 33.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Proc Natl Acad Sci U S A 2012; 109: E1453-61; PMID:22566615; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Nature 2005; 433: 326-30; PMID:15662426; http://dx.doi.org/10.1038/nature03229 35.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
J Biol Chem 2006; 281: 37661-7; PMID:17015439; http://dx.doi.org/10.1074/jbc.M608184200 36.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant J 2010; 62: 560-70; PMID:20163555; http://dx.doi.org/10.1111/j.1365-313X.2010.04175.x 37.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Nucleic Acids Res 2012; 40: 5052-64; PMID:22362750; http://dx.doi.org/10.1093/nar/gks164 38.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Nature 2013; 504: 168-71;PMID:24162847; http://dx.doi.org/10.1038/nature12651 39.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Gene 2010; 454: 39-46; PMID:20117193; http://dx.doi.org/10.1016/j.gene.2010.01.008 40.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant J 2010; 63: 499-511; PMID:20497377; http://dx.doi.org/10.1111/j.1365-313X.2010.04258.x 41.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant J 2015; 81: 661-9; PMID:25585673; http://dx.doi.org/10.1111/tpj.12756 42.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
J Biol Chem 2010; 285: 32192-9;PMID:20682769; http://dx.doi.org/10.1074/jbc.M110.147603 43.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant J 2012; 71: 413-26; PMID:22429648; http://dx.doi.org/10.1111/j.1365- 313x.2012.04998.x.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Nucleic Acids Res 2013; 41: 6650-63;PMID:23658225; http://dx.doi.org/10.1093/nar/gkt337 45.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
RNA 2002; 8: 497-511; PMID:11991643; http://dx.doi.org/10.1017/S1355838202029424 46.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
PLoS Genet 2012; 8: e1002910;PMID:22916040; http://dx.doi.org/10.1371/journal.pgen.1002910 47.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Nucleic Acids Res2012; 40: 2712-23; PMID:22127869; http://dx.doi.org/10.1093/nar/ gkr1084 48.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
BMC Bioinformatics 2007; 8: 2; PMID:17199898; http://dx.doi.org/10.1186/ 1471-2105-8-2 50.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
"Babot M, Birch A, Labarbuta P, Galkin A. Characterisation of the active/de-active transition of mitochondrial complex I. BiochimBiophys Acta 2014; 1837: 1083-92; PMID:24569053; http://dx.doi.org/ 10.1016/j.bbabio.2014.02.018 51.",OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Biochim Biophys Acta 2015; 1847: 779-85; PMID:25585161; http://dx.doi.org/10.1016/j.bbabio.2014.12.010 53.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
FEBS Lett 2007; 581: 4132-8; PMID:17707818; http://dx.doi.org/ 10.1016/j.febslet.2007.07.075 54.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
FEBS Lett 2008; 582: 4163-8; PMID:19041647; http://dx.doi.org/ 10.1016/j.febslet.2008.11.017 55.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant Cell 2013; 25: 868-83; PMID:23463776; http://dx.doi.org/10.1105/tpc.112.106781 56.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
RNA 2009; 15: 2299-311; PMID:19946041;http://dx.doi.org/10.1261/rna.1776409 5 7 .,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant J 2011; 67: 1067-80; PMID:21623974; http://dx.doi.org/10.1111/j.1365- 313X.2011.04658.x 58.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
"Two pentatricopeptide repeat domain proteins are required for the synthesis of respiratory complex I. Curr Genet 2015; 61: 19-29; PMID:25108509; http://dx.doi.org/10.1007/s00294-014-0441-2 59. des Francs-Small CC, de Longevialle AF, Li Y, Lowe E, Tanz SK, Smith C, Bevan MW, Small I.",Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant Physiol 2014; 165: 1409-16; PMID:24958715; http://dx.doi.org/10.1104/pp.114.244616 60.,Non-OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Clin Sci 2015; 128: 895-904;PMID:25626417; http://dx.doi.org/10.1042/CS20140705 61.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Plant J 2015; 84: 283-95;PMID:26303363; http://dx.doi.org/10.1111/tpj.12993 62.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Nat Protoc 2006; 1: 641-6; PMID:17406292; http://dx.doi.org/10.1038/nprot.2006.97 63.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Nucleic Acids Res 2007; 35: e114; PMID:17726051; http://dx.doi.org/10.1093/nar/gkm640 64.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
Cell Mol Life Sci 2006; 63: 698-708;PMID:16465445; http://dx.doi.org/10.1007/s00018-005-5449-9604 K.-C. LEU ET AL.,OADS,/arxiv_data1/oa_pdf/b6/47/krnb-13-06-1184384.PMC4962808.pdf
"6, 569 â581 http://dx.doi.org/10.1080/15476286.2016.1176663",Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
"6.7 (http://david.abcc.ncifcrf.gov/) comparing genes with a CELF2 CLIPpeak in at least one of 3 regions proximal to RefSeq internal exons (within 300 nt upstream, within 300 nt downstream, or within the exon) or genes bound by CELF2 elsewhere (e.g., dis-tal intronic or UTR regions) to all transcripts expressed in JSL1cells, as de ï¬ned by RNA-seq.",Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Nat Rev Genet 2014; 15:689-701;PMID:25112293; http://dx.doi.org/10.1038/nrg3778 2.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Immunol Rev 2013; 253:216-36; PMID:23550649; http://dx.doi.org/10.1111/imr.12047 3.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Semin Cancer Biol 2012; 22:417-27;PMID:22548723; http://dx.doi.org/10.1016/j.semcancer.2012.04.003 4.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
"Prog Mol Subcell Biol 2003; 31:187-216;PMID:12494767; http://dx.doi.org/10.1007/978-3-662-09728-1_7 5. Cooper TA, Wan L, Dreyfuss G. RNA and disease.",Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Cell 2009; 136:777- 93; PMID:19239895; http://dx.doi.org/10.1016/j.cell.2009.02.011 6.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Mol Cell Biol 2011; 31:2184-95;PMID:21444716; http://dx.doi.org/10.1128/MCB.05170-11 8.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
RNA 2002; 8:671-85;PMID:12022233; http://dx.doi.org/10.1017/S1355838202027036 9.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Mol Cell Biol 2001; 21:1285-96; PMID:11158314;http://dx.doi.org/10.1128/MCB.21.4.1285-1296.200110.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Proc Natl Acad Sci U S A2008; 105:20333-8; PMID:19075228; http://dx.doi.org/10.1073/ pnas.0809045105 11.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Wiley Interdiscip Rev RNA 2011; 3:104-21; PMID:22180311; http://dx.doi.org/10.1002/wrna.107 12.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Genes Dev 2010; 24:653-8; PMID:20299448; http://dx.doi.org/10.1101/ gad.1894310 13.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Nucleic Acids Res 2005; 33:2769-80; PMID:15894795; http://dx.doi.org/10.1093/nar/gki561 14.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
ETR-3 and CELF4 protein domains required for RNA binding and splicing activity in vivo.Nucleic Acids Res 2004; 32:1232-41; PMID:14973222; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Nucleic Acids Res 2010; 38:7273-85;PMID:20631008; http://dx.doi.org/10.1093/nar/gkq573 16.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Dev Dyn 2013; 242:767-77;PMID:23468433; http://dx.doi.org/10.1002/dvdy.23959 17.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Circ Res 1990; 66:1204-16;PMID:2139820; http://dx.doi.org/10.1161/01.RES.66.5.1204 18.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Genes Dev 2015; 29:2054-66; PMID:26443849; http://dx.doi.org/10.1101/gad.267245.115 19.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Nucleic Acids Res 2009; 37:4275-86; PMID:19443441; http://dx.doi.org/10.1093/nar/gkp346 20.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
RNA 2015; 21:2053-66;PMID:26437669; http://dx.doi.org/10.1261/rna.052969.115 21.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Mol Cell Biol 2000; 20:70-80; PMID:10594010; http://dx.doi.org/10.1128/MCB.20.1.70-80.2000 22.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Mol Cell Biol 2014; 34:71-83;PMID:24164894; http://dx.doi.org/10.1128/MCB.00740-13 24.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Cell 2014;158:764-77; PMID:25126784; http://dx.doi.org/10.1016/j.cell.2014.06.023 25.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Mol Cell Biol 2005; 25:879-87;PMID:15657417; http://dx.doi.org/10.1128/MCB.25.3.879-887.2005 26.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Mol Cell 2013; 50:223-35; PMID:23562324; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Rbfox proteins regulate alterna- tive mRNA splicing through evolutionarily conserved RNA bridges.Nat Struct Mol Biol 2013; 20:1434-42; PMID:24213538; http://dx.doi.org/10.1038/nsmb.2699 29.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Cell 2012; 150:710-24; PMID:22901804; http://dx.doi.org/ 10.1016/j.cell.2012.06.041 30.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
PLoS Genet 2009; 5:e1000595; PMID:19680430; http://dx.doi.org/10.1371/journal.pgen.1000595 31.,Non-OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Genome Res 2015; 25:858-71; PMID:25883322; http://dx.doi.org/10.1101/gr.184390.11432.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Sci Rep 2012: 2:209; PMID:22355723;http://dx.doi.org/10.1038/srep00209 33.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Mol Cell 2008; 29:263-70; PMID:18243120; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Mol Cell 2003; 12:1317-24; PMID:14636588; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Genome Res 2004; 14:1188-90; PMID:15173120; http://dx.doi.org/10.1101/gr.849004 36.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
Nucleic Acids Res 2015; 43:9006-16; PMID:26261210; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
J Biol Chem 2001; 276:24341-7; PMID:11306584; http://dx.doi.org/10.1074/jbc.M102175200RNA BIOLOGY 581,OADS,/arxiv_data1/oa_pdf/9e/ee/krnb-13-06-1176663.PMC4962813.pdf
TheContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2016.06.005 2213-0489/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.lrr.2016.06.005 .,OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"(2014) 220 â229, http://dx.doi.org/10.1007/s12185-014-1644-5 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"81 (2003) 171 â175, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"Dalton, et al., Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia, Nature 446 (2007) 758 â764, http://dx.doi.org/10.1038/ nature05690 .",OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"van Leeuwen, et al., High-resolution genomic pro ï¬ling of childhood ALL reveals novel recurrent genetic lesions affecting pathways in- volved in lymphocyte differentiation and cell cycle progression, Leukemia 21(2007) 1258 â1266, http://dx.doi.org/10.1038/sj.leu.2404691 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
3 (2013) 1 â13 â©http://www.pubmedcentral.nih.gov/articlerender.,Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"Miller, I. Radtke, L. a Phillips, J. Dalton, J. Ma, et al., BCR- ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros, Nature 453 (2008) 110 â114, http://dx.doi.org/10.1038/nature06866 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"van Reijmersdal, R. Venkatachalam, B. Scheijen, et al., IKZF1 deletions predict relapse in uni- formly treated pediatric precursor B-ALL, Leukemia 24 (2010) 1258 â1264, http://dx.doi.org/10.1038/leu.2010.87 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"360 (2009) 470 â480, http://dx.doi.org/10.1056/NEJMoa0808253 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"Haematologica 98 (2013) 1226 â1231, http://dx.doi.org/10.3324/ haematol.2012.075432 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"[12] A. Caye, K. Beldjord, K. Mass-Malo, S. Drunat, J. Soulier, V. Gandemer, et al., Breakpoint-speci ï¬c multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia, Haematologica 98 (2013) 597â601, http://dx.doi.org/10.3324/haematol.2012.073965 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"Gaub, M. Legrain, B. Drenou, L. Mauvieux, P. Lutz, et al., Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations, Leukemia 27 (2013) 503 â507, http://dx.doi.org/10.1038/leu.2012.204 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"[14] a Karachunskiy, R. Herold, a von Stackelberg, N. Miakova, a Timakow, T. Mahortih, et al., Results of the ï¬rst randomized multicentre trial on child- hood acute lymphoblastic leukaemia in Russia, Leukemia 22 (2008) 1144 â1153, http://dx.doi.org/10.1038/leu.2008.63 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"91 (2012) 1039 â1049, http://dx.doi.org/ 10.1007/s00277-012-1415-4 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"35 (2011) 1312 â1320, http://dx.doi.org/10.1016/j.leukres.2011.04.013 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"Giles, T. Law, et al., Highly sensitive MRD tests for ALL based on the IKZF1 Î3-6 microdeletion, Leukemia 26 (2012) 1414 â1416, http://dx.doi.org/10.1038/leu.2011.348 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"De Moerloose, P. Kastner, et al., IKZF1 deletion is an independent prognostic marker in childhood B-cell pre-cursor acute lymphoblastic leukemia, and distinguishes patients bene ï¬ting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951, Leukemia (2015) 2154 â2161, http://dx.doi.org/ 10.1038/leu.2015.134 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"27 (2009)5202 â5207, http://dx.doi.org/10.1200/JCO.2008.21.6408 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"Downing, Genome-wide pro ï¬ling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions, Leukemia23 (2009) 1209 â1218, http://dx.doi.org/10.1038/leu.2009.18 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
3 (2013) 165 â173 â©http://www.pubmedcentral.nih.gov/arti clerender.fcgi?artid Â¼3649816&tool Â¼pmcentrez&rendertype Â¼abstract âª.,Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"[23] S. Krentz, J. Hof, a Mendioroz, R. Vaggopoulou, P. DÃ¶rge, C. Lottaz, et al., Prognostic value of genetic alterations in children with ï¬rst bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia, Leukemia 27 (2013) 295 â304, http://dx.doi.org/10.1038/leu.2012.155 .",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
"Van Reijmersdal, L. J. Russell, et al., Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell pre- cursor ALL, Blood 122 (2013) 2622 â2629, http://dx.doi.org/10.1182/ blood-2012-10-462358 .V.",Non-OADS,/arxiv_data1/oa_pdf/e7/f0/main.PMC4962816.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sun protection Secondary schoolsSurvey questionnaireSkin cancer prevention 1.,Non-OADS,/arxiv_data1/oa_pdf/54/88/main.PMC4962859.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.03.0012211-3355/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/88/main.PMC4962859.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/88/main.PMC4962859.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/54/88/main.PMC4962859.pdf
Available from: http://www.sunsmartschools.org.nz/teachers/curriculum- resources .,Non-OADS,/arxiv_data1/oa_pdf/54/88/main.PMC4962859.pdf
Available from: http://globocan.iarc.fr/old/bar_sex_site.asp?selection= 16120&title=Melanoma+of+skin&statistic=2&populations=5&window=1&grid=1&info=1&color1=5&color1e=&color2=4& color2e=&submit=%C2%A0Execute%C2% A02013.).,OADS,/arxiv_data1/oa_pdf/54/88/main.PMC4962859.pdf
The National Administration Guidelines (NAGs ).Available from: http://www.education.govt.nz/ministry-of-education/legislation/nags/ .,Non-OADS,/arxiv_data1/oa_pdf/54/88/main.PMC4962859.pdf
Available from: http://www.health.govt.nz/system/ ï¬les/documents/publications/ cancer-new-registrations-deaths-2011-v4sept14.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/54/88/main.PMC4962859.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/df/omw019.PMC4962885.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/71/omw018.PMC4962886.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/e0/omw062.PMC4962887.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/13/omw061.PMC4962888.pdf
"Avaialbe from http://www.fda.gov/drugs/drugsafety/ ucm475463.html (9 May 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/f2/13/omw061.PMC4962888.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/9f/omw023.PMC4962889.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/88/omw063.PMC4962890.pdf
Keywords Spatial modelling; Reforestation scenario; Land use changes; Landscape pattern; Central Alps This is an open access article under the CC BY-NC-NDlicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/d0/emss-69037.PMC4962904.pdf
"Available from: http://download.geofabrik.de/europe/ austria.html Osterburg B, Runge T. Agri-Environmental Measures in Germany â Their Evolution in Practice and  New Approaches to Strengthen Efficiency.",Non-OADS,/arxiv_data1/oa_pdf/0c/d0/emss-69037.PMC4962904.pdf
"4, 1080 â1084 http://dx.doi.org/10.1080/21645515.2015.1114196",Non-OADS,/arxiv_data1/oa_pdf/fa/d5/khvi-12-04-1114196.PMC4962929.pdf
"Public Health 2007; 121:742-51; PMID:17572457; http://dx.doi.org/10.1016/j.puhe.2007.02.011 [3] Lode H, Ludwig E, Kassianos G. Pneumococcal infection-low aware- ness as a potential barrier to vaccination: results of a European study.",Non-OADS,/arxiv_data1/oa_pdf/fa/d5/khvi-12-04-1114196.PMC4962929.pdf
"Adv Ther 2013; 30:387-405; PMID:23605248; http://dx.doi.org/10.1007/s12325-013-0025-4 [4] Mart /C19Ä±nez-P /C19erez B, de la Torre-D /C19Ä±ez I, L /C19opez-Coronado M, Sainz-De- Abajo B.",Non-OADS,/arxiv_data1/oa_pdf/fa/d5/khvi-12-04-1114196.PMC4962929.pdf
Available at: http://www.salute.gov.it/imgs/c_17_pubblicazioni_1721_allegato.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fa/d5/khvi-12-04-1114196.PMC4962929.pdf
"Available at: http://www.cdc.gov/vaccines/vpd- vac/pneumo/vacc-in-short.htm [8] O âMalley G, Dowdall G, Burls A, Perry IJ, Curran N. Exploring the usability of a mobile app for adolescent obesity management.",Non-OADS,/arxiv_data1/oa_pdf/fa/d5/khvi-12-04-1114196.PMC4962929.pdf
Vac- cine 2011; 29:6472-84; PMID:21756960; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fa/d5/khvi-12-04-1114196.PMC4962929.pdf
Health Psy-chol 2007; 26:136-45; PMID:17385964; http://dx.doi.org/10.1037/ 0278-6133.26.2.1361084 D. PANATTO ET AL.,Non-OADS,/arxiv_data1/oa_pdf/fa/d5/khvi-12-04-1114196.PMC4962929.pdf
"4, 955 â959 http://dx.doi.org/10.1080/21645515.2015.1113357",Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Philadelphia: Saunders, 2013:447-92 [3] Amirthalingam G, Gupta S, Campbell H. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review.Euro Surveill 2013; 18: pii:20587; PMID:24084340; http://dx.doi.org/10.2807/1560-7917.ES2013.18.38.20587 [4] Braeye T, Linina I, De RR, Hutse V, Wauters M, Cox P, Mak R. Mumps increase in Flanders, Belgium, 2012 â2013: results from tem- porary mandatory noti ï¬cation and a cohort study among university students.",Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
Vaccine 2014; 32:4393-8; PMID:24973734; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Trends Microbiol 2012; 20:211-3; PMID:22494804;http://dx.doi.org/10.1016/j.tim.2012.03.003 [6] Gabutti G, Azzari C, Bonanni P, Prato R, Tozzi A E, Zanetti A, Zuc- cotti G. Pertussis: Current perspectives on epidemiology and preven- tion.",Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Hum Vaccin Immunother 2015; 11(1):108-17;PMID:25483523; http://dx.doi.org/10.4161/hv.34364 [7] Zamir CS, Schroeder H, Shoob H, Abramson N, Zentner G. Charac- teristics of a large mumps outbreak: Clinical severity, complicationsand association with vaccination status of mumps outbreak cases.Hum Vaccin Immunother 2015; 11:1413-7; PMID:25874726; http:// dx.doi.org/10.1080/21645515.2015.1021522 [8] Burgmeijer R, Hoppenbrouwers K, Hahn /C19e S. Bof (parotitis epide- mica), In: Burgmeijer R, Hoppenbrouwers K, Van Gompel F, eds.Handboek Vaccinaties.",Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
ActaClin Belg 2014; 69: 104-10; PMID:24724749; http://dx.doi.org/ 10.1179/0001551214Z.00000000032 [10] Pierard D. Bordetella Pertussis.,Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Lancet 1998; 351:356-61; PMID:9652634;http://dx.doi.org/10.1016/S0140-6736(97)04334-1 [12] Burgmeijer R, Hoppenbrouwers K. Kinkhoest (pertussis), In: Burg- meijer R, Hoppenbrouwers K, Van Gompel F, eds.",OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Vaccine 2015; 33:2125-31; PMID:25796339; http://dx.doi.org/10.1016/j.vaccine.2015.03.020 [14] Mooi FR, Van Der Maas NA, de Melker HE.",Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Epidemiol Infect 2014; 142:685-94; PMID:23406868; http://dx.doi.org/10.1017/S0950268813000071 [15] Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, Duprex WP.",Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"J Virol 2012; 86:615-20; PMID:22072778;http://dx.doi.org/10.1128/JVI.06125-11 [16] Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, Rota PA, Sirota L, Beeler J.",OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"J Infect Dis 2008; 198:508-15; PMID:18558869; http://dx.doi.org/10.1086/590115 [17] Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, et al.",OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"MBio 2014; 5:e01074; PMID:24757216; http://dx.doi.org/10.1128/mBio.01074-14 [18] Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, He Q.",OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Clin Vaccine Immunol 2012; 19:1703-4;PMID:22914363; http://dx.doi.org/10.1128/CVI.00367-12 [19] Fine PEM, Mulholland K. Community Immunity, In: Plotkin SA, Orenstein WA, Of ï¬t PA, eds.",Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Vaccine 2014;32:345-9; PMID:24269616; http://dx.doi.org/10.1016/j.vaccine.2013.11.041 [21] Weinberg GA, Szilagyi PG.",Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"J Infect Dis 2010;201:1607-10; http://dx.doi.org/10.1086/652404 [22] Rubin SA, Vandermeulen C. Mumps virus, In: Samal S, ed.",Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Vaccine 2004; 22:2713-6; PMID:15246601; http://dx.doi.org/10.1016/j.vaccine.2004.02.001 [25] Vandermeulen C, Clement F, Roelants M, Van DP, Hoppenbrouwers K, Leroux-Roels G. Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to16 years after their last vaccination.",OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"J Infect Dis 2009; 199:1457-60; http://dx.doi.org/10.1086/598482 [26] Vandermeulen C, Verhoye L, Vaidya S, Clement F, Brown KE, Hoppenbrouwers K, Leroux-Roels G. Detection of mumps virus-speci ï¬c memory B cells by transfer of peripheral blood mononu- clear cells into immune-de ï¬cient mice.",OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
J Infect Dis 2014; 209 Suppl 1:S10-S15; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Arch Pediatr Adolesc Med 1997; 151:283-9; PMID:9080938; http://dx.doi.org/10.1001/archpedi.1997.02170400069013 [30] Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH.",OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
PLoSPathog 2013; 9:e1003264; PMID:23592988; http://dx.doi.org/ 10.1371/journal.ppat.1003264 [31] Plotkin SA.,OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
Clin Vaccine Immunol 2010; 17:1055-65; PMID:20463105; http://dx.doi.org/10.1128/CVI.00131-10 [32] Plotkin SA.,Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Clin Infect Dis 2013; 56:1458-65; PMID:23386629; http://dx.doi.org/10.1093/cid/cit048 [33] Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, Lawler J, McLean HQ, Pollock L, Rausch-Phung E, et al.",OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak.Pediatrics 2012; 130:e1567-74; PMID:23129075; http://dx.doi.org/10.1542/peds.2012-0177 [34] Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P. Rationale for pertussis booster vac-cination throughout life in Eu rope.",Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
Lancet Infect Dis 2011; 11:557-70; PMID:21600850; http://dx.doi.org/10.1016/S1473-3099 (11)70007-XHUMAN VACCINES & IMMUNOTHERAPEUTICS 959,Non-OADS,/arxiv_data1/oa_pdf/fc/16/khvi-12-04-1113357.PMC4962935.pdf
"References 99designs (2014) Retrieved February 20, 2014, from http://www.99designs.comAfuah, A. and Tucci, C. L. (2012) âCrowdsourcing as a Solution for Distant Searchâ, Academy of Management  Review 37(3): 355â75.",Non-OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
"Retrieved from  http://de.slideshare.net/ar1815/digital-malaysia-csp-prospectus-14-may-2014 Djelassi, S. and Decoopman, I.",Non-OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
"Retrieved from http://nrl.northumbria.ac.uk/11191/ Franke, N., Keinz, P. and Klausberger, K. (2013) âDoes This Sound like a Fair Deal?",Non-OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
"Retrieved October 5, 2014, from http://www.npr.org/blogs/alltechconsidered/2013/11/13/244860511/whats-mine-is-yours-for-a-price-in-the-sharing-economy Ho, V. (2013) âDesign Competition Model Is Working for 99designs, Especially in Asiaâ, TechCrunch.",Non-OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
"Retrieved February 21, 2014, from http://techcrunch.com/2013/08/06/design-competition-model-is-working-for-99designs-especially-in-asia/ Howe, J.",Non-OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
Retrieved from http://archive.wired.,Non-OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
"InnoCentive (2014) Retrieved October 5, 2014, from http://www.innocentive.com/about-innocentive/facts- stats Irani, L. and Silberman, M. (2013) âTurkopticon: Interrupting Worker Invisibility in Amazon Mechanical  Turkâ, in Proceedings CHI 2013, Paris, 27 Aprilâ2 May, pp.",Non-OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
"Retrieved from http://proceedings.aom.org/content/2014/1/12957.abstract Latham, G. P. (2007) Work Motivation: History, Theory, Research, and Practice.",Non-OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
"Lifshitz-Assaf, H. (2014) âFrom Problem Solvers to Solution Seekers: Dismantling Knowledge Boundaries at  NASAâ, Retrieved from http://dx.doi.org/10.2139/ssrn.2431717 Linux Foundation (2012) âLinux Kernel Development: How Fast It Is Going, Who Is Doing It, What They  Are Doing, and Who Is Sponsoring Itâ, Report, Linux Foundation, San Francisco.",Non-OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
"(2010) âTom Sawyer Production on the Internet: Getting the Good Stuff in, Keeping the  Bad Stuff Outâ, Retrieved from http://deepblue.lib.umich.edu/handle/2027.42/78183 Marquis, C., Lounsbury, M. and Greenwood, R. (2011) âCommunity as an Institutional Order and a Type of  Organizingâ, Research in the Sociology of Organizations 33: ixâxxvii.",Non-OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
"Mturk (2014) Retrieved February 20, 2014, from https://www.mturk.com/mturk/welcomeNickerson, J.",Non-OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
"Retrieved from http://dx.doi.org/10.2139/ssrn.1876186 Papadimitriou, C. (1994) Computational Complexity.",OADS,/arxiv_data1/oa_pdf/c8/79/10.1177_1350508415585030.PMC4962956.pdf
"4, 1051 â1055 http://dx.doi.org/10.1080/21645515.2015.1108502",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"These outbreaks occurred in Nigeria in 1975, in Niger in 1991, and in Nigeria in 2013 â2014 (http://www.who.int/mediacentre/news/situation-assessments/meningitis-niger/en/).",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Lancet 2007; 369:2196-210; PMID:17604802; http://dx.doi.org/10.1016/S0140-6736(07)61016-2 [2] Urwin R, Maiden MCJ.",OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Trends Microbiol 2003; 11:479-487; PMID:14557031; http://dx.doi.org/10.1016/j.tim.2003.08.006 [3] Turner KME, Feil EJ.",OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
2012; 30Suppl 2:B26-36; PMID:22178525; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Hum Vaccin Immunother 2015; 11(9):2281-6;PMID:26036710; http://dx.doi.org/10.1080/21645515.2015.1051276 [7] Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A, Gray S, Kaczmarski E. Serogroup W135 meningococcal disease inHajj pilgrims.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Clin Infect Dis 2015;60:578-85; PMID:25389259; http://dx.doi.org/10.1093/cid/ciu881 [9] Hong E, Giuliani MM, Deghmane AE, Comanducci M, Brunelli B, Dull P, Pizza M, Taha MK.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Vaccine 2013 Feb 4; 31 (7):1113-6; http://dx.doi.org/10.1016/j.vaccine.2012.12.022 [10] Trotter CL, Gay NJ, Edmunds WJ.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Am J Epidemiol 2005; 162:89-100; PMID:15961591; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Epidemiol Infect 2006; 134:556-66; PMID:16238823; http://dx.doi.org/10.1017/S0950268805005339 [12] Pollard AJ, Frasch C. Development of natural immunity to Neisseria meningitidis .",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
PLoS One 2015 feb6 10(2):e0116725; http://dx.doi.org/10.1371/journal.pone.0116725 [15] MenAfriCar consortium.,Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"J Infect Dis.2015 Oct 15; 212(8):1298-307; http://dx.doi.org/10.1093/infdis/jiv211 [16] Trotter CL, Greenwood BM.",OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Lancet Infect Dis 2007; 7:797-803; PMID:18045562;http://dx.doi.org/10.1016/S1473-3099(07)70288-8 [17] Mueller JE, Gessner BD.",OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Int J InfectDis 2010; 14:e553-559; PMID:20018546; http://dx.doi.org/10.1016/j.ijid.2009.08.013 [18] Maiden MC, Stuart JM: UK meningococcal carriage group.",OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Lancet 2002; 359:1829-31; PMID:12044380; http://dx.doi.org/10.1016/S0140-6736(02)08679-8[19] S /C18afadi MA, Carvalhanas TR, De Lemos AP, Gorla MC, Salgado M, Fukasawa LO, Gon Â¸calves MG, Higa F, Brandileone MC, Sacchi CT, et al.",OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Emerg Infect Dis 2014; 20:806-11; http://dx.doi.org/10.3201/eid2005.130948 [20] Trotter CL, Ramsay ME, Kaczmarski EB.",OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"J Med Microbiol 2002; 51:855-60;PMID:12435065; http://dx.doi.org/10.1099/0022-1317-51-10-855 [22] Gilmore A, Jones G, Barker M, Soltanpoor N, Stuart JM.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Epidemiol Infect 1999; 123:185-92; PMID:10579436; http://dx.doi.org/10.1017/S0950268899002794 [23] Khatami A, Pollard AJ.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Expert Rev Vaccines 2010; 9:285-98; PMID:20218857; http://dx.doi.org/10.1586/erv.10.3 [24] McIntyre PB, O âBrien KL, Greenwood B, van de Beek D. Effect of vac- cines on bacterial meningitis worldwide.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Lancet 2012; 380:1703-11; PMID:23141619; http://dx.doi.org/10.1016/S0140-6736(12)61187-8 [25] Vipond C, Care R, Feavers IM.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Vaccine 2012; 30 (5): Suppl:B10-7; PMID:22607894; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Vaccine 2009; 27 (suppl 2): B20-9; PMID:19477053; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"J Med Microbiol 2002; 51:717-22; PMID:12358061; http://dx.doi.org/10.1099/0022-1317-51-9-717 [28] Borrow R, Abad R, Trotter C, van der Klis FRM, Vazquez JA.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Vac- cine 2013; 4477-86; PMID:23933336; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"JInfect Dis 2008; 197:737-43; PMID:18271745; http://dx.doi.org/10.1086/527401 [31] De Greef SC, de Melker HE, Spanjaard L, Schouls LM, van Derende A.",OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Protection from routine vaccination at the age of 14 months withmeningococcal serogroup C conjugate vaccine in the Netherlands.Pediatr Infect Dis 2006; 25:79-80; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"BMC Infect Dis 2012; 12:35; PMID:22316426; http://dx.doi.org/10.1186/1471-2334-12-35 [33] Larrauri A, Cano R, Garcia M, Mateo S. Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Vaccine 2005; 23:4097-100; PMID:15908059; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Pediatr Infec Dis 2009;28:220-4; http://dx.doi.org/10.1097/INF.0b013e31819040e71054 P. STEFANELLI AND G. REZZA,Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Hum Vaccin Immunother 2015 Aug 26; http://dx.doi.org/ 10.1080/21645515.2015.1078951 [37] de Cantuaria Tauil M, de Carvalho CSR, Vieira AC, Waldman EA.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Braz J Infect Dis 2014; 18:379-86; PMID:24698710; http://dx.doi.org/10.1016/j.bjid.2013.11.012 [38] Ramsay ME, Andrews N, Kaczmarski EB, Miller E. Ef ï¬cacy of meningococcal serogroup C conjugate vaccine in teenagers and tod- dlers in England.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Lancet 2001; 357:195-6; PMID:11213098; http://dx.doi.org/10.1016/S0140-6736(00)03594-7 [39] Ramsay ME, Andrews NJ, Trotter CL, Kaczmarski EB, Miller E. Herd immunity from meningococcal serogroup C conjugate vaccination in England.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Lancet 2004; 364:365-7; PMID:15276396;http://dx.doi.org/10.1016/S0140-6736(04)16725-1 [41] Ibarz-PavRn AB, MacLennan J, Andrews NJ, Gray SJ, Urwin R, Clarke SC, Walker AM, Evans MR, Kroll JS, Neal KR, et al.",OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"J Infect Dis 2011; 204:1046-53; http://dx.doi.org/10.1093/infdis/jir466 [42] Trotter CL, Borrow R, Findlow J, Holland A, Frankland S, A n d r e w sN J ,M i l l e rE .S e r o p r e v a l e n c eo fa n t i b o d i e sa g a i n s tserogroup C meningococci in England in the postvaccination era.",Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Clin Vacc Immunol 2008; 15:1694-8; http://dx.doi.org/ 10.1128/CVI.00279-08[43] Kupferschmidt K. A new vaccine vanquishes meningitis A in Africa.,Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Science 2014; 345:1265; PMID:25214605; http://dx.doi.org/10.1126/science.345.6202.1265 [44] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"2015; 33:1492-8;PMID:25636915; http://dx.doi.org/10.1016/j.vaccine.2015.01.043 [46] Daugla DM, Gami JP, Gamougam K, Naibei N, Mbainadji L, Narb /C19e M, Toralta J, Kodbesse B, Ngadoua C, Coldiron ME, et al.",OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Lancet 2013; 383:40-7; PMID:24035220; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Em Infect Dis 2015; 21:115-8; http://dx.doi.org/10.3201/eid2101.140256 [48] Maurice J.,Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"Lancet 2015; 385:2241; PMID:26088485; http://dx.doi.org/10.1016/ S0140-6736(15)61050-9 [49] Maiden MCJ, MacLennan JM.",OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
Clin Infect Dis 2014; 59:1222-4; PMID:25069870; http://dx.doi.org/ 10.1093/cid/ciu599HUMAN VACCINES & IMMUNOTHERAPEUTICS 1055,Non-OADS,/arxiv_data1/oa_pdf/cd/f2/khvi-12-04-1108502.PMC4962961.pdf
"4, 879 â885 http://dx.doi.org/10.1080/21645515.2015.1130193",Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"2005; 24(6 Suppl):S104-8; PMID:15931137;http://dx.doi.org/10.1097/01.inf.0000166154.47013.47 [2] Halperin SA, Wang EE, Law B, Mills E, Morris R, D /C19ery P, Lebel M, MacDonald N, Jadavji T, Vaudry W, et al.",OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"1999;28:1238-43; PMID:10451159; http://dx.doi.org/ 10.1086/514792 [3] Haberling DL, Holman RC, Paddock CD, Murphy TV.",Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"2009;28:194-8; PMID:19209089; http://dx.doi.org/10.1097/INF.0b013e31818c9032 [4] van Hoek AJ, Campbell H, Amirthalingam G, Andrews N, Miller E. The number of deaths among infants under one year of age in Eng- land with pertussis: results of a capture/recapture analysis for the period 2001 to 2011.",Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
2011;24:190-5; PMID:21415741; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
Hum Vaccin Immun-other 2015;11:1165-72; PMID:25874807; http://dx.doi.org/10.1080/21645515.2015.1019188 [7] Englund JA.,OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"2010;29:209-15; PMID:20009964;http://dx.doi.org/10.1097/INF.0b013e3181bc98d5 [9] Halasa NB, O âShea A, Shi JR, LaFleur BJ, Edwards KM.",OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"2008;153:327-32; PMID:18534242;http://dx.doi.org/10.1016/j.jpeds.2008.03.011 [10] Quinn HE, Snelling TL, Habig A, Chiu C, Spokes PJ, McIntyre PB.",OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"2014;134:713-20; PMID:25225136; http://dx.doi.org/10.1542/peds.2014-1105 [11] Healy CM, Rench MA, Baker CJ.",OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
2011;52:157-62; PMID:21288837; http://dx.doi.org/10.1093/cid/ciq001 [12] Advisory Committee on Immunization Practices.,Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"2015; 60:333-7; PMID:25332078; http://dx.doi.org/10.1093/cid/ciu821 [14] Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller E, Ramsay M. Effectiveness of maternal pertussis vacci- nation in England: an observational study.",Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
2014; 384(9953):1521- 8; PMID:25037990; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"2013;31(Suppl 4):D52-7;PMID:23973347; http://dx.doi.org/10.1016/j.vaccine.2013.02.029 [18] Graham BS, Anderson LJ.",Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"Curr Top Microbiol Immunol.2013;372:391-404; PMID:24362701; http://dx.doi.org/10.1007/978-3- 642-38919-1_20 [19] MacDougall DM, Halperin SA.",Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
Hum Vaccin Immunother.2015 Nov 9 [Epub ahead of print]; PMID:26552807; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"2013;31(37):3972-8; PMID:23777954; http://dx.doi.org/10.1016/j.vaccine.2013.06.015 [21] Chamberlain AT, Seib K, Ault KA, Orenstein WA, Frew PM, Malik F, Cort /C19es M, Cota P, Whitney EA, Flowers LC, et al.",OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"PLoS Curr 2015;7. pii: ecurrents.outbreaks.d37b61bceebae5a7a06- d40a301cfa819; PMID:25789203; http://dx.doi.org/10.1371/currents.outbreaks.d37b61bceebae5a7a06d40a301cfa819 [22] Clark SJ, Adolphe S, Davis MM, Cowan AE, Kretsinger K. Attitudes of US obstetricians toward a combined tetanus-diphtheria-acellular pertussis vaccine for adults.",Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"2006;2006:87040 (1-5); PMID:17485814; http://dx.doi.org/10.1155/IDOG/ 2006/87040 [23] Varan AK, Esteves-Jaramillo A, Richardson V, Esparza-Aguilar M, Cervantes-Powell P, Omer SB.",OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"2014; 32:785-92; PMID:24394441; http://dx.doi.org/10.1016/j.vaccine.2013.12.054 [24] Beel ER, Rench MA, Montesinos DP, Mayes B, Healy CM.",OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
"Hum Vaccin Immunother2013; 9:1926-31; PMID:23782490; http://dx.doi.org/10.4161/hv.25096 [25] Halperin BA, MacDougall D, MacKinnon-Cameron D, Li L, McNeil SA, Langley JM, Halperin SA.",Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
2015; 33:6840-8; PMID:26392011; http://dx.doi.rog/10.1016/j.vaccine.2015.09.012 [26] Statistics Canada.,Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
Available from: http://www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-010-x/99-010-x2011001-eng.cfm#a3.,OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
Avail-able from: http://www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-012- x/2011001/tbl/tbl01-eng.cfm.,Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
2011; 53:885-92; PMID:21946190; http://dx.doi.org/10.1093/cid/cir538HUMAN VACCINES & IMMUNOTHERAPEUTICS 885,Non-OADS,/arxiv_data1/oa_pdf/8a/9a/khvi-12-04-1130193.PMC4962967.pdf
http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/ConductingClinicalTrials/ucm379576.htm .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://www.policymed.com/2014/02/fda-policies-and-procedures-for- proposed-trial-design-aimed-at-multiple-chronic-conditions.html .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.4103/0974-1208.82352 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
Boca Raton: Chapman and Hall/CRC;  2009. http://dx.doi.org/10.1201/9781584888178 8.,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
2012; 13:120. http://dx.doi.org/ 10.1186/1745-6215-13-120 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.2105/AJPH.94.3.416 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.2307/2529712 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
2012; 36(10):1767â 1778. http://dx.doi.org/10.1111/j.1530-0277.2012.01786.x .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1002/ sim.4780122410 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1191/1740774504cn024oa .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1016/ j.cmpb.2006.04.011 .,OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
2005; 5(1):10. http://dx.doi.org/10.1186/1471-2288-5-10 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
2011; 12(1):100. http://dx.doi.org/10.1186/1745-6215-12-100 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1097/NNR.,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1191/1740774505cn073oa .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1191/1740774504cn006rr .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
2015; 15 http://dx.doi.org/10.1186/s12874-015-0012-3 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
2015; 10 http://dx.doi.org/10.1186/ s13012-015-0341-y .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1177/1740774512454243 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
2015; 10(7) http://dx.doi.org/10.1371/journal.pone.0129545 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
2010; 10:15. http://dx.doi.org/10.1186/1471-2288-10-15 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1016/j.jclinepi.2014.12.006 .,OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1177/0962280212436447 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1111/j.1541-0420.2005.00496.x .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.1093/ biomet/25.3-4.285 .,OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
http://dx.doi.org/10.2307/2283724 .,Non-OADS,/arxiv_data1/oa_pdf/22/74/nihms777064.PMC4963011.pdf
"The full terms of this license are available at https:// www.dovepress.com/terms.php  and incorporate the Creative Commons Attribution â Non Commercial (unported, v3.0) License  (http://creativecommons.org/licenses/by-nc/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/fd/04/nihms802517.PMC4963021.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php ).",Non-OADS,/arxiv_data1/oa_pdf/fd/04/nihms802517.PMC4963021.pdf
"Available from: http://apps.who.int/iris/bitstream/ 10665/112736/1/9789240692763_eng.pdf  [Accessed July 13, 2015] 2.",Non-OADS,/arxiv_data1/oa_pdf/fd/04/nihms802517.PMC4963021.pdf
Available from: http://www.pewinternet.org/data-trend/mobile/cell-phone-and- smartphone-ownership-demographics/ 8.,Non-OADS,/arxiv_data1/oa_pdf/fd/04/nihms802517.PMC4963021.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/66/c0/tom146.PMC4963031.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2016.00157 146 TOMOGRAPHY.ORG | VOLUME 2 NUMBER 2 |JUNE 2016,Non-OADS,/arxiv_data1/oa_pdf/66/c0/tom146.PMC4963031.pdf
Supplemental Materials Figure S1: http://dx.doi.org/10.18383/j.tom.2016.00157.sup.01 Figure S2: http://dx.doi.org/10.18383/j.tom.2016.00157.sup.02 Figure S3: http://dx.doi.org/10.18383/j.tom.2016.00157.sup.03 ACKNOWLEDGMENTS This work was supported by United States National Institutes of Health grant R01CA170198.,Non-OADS,/arxiv_data1/oa_pdf/66/c0/tom146.PMC4963031.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 3.0/), which permits unrestricted use, distribu- tion, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"5, 1257 â1264 http://dx.doi.org/10.1080/21645515.2015.1137405",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
2011 Nov 10; 365(19):1760-1; http://dx.doi.org/10.1056/NEJMp1110539 [3] Duclos P. National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening.,Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Vac-cine 2010; 28(Suppl 1):A18-25; PMID:20412991; http://dx.doi.org/ 10.1016/j.vaccine.2010.02.027 [4] Giesecke J.,OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Vaccine 2010; 28 (Suppl 1):A68-75; PMID:20413002; http://dx.doi.org/10.1016/j.vaccine.2010.02.037 [6] Hall AJ.,Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Vaccine 2010; 28(Suppl 1):A54-7; PMID:20412998; http://dx.doi.org/10.1016/j.vaccine.2010.02.034 [7] Nolan TM.,Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Vaccine 2010; 28(Suppl 1):A76-83; PMID:20413003; http://dx.doi.org/10.1016/j.vaccine.2010.02.038 [8] Canadian Agency for Drugs and Technologies in Health (CADTH).,Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Expert Rev Vaccines 2014 Nov; 13(11):1291-6; http://dx.doi.org/10.1586/14760584.2014.939637[10] Weinstein MC, O âBrien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Value Health 2003; 6(1):9-17; PMID:12535234; http://dx.doi.org/10.1046/j.1524- 4733.2003.00234.x [11] Berger ML, Mamdani M, Atikns D, Johnson ML.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"2009; 12(8):1044-52; PMID:19793072; http://dx.doi.org/ 10.1111/j.1524-4733.2009.00600.x [12] Cox E, Martin BC, Van Staa T, Garbe E, Siebert U, Johnson ML.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Value Health 2009; 12(8):1053-61; PMID:19744292; http://dx.doi.org/10.1111/j.1524-4733.2009.00601.x [13] Johnson ML, Crown W, Martin BC, Dormuth CR, Siebert U.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Value Health 2009; 12(8):1062-73; PMID:19793071; http://dx.doi.org/10.1111/j.1524-4733.2009.00602.x [14] Pitman R, Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, Brisson M. Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5.",OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Value Health 2012; 15:828-34; PMID:22999132; http://dx.doi.org/10.1016/j.jval.2012.06.011 [15] Briggs A, Weinstein MC, Fenwick EAL, Karnon J, Sculpher MJ, Pal- tiel D. Model parameter estimation and uncertainty analysis: Areport of the ISPOR-SMDM Modeling Good Research PracticesTask Force Working Group.",OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Value Health 2003; 6(4):407-16; PMID:12859580; http://dx.doi.org/10.1046/ j.1524-4733.2003.64245.x [17] Drumond M, Barbieri M, Cook J, Glick H, Lis J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J. Transferability of economic evalua- tions across jurisdictions: ISPOR good research practices task forcereport.",OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Value Health 2009; 12(4):409-18; PMID:19900249; http://dx.doi.org/10.1111/j.1524-4733.2008.00489.x [18] Hay JW, Smeeding J, Carroll NV, Drummond M, Garrision L, Man- sely EC, Mullins CD, Mycka JM, Seal B, Shi L. Good research practi-ces for measuring drug costs in cost effectiveness analyses: issues andrecommendations: The ISPOR drug cost task force report âPart I.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Value Health 2010; 13(1):3-7; PMID:19874571; http://dx.doi.org/ 10.1111/j.1524-4733.2009.00663.x [19] Garrison L, Mansley EC, A bbot TA, Bresnahan B, Hay JW, Smeeding J.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Value in Health 2010; 13(1):8-13vvhe_663 3..7; PMID:19883405; http://dx.doi.org/10.1111/j.1524-4733.2009.00660.x [20] University of Connecticut guide to using the Likert scale.,Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Available at: http://www.who.int/choice/costs/CER_thresholds/en/.,Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Available at: http://data.worldbank.org/indicator/NY.GDP.PCAP.CD.,OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Vaccine 2010; 28:A58-63; PMID:20412999; http://dx.doi.org/ 10.1016/j.vaccine.2010.02.035 [25] De Wals P, Erickson L. Economic analysis of the 1992 â1993 mass immunization campaign against serogroup C meningococcal diseasein Quebec.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Vaccine 2004; 22(9):1233-40; PMID: 15003652; http://dx.doi.org/10.1016/j.vaccine.2003.09.022 [27] Krahn MD, John-Baptiste A, Yi Q, Doria A, Remis RS, Ritvo P, Friedman S. Potential cost-effectiveness of a preventive hepatitis Cvaccine in high risk and average risk populations in Canada.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Vaccine 2005; 23(13):1549-58; PMID:15694507; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Vaccine 2007; 25(51):8536-48; PMID:17996339; http://dx.doi.org/10.1016/j.vaccine.2007.10.001 [29] Brisson M, Van de Velde N, De Wals P, Boily MC.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Vaccine 2007; 25(29):5399-408; PMID:17561316; http://dx.doi.org/10.1016/j.vaccine.2007.04.086 [30] De Wals P, Coudeville L, Trottier P, Chevat C, Erickson LJ.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Vaccine 2007; 25(29):5433-40;PMID:17560695; http://dx.doi.org/10.1016/j.vaccine.2007.04.071 [31] Brisson M, Pellissier JM, Camden S, Quach C, De Wals P. The poten- tial cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Human Vaccines 2008; 4(3):238-45;PMID:18382137; http://dx.doi.org/10.4161/hv.4.3.5686 [32] Debicki D, Ferko N, Demarteau N, Gallivan S, Bauch C, Anonychuk A, Annemans L. Comparison of detailed and succinct cohort model-ling approaches in a multi-regional evaluation of cervical cancer vac-cination.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Vaccine 2008; 26:F16-28; PMID:18992379; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Pharmacoeconomics 2009; 27(12):991-1004; PMID:19908924; http://dx.doi.org/ 10.2165/11314010-000000000-00000 [34] Anonychuk AM, Bauch CT, Merid MF, Van Kriekinge G, Demarteau N. A cost-utility analysis of cervical cancer vaccination in preadoles- cent Canadian females.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"BMC Public Health 2009; 9(1):401; PMID:19878578; http://dx.doi.org/10.1186/1471-2458-9-401 [35] Poirier B, De Wals P, Petit G, Erickson LJ, & P /C19epin J. Cost-effective- ness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Vaccine 2009; 27(50):7105-09; PMID:19786137; http://dx.doi.org/10.1016/j.vaccine.2009.09.057 [36] Sander B, Bauch CT, Fisman D, Fowler RA, Kwong JC, Maetzel A, Krahn M. Is a mass immunization program for pandemic (H1N1) 2009 good value for money?",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Vaccine 2010; 28(38):6210-20; PMID:20643091; http://dx.doi.org/10.1016/j.vaccine.2010.07.010 [37] Sander B, Kwong JC, Bauch CT, Maetzel A, McGeer A, Raboud JM, Krahn M. Economic appraisal of Ontario âs Universal In ï¬u- enza Immunization Program: a cost-utility analysis.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"PLoS Med2010; 7(4):e1000256; PMID:20386727; http://dx.doi.org/10.1371/ journal.pmed.1000256[38] Chuck AW, Jacobs P, Tyrrell G, Kellner JD.",OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Pharmacoeconomic evaluation of 10-and 13-valent pneumococcal conjugate vaccines.Vaccine 2010; 28(33):5485-90; PMID:20554066; http://dx.doi.org/10.1016/j.vaccine.2010.05.058 [39] Wong WW, Woo G, Jenny Heathcote E, Krahn M. Cost effective- ness of screening immigrants for hepatitis B. Liver Int 2011; 31(8):1179-90; PMID:21745300; http://dx.doi.org/10.1111/j.1478- 3231.2011.02559.x [40] Tully SP, Anonychuk AM, Sanchez DM, Galvani AP, Bauch CT. Time for change?",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Vaccine 2012; 30(2):425-35; PMID:22075091; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"BMCPublic Health 2012; 12(1):872; PMID:23061913; http://dx.doi.org/10.1186/1471-2458-12-872 [45] Fisman DN, Chan CH, Lowcock E, Naus M, Lee V. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Colum-bia: A model-based evaluation.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Vaccine 2012; 30(52):7601-7; PMID:23107595; http://dx.doi.org/10.1016/j.vaccine.2012.10.034 [46] Coyle D, Coyle K, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW, Le Saux N. Cost effectiveness of infant vaccination for rotavirusin Canada.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"Am J Infect Control 2002; 30(3):145-52; PMID:11988708; http://dx.doi.org/10.1067/mic.2002.121099 [49] Weinstein MC, Torrance G, McGuire A. QALYs: The Basics.",Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Value Health 2009; 12(1):S5-9; PMID:19250132; http://dx.doi.org/10.1111/ j.1524-4733.2009.00515.x [50] National Advisory Committee on Immunization.,Non-OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
Curr Oncol Reports2001; 3(5):410-13; PMID:11489241; http://dx.doi.org/10.1007/s11912- 001-0027-21264 A. CHIT ET AL.,OADS,/arxiv_data1/oa_pdf/1c/18/khvi-12-05-1137405.PMC4963050.pdf
"5, 1235 â1243 http://dx.doi.org/10.1080/21645515.2015.1136041",Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
"Global illness and deaths caused by rotavirus disease in children.Emerg Infect Dis 2003; 9:565-72; PMID:12737740; http://dx.doi.org/10.3201/eid0905.020562 [2] Cortese MM, Parashar UD.",Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
"Hum Vaccin Immunother 2014; 10:2255-66; PMID:25424930; http://dx.doi.org/10.4161/hv.29511 [4] Krishnarajah G, Davis EJ, Fan Y, Standaert BA, Buikema AR.",Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
"Vaccine 2012;30:3717-22; PMID:22214886; http://dx.doi.org/10.1016/j.vaccine.2011.12.077 [5] Panozzo CA, Becker-Dreps S, Pate V, Jonsson Funk M, St â¬urmer T, Weber DJ, Brookhart MA.",OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
Plos One 2013; 8: e73825; PMID:24066076; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
Vaccine 2015; 33:479-86; PMID:24962753; http://dx.doi.org/ 10.1016/j.vaccine.2014.06.059 [7] The Henry J. Kaiser Family Foundation [Internet].,Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
Available from: http://kff.org/other/state-indicator/total-population/) [8] The Henry J. Kaiser Family Foundation [Internet].,Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
Availablefrom: http://kff.org/health-reform/issue-brief/medicaid-moving-for ward/ [9] Medicaid Keeping America Healthy [Internet].,Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
Available from: http://www.medicaid.,Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
Available from:https://www.kmap-state-ks.us/Documents/Content/Provider%20Manuals/Professional_04062010_10021.pdf [11] The Henry J. Kaiser Family Foundation [Internet].,Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
Available from: http://kff.org/health-reform/issue-brief/childrens- health-coverage-medicaid-chip-and-the-aca/ [12] The Henry J. Kaiser Family Foundation [Internet].,Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
"Available from: http://kff.org/medicaid/issue-brief/medicaid-per-enrollee-spending-variation-across-states/ [13] Desai SN, Esposito DB, Shapiro ED, Dennehy PH, Vazquez M. Effec- tiveness of rotavirus vaccine in preventing hospitalization due to1242 M. CALNAN ET AL.",Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
Impact of the introduction of rotavirus vaccine on the timeliness of other sched- uled vaccines: the Australian experience.Vaccine 2013; 31:1964-9; PMID:23422140; http://dx.doi.org/10.1016/j.vaccine.2013.02.007 [18] Greenland S. Model-based estimation of relative risks and other epi- demiological measured in studies of common outcomes and in case- control studies.,Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
Am J Epidemiol 2004; 160:301-5; PMID:15286014;http://dx.doi.org/10.1093/aje/kwh221 [19] Zou G. A modi ï¬ed Poisson regression approach to prospective stud- ies with binary data.,OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
Am J Epidemiol 2004; 159:702-6; PMID:15033648; http://dx.doi.org/10.1093/aje/kwh090HUMAN VACCINES & IMMUNOTHERAPEUTICS 1243,Non-OADS,/arxiv_data1/oa_pdf/d9/ea/khvi-12-05-1136041.PMC4963051.pdf
"5, 1202 â1216 http://dx.doi.org/10.1080/21645515.2015.1131369",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
Annu Rev Med 2006; 57:139-54; PMID:16409141; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Eur J Pediatr 2014; 173:265-76; PMID:23661234; http://dx.doi.org/10.1007/s00431-013-2023-6 [5] Ashkenazi S, Vertruyen A, Ar /C19Ä±stegui J, Esposito S, McKeith DD, Klemola T, Biolek J, K â¬uhr J, Bujnowski T, Desgrandchamps D, et al.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Pediatr Infect Dis J 2006; 25:870-9; PMID:17006279; http://dx.doi.org/10.1097/01.inf.0000237829.66310.85 [6] Baguelin M, Van Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine 2010; 28:2370-84; PMID:20096762; http://dx.doi.org/10.1016/j.vaccine.2010.01.002 [7] Ambrose CS, Wu X, Knuf M, Wutzler P. The ef ï¬cacy of intrana- sal live attenuated in ï¬uenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
Vaccine 2012; 30:886-92; PMID:22155144; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vac cine 2011; 29:7554-8; PMID:21820477; http://dx.doi.org/10.1016/j.vaccine.2011.08.015 [9] Pitman RJ, Nagy LD, Sculpher MJ.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine 2013; 31:927-42; PMID:23246550; http://dx.doi.org/10.1016/j.vaccine.2012.12.010 [10] Zhou F, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A, Moore M, Murphy T V, Cortese M, Rodewald L. Economic evalua- tion of the routine childhood immunization program in the United States, 2009.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Pediatrics 2014; 133:577-85; PMID:24590750; http://dx.doi.org/10.1542/peds.2013-0698 [11] Luce BR, Zangwill KM, Palmer CS, Mendelman PM, Yan L, Wolff MC, Cho I, Marcy SM, Iacuzio D, Belshe RB.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Pediatrics 2001; 108:E24; PMID:11483834; http://dx.doi.org/10.1542/peds.108.2.e24 [12] Marchetti M, K â¬uhnel UM, Colombo GL, Esposito S, Principi N. Cost-effectiveness of adjuvanted in ï¬uenza vaccination of healthy children 6 to 60 months of age.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Hum Vaccin 2007; 3:14-22; PMID:17245134; http://dx.doi.org/10.4161/hv.3.1.3657 [13] Hibbert CL, Piedra PA, McLaurin KK, Vesikari T, Mauskopf J, Mahadevia PJ.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Clin Infect Dis 2001; 33:1879-85; PMID:11692300; http://dx.doi.org/ 10.1086/324491 [15] Prosser LA, Lavelle TA, Fiore AE, Bridges CB, Reed C, Jain S, Dun- ham KM, Meltzer MI.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Arch Pediatr Adolesc Med 2011; 165:112-8; PMID:20921341; http://dx.doi.org/10.1001/archpediat-rics.2010.182 [17] Lugner AK, van Boven M, de Vries R, Postma MJ, Wallinga J.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Emerg Infect Dis 2003; 9:37-48; PMID:12533280; http://dx.doi.org/10.3201/eid0901.020168 [19] Jit M, Choi YH, Edmunds WJ.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Value Heal 2008; in press 11 (7):1022-32; http://dx.doi.org/10.1111/j.1524-4733.2008.00342.x [21] Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
J Natl Cancer Inst 2008; 100:308-20; PMID:18314477; http://dx.doi.org/10.1093/jnci/djn019 [22] Chesson HW.,Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Emerg Infect Dis 2008; 14:244-51; PMID:18258117; http://dx.doi.org/10.3201/eid1402.070499 [23] Bergeron C, Largeron N, McAllister R, Mathevet P, Remy V. Cost-effectiveness analysis of the introduction of a quadrivalenthuman papillomavirus vaccine in France.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Int J Technol Assess Health Care 2008; 24:10-9; PMID:18218164; http://dx.doi.org/ 10.1017/S0266462307080026 [24] Mennini FS, Giorgi Rossi P, Palazzo F, Largeron N. Health and eco- nomic impact associated with a quadrivalent HPV vaccine in Italy.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Gynecol Oncol 2009; 112:370-6; PMID:19041125; http://dx.doi.org/10.1016/j.ygyno.2008.09.031 [25] Hillemanns P, Petry KU, Largeron N, McAllister R, Tolley K, B â¬usch K. Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"J Public Health (Bangkok) 2009; 17:77-86; http://dx.doi.org/10.1007/s10389-008-0228-3 [26] Diaz M, De Sanjose S, Ortendahl J, O âShea M, Goldie SJ, Bosch FX, Kim JJ.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Eur J Cancer 2010; 46:2973-85; PMID:20638840;http://dx.doi.org/10.1016/j.ejca.2010.06.016 [27] Jit M, Chapman R, Hughes O, Choi YH.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine 2008; 26:706-15; PMID:18166250;http://dx.doi.org/10.1016/j.vaccine.2007.11.064 [29] Jit M, Bilcke J, Mangen M-JJ, Salo H, Melliez H, Edmunds WJ, Yaz- dan Y, Beutels P. The cost-effectiveness of rotavirus vaccination:Comparative analyses for ï¬ve European countries and transferability in Europe.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
Vaccine 2009; 27:6121-8; PMID:19715781; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
Vaccine 2009; 27:3904-11; PMID:19446934; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine 2009; 27:3450-3;PMID:19200850; http://dx.doi.org/10.1016/j.vaccine.2009.01.054 [32] Martin A, Batty A, Roberts JA, Standaert B.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
Vaccine 2009; 27:4520-8; PMID:19446594; http://dx.doi.org/10.1016/j.vaccine.2009.05.0061214 E. GIBSON ET AL.,Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine 2009; 27:4025-30;PMID:19389452; http://dx.doi.org/10.1016/j.vaccine.2009.04.030 [34] Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine 2012; 30:6766-76; PMID:23000223; http://dx.doi.org/10.1016/j.vaccine.2012.09.025 [35] Knoll S, Mair C, Benter U, Vouk K, Standaert B.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?Health Econ Rev 2013; 3:27; PMID:24246029; http://dx.doi.org/10.1186/2191-1991-3-27 [36] Imaz I, Rubio B, Cornejo AM, Gonz /C19alez-Enr /C19Ä±quez J.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Prev Med (Baltim) 2014; 61:116-21; http://dx.doi.org/10.1016/j.ypmed.2013.12.013 [37] Aidelsburger P, Grabein K, B â¬ohm K, Dietl M, Wasem J, Koch J, Ultsch B, Weidemann F, Wichmann O.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
Vaccine 2014; 32:1964-74;PMID:24561052; http://dx.doi.org/10.1016/j.vaccine.2014.01.061 [38] Szucs T. Cost-effectiveness of hepatitis A and B vaccination pro- gramme in Germany.,Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine 2000; 18:S86-9; PMID:10683559;http://dx.doi.org/10.1016/S0264-410X(99)00474-0 [39] Siddiqui MR, Gay N, Edmunds WJ, Ramsay M. Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine2011; 29:466-75; PMID:21073988; http://dx.doi.org/10.1016/j.vaccine.2010.10.075 [40] Boccalini S, Taddei C, Ceccherini V, Bechini A, Levi M, Bartolozzi D, Bonanni P. Economic analysis of the ï¬rst 20 y of universal hepatitis B vaccination program in Italy: An a posteriori evaluation and forecastof future bene ï¬ts.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Hum Vaccines Immunother 2013; 9:1119-28; http://dx.doi.org/10.4161/hv.23827 [41] Trotter CL, Edmunds WJ.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"BMJ 2002; 324:809; PMID:11934772; http://dx.doi.org/ 10.1136/bmj.324.7341.809 [42] Ortega-Sanchez IR, Lee GM, Jacobs RJ, Prosser LA, Molinari N-A, Zhang X, Baine WB, McCauley MM, Miller T. Projected cost-effec- tiveness of new vaccines for adolescents in the United States.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Pediat- rics 2008; 121 Suppl:S63-78; PMID:18174323; http://dx.doi.org/10.1542/peds.2007-1115H [43] Christensen H, Trotter CL, Hickman M, Edmunds WJ.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
Vac-cine 2013; 31:2638-46; PMID:23566946; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Pharmacoeconomics 2003; 21:587-600; PMID:12751916; http://dx.doi.org/10.2165/00019053-200321080- 00005 [46] Melegaro A, Edmunds WJ.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
Vaccine 2004; 22:4203-14; PMID:15474710; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"PediatrInfect Dis J 2006; 25:494-501; PMID:16732146; http://dx.doi.org/10.1097/01.inf.0000222403.42974.8b [48] Lieu T a, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF, Miller MA, Shine ï¬eld HR.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"JAMA 2000; 283:1460-8; PMID:10732936; http://dx.doi.org/10.1001/jama.283.11.1460 [49] Lloyd A, Patel N, Scott DA, Runge C, Claes C, Rose M. Cost-effec- tiveness of heptavalent conjugate pneumococcal vaccine (Prevenar)in Germany: Considering a high-risk population and herd immunityeffects.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Eur J Heal Econ 2008; 9:7-15; http://dx.doi.org/10.1007/ s10198-006-0013-6 [50] Ray GT, Pelton SI, Klugman KP, Strutton DR, Moore MR. Cost- effectiveness of pneumococcal conjugate vaccine: An update after 7 years of use in the United States.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine 2009; 27:6483-94; PMID:19720366; http://dx.doi.org/10.1016/j.vaccine.2009.08.045 [51] Giorgi-Rossi P, Merito M, Borgia P. Cost-effectiveness of introducing the conjugated pn eumococcal vaccine to routine free immunizations for infants in Lazio, Italy.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Health Policy(New York) 2009; 89:225-38; http://dx.doi.org/10.1016/j.healthpol.2008.05.016 [52] Claes C, Reinert RR, Von Der Schulenburg JMG.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Eur J Heal Econ 2009; 10:25-38;http://dx.doi.org/10.1007/s10198-008-0098-1 [53] D /C19Ä±ez-Domingo J, Ridao-L /C19opez M, Guti /C19errez-Gimeno MV, Puig-Bar- ber/C19a J, Lluch-Rodrigo JA, Pastor-Villalba E. Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination pro-gramme in the Valencian public health system (Spain).",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine 2011; 29:9640-8; http://dx.doi.org/10.1016/j.vaccine.2011.10.038 [54] Thiry N, Beutels P, Tancredi F, RomanR L, Zanetti A, Bonanni P, Gabutti G, Van Damme P. An economic evalua- tion of varicella vaccination in Italian adolescents.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine 2006; 24:6980-9; PMID:16860909; http://dx.doi.org/10.1016/j.vaccine.2006.04.051 [56] Coudeville L, Brunot A, Szucs TD, Dervaux B.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Value Heal2005; 8:209-22; http://dx.doi.org/10.1111/j.1524-4733.2005.04005.x [57] Zhou F, Ortega-Sanchez IR, Guris D, Shefer A, Lieu T, Seward JF.",OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"J Infect Dis 2008; 197 Suppl:S156-64;PMID:18419391; http://dx.doi.org/10.1086/522135 [58] Drummond MF, Jefferson TO.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
Lancet Infect Dis 2008 [cited 2015 Sep 15]; 8:727-33; PMID:18992409; http://dx.doi.org/10.1016/S1473-3099(08) 70258-5 [62] Hope-Simpson RE.,OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"J Hyg (Lond) 1981 [cited 2015 Sep 15]; 86:35-47; PMID: 7462597; http://dx.doi.org/10.1017/S0022172400068728 [63] Bin-Chia Wu D, Chaiyakunapruk N, Chong H-Y, Beutels P. Choos- ing between 7-, 10- and 13-valent pneumococcal conjugate vaccinesin childhood: A review of economic evaluations (2006-2014).",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"Vaccine 2011; 29:9521-8; PMID:22008820; http://dx.doi.org/ 10.1016/j.vaccine.2011.10.013 [65] Pitman RJ, Melegaro A, Gelb D, Siddiqui MR, Gay NJ, Edmunds WJ.",Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
Medicine Academia and Clinic The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies ThatEvaluate Health Care Interven tions: Ann Intern Med 2009; 151: W65-94; PMID:19622512; http://dx.doi.org/10.7326/0003-4819- 151-4-200908180-00136[67] MEPS.,Non-OADS,/arxiv_data1/oa_pdf/9e/8f/khvi-12-05-1131369.PMC4963059.pdf
"5, 1102 â1116 http://dx.doi.org/10.1080/21645515.2015.1122146",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Virol 2013; 87:2686-92; PMID:23255805; http://dx.doi.org/10.1128/JVI.02146-12 [2] Billeter MA, Naim HY, Udem SA.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Proc Soc Exp Biol Med 1954; 86:277-86; PMID:13177653; http://dx.doi.org/10.3181/00379727-86-21073 [4] Enders JF, Katz SL, Milovanovic MV, Holloway A.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"N Engl JMed 1960; 263:153-9; PMID:13820246; http://dx.doi.org/10.1056/ NEJM196007282630401 [5] Bankamp B, Takeda M, Zhang Y, Xu W, Rota PA. Genetic charac- terization of measles vaccine strains.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Infect Dis 2011; 204 (Suppl1):S533-48; PMID:21666210; http://dx.doi.org/10.1093/infdis/jir097 [6] Erlenh â¬ofer C, Duprex WP, Rima BK, ter Meulen V, Schneider- Schaulies J.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
J Gen Virol 2002; 83:1431-6; PMID:12029158; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Virology 2002; 299:155-61;PMID:12202217; http://dx.doi.org/10.1006/viro.2002.1471 [8] Zuniga A, Wang Z, Liniger M, Hangartner L, Caballero M, Pavlovic J, Wild P, Viret JF, Glueck R, Billeter MA, et al.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Vaccine 2007; 25:2974-83;PMID:17303293; http://dx.doi.org/10.1016/j.vaccine.2007.01.064 [9] Ikic D, Juzbasic M, Beck M, Hrabar A, Cimbur-Schreiber T. Atten- uation and characterisation of Edmonston-Zagreb measles virus.Ann Immunol Hung 1972; 16:175-81; PMID:4679646 [10] Ikic D. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Rev Infect Dis 1983; 5:558-63; PMID:6879014; http://dx.doi.org/10.1093/clinids/5.3.558 [11] Beck M, Smerdel S, Dedic I, Delimar N, Rajninger-Miholic M, Juz- basic M, Manhalter T, Vlatkovic R, Borcic B, Mihajic Z.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Vaccine 2012; 30:5991-98; PMID:22732429; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Virus Genes 1993; 7:67-81;PMID:8470368; http://dx.doi.org/10.1007/BF01702349 [14] Mirchamsy H, Shafyi A, Bahrami S, Kamali M, Nazari P. Use of human diploid cell MRC-5 for production of measles and rubellavirus vaccines.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Rev Infect Dis 1983; 5:504-5;PMID:6410489; http://dx.doi.org/10.1093/clinids/5.3.504 [16] Zuniga A, Liniger M, Morin TN, Marty RR, Wiegand M, Ilter O, Weibel S, Billeter MA, Knuchel MC, Naim HY.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Hum Vaccin Immunother 2013; 9:607-13;PMID:23324616; http://dx.doi.org/10.4161/hv.23242 [17] WHO position on measles vaccines.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Vaccine 2009; 27:7219-21; PMID:19833246; http://dx.doi.org/10.1016/j.vaccine.2009.09.116 [18] Brandler S, Tangy F. Recombinant vector derived from live attenu- ated measles virus: potential for ï¬avivirus vaccines.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"NaunynSchmiedebergs Arch Pharmacol 2012; 385:1211-25; PMID:22983013; http://dx.doi.org/10.1007/s00210-012-0793-4 [21] Msaouel P, Dispenzieri A, Galanis E. Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an over- view.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Trends Microbiol 2012; 20:429-39; PMID:22721863;http://dx.doi.org/10.1016/j.tim.2012.05.006 [24] Msaouel P, Opyrchal M, Domingo ME, Galanis E. Oncolytic mea- sles virus strains as novel anticancer agents.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Expert Opin Biol Ther2013; 13:483-502; PMID:23289598; http://dx.doi.org/10.1517/ 14712598.2013.749851 [25] U.S. National Institutes of Health.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Lancet Infect Dis 2015; 15:519-527; PMID:25739878; http://dx.doi.org/ 10.1016/S1473-3099(15)70043-5 [27] Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Cancer Res 2010; 70:875-82;PMID:20103634; http://dx.doi.org/10.1158/0008-5472.CAN-09- 2762 [28] Galanis E, Atherton PJ, Maurer MJ, Knutson KL, Dowdy SC, Cliby WA, Haluska PJ Jr, Long HJ, Oberg A, Aderca I, et al.Oncolytic measles virus express ing the sodium iodide symporter to treat drug-resistant ovarian cancer.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Cancer Res 2015; 75:22-30; PMID:25398436; http://dx.doi.org/10.1158/0008-5472.CAN-14-2533 [29] Russell SJ, Federspiel MJ, Peng KW, Tong C, Dingli D, Morice WG, Lowe V, O âConnor MK, Kyle RA, Leung N, et al.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Mayo Clin Proc 2014; 89:926-33; PMID:24835528; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Curr Gene Ther2013; 13:385-94; PMID:24195604; http://dx.doi.org/10.2174/15665232113136660005 [34] Grif ï¬n D. Measles Virus.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Gen Virol 2006; 87:2767-79; PMID:16963735; http://dx.doi.org/10.1099/vir.0.82221-0 [36] de Vries RD, Mesman AW, Geijtenbeek TB, Duprex WP, de Swart RL.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Curr Opin Virol 2012; 2:248-55; PMID:22483507; http://dx.doi.org/10.1016/j.coviro.2012.03.005 [37] de Witte L, de Vries RD, van der Vlist M, Y â¬uksel S, Litjens M, de Swart RL, Geitenbeek TB.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"PLoS Pathog 2008; 4(4):e1000049; PMID:18421379; http://dx.doi.org/10.1371/journal.ppat.1000049 [38] Bloch AB, Orenstein WA, Ewing WM, Spain WH, Mallison GF, Herrmann KL, Hinman AR.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Front Biosci 2008; 13:1352-70; PMID:17981635; http://dx.doi.org/10.2741/2767 [41] Public Health Agency of Canada [Internet].,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Availablefrom: http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/measles-rou geole-eng.php [42] Atkinson W, Wolfe S, Hamborsky J, McIntyre L. Epidemiology and prevention of vaccine-preventable diseases.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
[online] Available from: http://www.who.int/csr/resources/publications/biosafety/Biosafety7.pdf?ua=1 Access date 26-01-2016.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Available from: http://www.biosafety.be/ RA/Class/ClassBELdef.html [45] Directive 2000/54/EC of the European Parliament and of the Coun- cil of 18 September 2000 on the protection of workers from risksrelated to exposure to biological agents at work.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Cancer Res 2004; 64:4919-26; PMID:15256464; http://dx.doi.org/10.1158/0008-5472.CAN-04-0884 [48] de Vries RD, Lemon K, Ludlow M, McQuaid S, Y â¬uksel S, van Amerongen G, Rennick LJ, Rima BK, Osterhaus AD, de SwartRL, et al.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Virol 2010; 84:4714-24; PMID:20181691; http://dx.doi.org/10.1128/ JVI.02633-09 [49] Schnorr J, Dunster L, Nanan J, Schneider-Schaulies J, Schneider Schaulies S, ter Meulen V. Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement- mediated lysis of infected cells.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Eur J Immunol 1995; 25:976-984;PMID:7737301; http://dx.doi.org/10.1002/eji.1830250418 [50] Noyce RS, Bondre DG, Ha MN, Lin L-T, Sisson G, Tsao M-S, Richardson CD.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"PloS Pathog 2011; 7:e1002240;PMID:21901103; http://dx.doi.org/10.1371/journal.ppat.1002240 [51] Radecke F, Spielhofer P, Schneider H, Kaelin K, Huber M, D â¬otsch C, Christiansen G, Billeter MA.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Vaccine 2007; 25:2974-83;PMID:17303293; http://dx.doi.org/10.1016/j.vaccine.2007.01.064 [53] U.S. National Institutes of Health.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT00408590 [54] U.S. National Institutes of Health.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT02068794 [55] U.S. National Institutes of Health.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT00390299 [56] U.S. National Institutes of Health.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT00450814 [57] U.S. National Institutes of Health.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT02192775 [58] U.S. National Institutes of Health.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01503177 [59] U.S. National Institutes of Health.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Available from: https://clinicaltrials.gov/ct2/show/NCT01846091 [60] Guillerme JB, Gregoire M, Tangy F, Fonteneau JF.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Biology 2013; 2:587- 602; PMID:24832799; http://dx.doi.org/10.3390/biology2020587 [61] van den Akker E, van der Vlugt CJ, Bleijs DA, Bergmans HE.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Curr Gene Ther 2013; 13:395-412; PMID:24397527; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Vac- cine 2009; 27:3299-305; PMID:19200842; http://dx.doi.org/10.1016/ j.vaccine.2009.01.057 [63] Despres P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F. Live measles vaccine expressing the secreted form of the West Nilevirus envelope glycoprotein protects against West Nile virus encephalitis.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Infect Dis 2012; 206:212-9; PMID:22551814; http://dx.doi.org/10.1093/infdis/jis328 [65] Yoneda M, Georges-Courbot MC, Ikeda F, Ishii M, Nagata N, Jac- quot F, Raoul H, Sato H, Kai C. Recombinant measles virus vaccineexpressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"PLoS One 2013; 8:e58414; PMID:23516477; http://dx.doi.org/10.1371/journal.pone.0058414 [66] Brandler S, Ruf ï¬e C, Najburg V, Frenkiel M-P, Bedouelle H, Despr /C18es P, Tangy F. Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Vaccine 2010; 28:6730-9; PMID:20688034; http://dx.doi.org/10.1016/j.vaccine.2010.07.073 [67] del Valle JR, Devaux P, Hodge G, Wegner NJ, McChesney MB, Cat- taneo R. A vectored measles virus induces hepatitis B surface anti-gen antibodies while protecting macaques against measles viruschallenge.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Vaccine 2014; 32:4529-36; PMID:24951869; http://dx.doi.org/10.1016/j.vaccine.2014.06.024 [69] Cantarella G, Liniger M, Zuniga A, Schiller JT, Billeter M, Naim HY, Glueck R. Recombinant measles virus-HPV vaccine candidates1114 A. BALDO ET AL.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Vaccine 2009; 27:3385-90; PMID:19200837; http://dx.doi.org/10.1016/j.vaccine.2009.01.061 [70] Grif ï¬n DE, Pan CH.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Pediatr 1994; 124:273-6; PMID:8301437; http://dx.doi.org/10.1016/S0022- 3476(94)70318-3 [74] Moss WJ, Clements CJ, Halsey NA.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Ann Intern Med 1998; 192:104-106; PMID:NOT_FOUND; http://dx.doi.org/10.7326/ 0003-4819-129-2-199807150-00007 [76] Aaby P, Knudsen K, Whittle H, Lisse IM, Thaarup J, Poulsen A, Sodemann M, Jakobsen M, Brink K, Gansted U, et al.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Pediatr 1993; 122:904-908; PMID:8501567;http://dx.doi.org/10.1016/S0022-3476(09)90015-4 [77] Aaby P, Samb B, Simondon F, Knudsen K, Seck AM, Bennett J, Markowitz L, Rhodes P, Whittle H. Sex speci ï¬c mortality after high titre measles vaccines in rural Senegal.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Pediatr Infect Dis J 1993; 12:462-465;PMID:8345977; http://dx.doi.org/10.1097/00006454-199306000-00002 [79] National Institute of Health (NIH).,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Infect Dis 1996; 173:1320-1326; PMID:8648203; http://dx.doi.org/10.1093/infdis/173.6.1320 [81] Aaby P, Jensen H, Simondon F, Whittle H. High-titer measles vaccina- tion before 9 months of age and increased female mortality: do wehave an explanation?",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Semin Pediat Infect Dis 2003; 14:220-232; PMID:NOT_FOUND; http://dx.doi.org/10.1016/S1045-1870(03) 00037-2 [82] Katz SL.,OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Arch Gesamte Virusforsch 1965; 16, 222-30; PMID:14322868; http://dx.doi.org/10.1007/BF01253813 [83] Brandler S, Ruf ï¬/C19e C, Combredet C, Brault J-B, Najburg V, Prevost M-C, Habel A, Tauber E, Despr /C18es P, Tangy F. A recombinant mea- sles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikun- gunya virus.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Vaccine 2013; 31:3718-25; PMID:23742993; http://dx.doi.org/10.1016/j.vaccine.2013.05.086 [84] Stebbings R, F /C19evrier M, Li B, Lorin C, Koutsoukos M, Mee E, Rose N, Hall J, Page M, Almond N, Voss G, Tangy F. Immunogenicity ofa recombinant measles-HIV-1 clade B candidate vaccine.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"PLoS One2012; 7(11):e50397; PMID:23226275; http://dx.doi.org/10.1371/ journal.pone.0050397 [85] Stebbings R, Li B, Lorin C, Koutsoukos M, F /C19evrier M, Mee ET, Page M, Almond N, Tangy F, Voss G. Immunogenicity of a recombinantmeasles HIV-1 subtype C vaccine.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Vaccine 2013; 31:6079-86; PMID:24161574; http://dx.doi.org/10.1016/j.vaccine.2013.09.072 [86] Guerbois M, Moris A, Combredet C, Najburg V, Ruf ï¬/C19eC ,F /C19evrier M. Live attenuated measles vaccine expressing HIV-1 Gag virus likeparticles covered with gp160 DV1V2 is strongly immunogenic.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Virology 2009; 388:191-203; PMID:19345390; http://dx.doi.org/10.1016/j.virol.2009.02.047 [87] Ovsyannikova IG, Dhiman N, Jacobson RM, Vierkant RA, Poland GA.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Trends Microbiol 1994; 2:294-8; PMID:7981973; http://dx.doi.org/10.1016/0966-842X(94)90007-8 [90] U.S. National Institutes of Health.,OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Clini- calTrials.gov Identi ï¬er, NCT00434512; 2007 Fev 12 [updated 2011 Oct 27; cited 2016 Jan 26] Available from: http://clinical-trials.gov/ct2/s how/NCT00434512 [91] Akahata W, Yang ZY, Andersen H, Sun S, Holdaway HA, Kong WP, Lewis MG, Higgs S, Rossmann MG, Rao S, et al.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Nat Med 2010; 16:334-338; PMID:20111039; http://dx.doi.org/10.1038/nm.2105 [92] Chang L-J, Dowd KA, Mendoza FH, Saunders JG, Sitar S, Plummer SH, Yamshchikov G, Sarwar UN, Hu Z, Enama ME, et al.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Lancet2014; 384:2046-2052; PMID:25132507; http://dx.doi.org/10.1016/S0140-6736(14)61185-5 [93] Combredet C, Labrousse V, Mollet L, Lorin C, Delebecque F, Hur- trel B, McClure H, Feinberg MB, Brahic M, Tangy F. A molecularlycloned Schwarz strain of measles virus vaccine induces strongimmune responses in macaques and transgenic mice.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Virol 2003; 77:11546-54; PMID:14557640; http://dx.doi.org/10.1128/ JVI.77.21.11546-11554.2003 [94] Myers RM, Greiner SM, Harvey ME, Griesmann G, Kuffel MJ, Buh- row SA, Reid JM, Federspiel M, Ames MM, Dingli D, et al.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Clin Pharmacol Ther 2007; 82:700-10; PMID:17971816; http://dx.doi.org/10.1038/sj.clpt.6100409 [95] Bergmans H, Logie C, Van Maanen K, Hermsen H, Meredyth M, Van der Vlugt C. Identi ï¬cation of potentially hazardous human gene products in GMO risk assessment.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Env Biosafety Res 2008; 7:1-9; PMID:18384725; http://dx.doi.org/10.1051/ebr:2008001 [96] Hallak LK, Merchan JR, Storgard CM, Loftus JC, Russel SJ.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Cancer Res 2005; 65:5292-300; PMID:15958576; http://dx.doi.org/10.1158/ 0008-5472.CAN-04-2879 [97] Nakamura T, Peng KW, Harvey M, Greiner S, Lorimer IA, James CD, Russel SJ.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Nat Biotechnol 2005; 23:209-214; PMID:15685166;http://dx.doi.org/10.1038/nbt1060 [98] Jing Y, Tong C, Zhang J, Nakamura T, Iankov I, Russel SJ, Merchan JR. Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Cancer Res 2009;69:1459-1468; PMID:19208845; http://dx.doi.org/10.1158/0008-5472.CAN-08-2628 [99] Ungerechts G, Springfeld C, Frenzke ME, Lampe J, Johnston PB, Parker WB, Sorscher EJ, Cattaneo R. Lymphoma chemovirother-apy: CD20-targeted and convertase-armed measles virus canHUMAN VACCINES & IMMUNOTHERAPEUTICS 1115",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Cancer Res 2007; 67:10939-47; PMID:18006839; http://dx.doi.org/10.1158/0008-5472.CAN-07-1252 [100] Allen C, Paraskevakou G, Iankov I, Giannini C, Schroeder M, Sar- karia J, Puri RK, Russell SJ, Galanis E. Interleukin-13 displaying retargeted oncolytic measles virus strains have signi ï¬cant activity against gliomas with improved speci ï¬city.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Mol Ther 2008; 16:1556- 64; PMID:18665158; http://dx.doi.org/10.1038/mt.2008.152 [101] Paraskevakou G, Allen C, Nakamura T, Zollman P, James CD, Peng KW, Schroeder M, Russel SJ, Galanis E. Epidermal growth factorreceptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas; Mol Ther 2007; 15:677-86; PMID:17299404 [102] Nakatsu Y, Takeda M, Kidokoro M, Kohara M, Yanagi Y.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Virolog Methods 2006; 137:152-155; PMID:NOT_FOUND; http://dx.doi.org/10.1016/j.jviromet.2006.05.029 [103] Ong HT, Trejo TR, Pharm LD, Oberg AL, Russel SJ, Peng KW.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Mol Ther 2009.17:1012-21; PMID:19277014; http://dx.doi.org/10.1038/mt.2009.39 [104] Hasegawa K, Nakamura T, Harvey M, Ikeda Y, Oberg A, Figini M, Canevari S, Hartmann LC, Peng K-W.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Emerg InfectDis 1998; 4:29-35; PMID:9452396; http://dx.doi.org/10.3201/ eid0401.980105 [106] Knuchel MC, Marty RR, Azzouz Morin TN, Iter O, Zuniga A, Naim HY.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Hum Vaccines Immunother 2013; 9:599-606; PMID:23324399; http://dx.doi.org/10.4161/hv.23241 [107] Rager-Zisman B, Bazarsky E, Skibin A, Chamney S, Belmaker I, Shai I, Kordysh E, Grif ï¬n DE.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Vaccine 2003; 21:2580-2588;PMID:12744894; http://dx.doi.org/10.1016/S0264-410X(03)00053-7 [108] Wong-Chew RM, Beeler JA, Audet S, Santos JI.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Med Virol 2003; 70:276-280; PMID:12696117; http://dx.doi.org/10.1002/jmv.10390 [109] Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Vaccine 2003; 3398-305; PMID:12850348; http://dx.doi.org/10.1016/S0264-410X(03)00341-4 [110] Liniger M, Zuniga A, Tamin A, Azzouz-Morin TN, Knuchel M, Marty R, Wiegand M, Weibel S, Kelvin D, Rota PA, Naim HY.",Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Clin Cancer Res 2009; 15:7246-55; PMID:19934299; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"N Engl J Med 1960; 263:452-4; PMID:13829216; http://dx.doi.org/10.1056/NEJM196009012630907 [117] Lin W-H, Kouyos RD, Adams RJ, Grenfell BT, Grif ï¬n DE.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"J Virol 2015; 89:2192-2200; PMID:25473055;http://dx.doi.org/10.1128/JVI.02924-14 [119] Rota PA, Khan AS, Durigon E, Yuran T, Villamarzo YS, Bellini WJ.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Vaccine 2002; 20:1541-3; PMID:11858860; http://dx.doi.org/10.1016/S0264-410X(01)00495-9 [121] Vergison A, Lina B, Van Beers D., Van Ranst M, St /C19evart O, Lepage P, et al., editors.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"Hum Gene Ther 2003; 14:1565-77; PMID:14577918; http://dx.doi.org/10.1089/104303403322495070 [123] Kambara H, Saeki Y, Chiocca EA.",OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
Cancer Res 2005;65:11255-8; PMID:16357128; http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/ac/98/khvi-12-05-1122146.PMC4963060.pdf
"5, 1244 â1249 http://dx.doi.org/10.1080/21645515.2015.1121337",Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Lancet Infect Dis 2012; 12: 136-41; PMID:22030330; http://dx.doi.org/10.1016/S1473-3099(11)70253-5 [2] Parashar UD, Gibson CJ, Bresee JS, Glass RI.",OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Emerg Infect Dis 2006; 12: 304-6;PMID:16494759; http://dx.doi.org/10.3201/eid1202.050006 [3] Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI.",OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Emerg Infect Dis 2003; 9: 565-72; PMID:12737740; http://dx.doi.org/10.3201/eid0905.020562 [4] Kawamura Y, Ohashi M, Ihira M, Hashimoto S, Taniguchi K, Yoshi- kawa T. Nationwide survey of rotavirus-associated encephalopathy and sudden unexpected death in Japan.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Brain Dev 2014; 36: 601-7;PMID:23972382; http://dx.doi.org/10.1016/j.braindev.2013.07.013 [5] Grech V, Calvagna V, Falzon A, Mifsud A.",OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Ann Trop Paediatr 2001; 21: 147-8; PMID:11471258; http://dx.doi.org/10.1080/02724930120058214 [6] Nakano I, Taniguchi K, Ishibashi-Ueda H, Maeno Y, Yamamoto N, Yui A, Komoto S, Wakata Y, Matsubara T, Ozaki N. Sudden deathfrom systemic rotavirus infection and detection of nonstructuralrotavirus proteins.",OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"J Clin Microbiol 2011; 49: 4382-5; PMID:21998424; http://dx.doi.org/10.1128/JCM.01303-11 [7] Yokoo M, Arisawa K, Nakagomi O. Estimation of annual incidence, age-speci ï¬c incidence rate, and cumulative risk of rotavirus gastroen- teritis among children in Japan.",OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"J Infect Dis 2005; 192 Suppl 1: S106-10; PMID:16088792; http://dx.doi.org/10.1086/431503 [9] Kamiya H, Nakano T, Inoue M, Abd TT, Patel M, Orenstein WA, Parashar UD.",OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"J Infect Dis 2009; 200 Suppl 1: S140-6;PMID:19817592; http://dx.doi.org/10.1086/605028 [10] Ito H, Otabe O, Katsumi Y, Matsui F, Kidowaki S, Mibayashi A, Nakagomi T, Nakagomi O.",OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Vaccine 2011; 29: 7807-10; PMID:21821087; http://dx.doi.org/10.1016/j.vaccine.2011.07.105 [11] Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, Glass RI, Parashar UD.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Hum Vaccin Immunother 2014; 10: 1436-48;PMID:24755452; http://dx.doi.org/10.4161/hv.28857 [12] Leshem E, Lopman B, Glass R, Gentsch J, B /C19anyai K, Parashar U, Patel M. Distribution of rotavirus strains and strain-speci ï¬c effective- ness of the rotavirus vaccine after its introduction: a systematicreview and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Lancet Infect Dis 2014; 14: 847-56;PMID:25082561; http://dx.doi.org/10.1016/S1473-3099(14)70832-1 [13] Kawamura N, Tokoeda Y, Oshima M, Okahata H, Tsutsumi H, Van Doorn LJ, Muto H, Smolenov I, Suryakiran P.V., Han HH.Efï¬cacy, safety and immunogenicity of RIX4414 in Japanese infants during the ï¬rst two years of life.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
Vaccine 2011; 29: 6335-41; PMID:21640780; http://dx.doi.org/10.1016/j.vaccine.2011.05.0171248 K. ARAKI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Hum Vaccin Immun- other 2013; 9: 1626-33; PMID:23732903; http://dx.doi.org/10.4161/ hv.24846 [15] Oishi T, Taguchi T, Nakano T, Sudo S, Kuwajima H, Group SRS.",OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Jpn J Infect Dis 2014; 67: 304-6; PMID:25056079; http://dx.doi.org/10.7883/yoken.67.304 [16] National Institute of Ingectious Diseases and Tuberculosis asnd Infectious Diseases Control Division MoH, Labour and Welfare.Rotavirus,2010-2013,Japan.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Vaccine 2012; 30: 539-43; PMID:22122860; http://dx.doi.org/10.1016/j.vaccine.2011.11.071 [18] Bellido-Blasco JB, Sabater-Vidal S, Salvador-Ribera MeM, Arnedo- Pena A, Tirado-Balaguer MD, Meseguer-Ferrer N, Silvestre-SilvestreE, Romeu-Garcia MA, Herrero-Carot C, Moreno-Munoz M-R. Rota-virus vaccination effectiveness: a case-case study in the EDICS proj- ect, Castell /C19on (Spain).",Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Vaccine 2012; 30: 7536-40; PMID:23103196; http://dx.doi.org/10.1016/j.vaccine.2012.10.049 [19] Adlhoch C, Hoehne M, Littmann M, Marques AM, Lerche A, Dehnert M, Eckmanns T, Wichimann O, Koch J. Rotavirus vac- cine effectiveness and case-con trol study on risk factors for breakthrough infections in Germany, 2010-2011.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Pediatr InfectDis J 2013; 32: e82-9; PMID:23334342; http://dx.doi.org/10.1097/ INF.0b013e3182720b71 [20] Chang WC, Yen C, Wu FT, Huang YC, Lin JS, Huang FC, Yu HT, Chi CL, Lin HY, Tate JE, Parashar UD, Wu HS, Hsiung CA.",OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Pediatrics 2013; 132: e25-33; PMID:23776114; http://dx.doi.org/10.1542/peds.2012-3804 [23] Braeckman T, Van Herck K, Meyer N, Pir Â¸con JY, Soriano-Gabarr /C19o M, Heylen E, Zeller M, Azou M, Capiau H, Koster JD, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"JAMA 2009; 301: 2243-51; PMID:19491186; http://dx.doi.org/10.1001/jama.2009.756 [25] Mast TC, Khawaja S, Espinoza F, Paniagua M, Del Carmen LP, Car- dellino A, Sanchez E. Case-control study of the effectiveness of vacci- nation with pentavalent rotavirus vaccine in Nicaragua.",OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Pediatr Infect Dis J 2011; 30: e209-15; PMID:21768920; http://dx.doi.org/10.1097/INF.0b013e31822a8527 [26] Cardellino A, Khawaja S, S /C19anchez Cruz E, Mast TC.",OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Hum Vaccin Immunother2013; 9: 1449-53; PMID:23571175; http://dx.doi.org/10.4161/ hv.24338 [27] Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, Doorn LJ, Teoh YL, Teoh YL, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"Vaccine 2012; 30: 4552-7; PMID:22497874; http://dx.doi.org/10.1016/j.vaccine.2012.03.030 [28] Shono A, Kondo M. Factors that affect voluntary vaccination of chil- dren in Japan.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
Int J Epidemiol 1993; 22: 742-6; PMID:8225751; http://dx.doi.org/10.1093/ije/22.4.742HUMAN VACCINES & IMMUNOTHERAPEUTICS 1249,Non-OADS,/arxiv_data1/oa_pdf/37/0c/khvi-12-05-1121337.PMC4963066.pdf
"5, 1311 â1317 http://dx.doi.org/10.1080/21645515.2015.1123829",Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
Nature 1995; 377:632-5; PMID:7566175; http://dx.doi.org/10.1038/377632a0 [4] Grandi G. Antibacterial vaccine design using genomics and proteo- mics.,Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Science 2000; 287:1816-20; PMID:10710308;http://dx.doi.org/10.1126/science.287.5459.1816 [6] Giuliani MM, Adu-Bobie J, Comanducci M, AricR B, Savino S, Santini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, et al.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Proc Natl Acad Sci U S A 2006;103:10834-9; PMID:16825336; http://dx.doi.org/10.1073/ pnas.0603940103 [7] Finco O, Frigimelica E, Buricchi F, Petracca R, Galli G, Faenzi E, Meoni E, Bonci A, Agnusdei M, Nardelli F, et al.",Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Nat Biotechnol 2006;24:191-7; PMID:16415855; http://dx.doi.org/10.1038/nbt1179 [9] Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, Biolchi A, Brunelli B, Giuliani MM, Pizza M, Norais N, et al.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Proteomics 2006; 6:1856-66; PMID:16456881;http://dx.doi.org/10.1002/pmic.200500164 [10] Doro F, Liberatori S, Rodr /C19Ä±guez-Ortega MJ, Rinaudo CD, Rosini R, Mora M, Scarselli M, Altindis E, D âAurizio R, Stella M, et al.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Mol Cell Proteomics 2009; 8:1728-37; PMID:19401597; http://dx.doi.org/10.1074/mcp.M800486-MCP200 [11] Solis N, Larsen MR, Cordwell SJ.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Proteomics 2010; 10:3082- 96; PMID:20662103; http://dx.doi.org/10.1002/pmic.201000062 [13] Bensi G, Mora M, Tuscano G, Biagini M, Chiarot E, Bombaci M, Capo S, Falugi F, Manetti A, Donato P, et al.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Mol Cell Proteomics 2012; 11, 1-12; PMID:22286755; http://dx.doi.org/10.1074/mcp.M111.015693 [14] Maione D, Margarit y Ros I, Rinaudo D, Masignani V, Mora M, Scar- selli M, Tettelin H, Brettoni C, Iacobini ET, Rosini R, et al.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Science 2005; 309:148-50; PMID:15994562; http://dx.doi.org/10.1126/science.1109869 [15] Barinov A, Loux V, Hammani A, Nicolas P, Langella P, Ehrlich D, Maguin E, van de Guchte M. Prediction of surface exposed proteinsin Streptococcus pyogenes, with a potential application to otherGram-positive bacteria.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Proteomics 2009; 9:61-73; PMID:19053137; http://dx.doi.org/10.1002/pmic.200800195 [16] Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumor antigens, and subunit vaccines.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"BMC Bioinformatics 2007; 8:4; PMID:17207271; http://dx.doi.org/10.1186/1471-2105-8-4 [17] Altindis E, Cozzi R, Di Palo B, Necchi F, Mishra RP, Fontana MR, Soriani M, Bagnoli F, Maione D, Grandi G, et al.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Mol Cell Proteomics 2015; 14, 418-29; PMID:25368410;http://dx.doi.org/10.1074/mcp.M114.039362 [18] More ï¬ eld GL, Sokolovska A, Jiang D, HogenEsch H, Robinson JP, Hem SL.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Vaccine 2005; 23:1588-95;PMID:15694511; http://dx.doi.org/10.1016/j.vaccine.2004.07.050 [19] Kool M, P /C19etrilli V, De Smedt T, Rolaz A, Hammad H, van Nimwegen M, Bergen IM, Castillo R, Lambrecht BN, Tschopp J.",Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"J Immunol 2008; 181:3755-9; PMID:18768827; http://dx.doi.org/10.4049/jimmunol.181.6.3755 [20] Calabro S, Tortoli M, Baudner BC, Pacitto A, Cortese M, O âHagan DT, De Gregorio E, Seubert A, Wack A.",Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Vaccine 2011; 29:1812-23; PMID:21215831; http://dx.doi.org/10.1016/j.vaccine.2010.12.090 [21] Maisonneuve C, Bertholet S, Philpott DJ, De Gregorio Ennio.",Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"J Infect Dis 2012; 205:466-73; PMID:22147791; http://dx.doi.org/10.1093/infdis/jir769 [23] Tom Y-H, Wu TY-H, Singh M, Miller AT, De Gregorio E, Doro F, DâOro U, Skibinski DAG, Mbow L, Bufali S, et al.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Nat Rev Microbiol 2015; 13:605-19; PMID:26373371; http://dx.doi.org/10.1038/nrmicro3525 [26] Ellis N, Kuehn MJ.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
Microb Mol Biol Rev 2010; 74:81-94; PMID:20197500; http://dx.doi.org/10.1128/MMBR.00031-09 [27] Collins BS.,Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"J Immunol 2007; 179:7692-701; PMID:18025215; http://dx.doi.org/10.4049/ jimmunol.179.11.7692 [29] Kim OY, Hong BS, Park K-S, Yoon YJ, Choi SJ, Lee WH, Roh T-Y, Loâ¬tvall J, Kim Y-K, Gho YS.",Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"J Immunol 2013; 190:4092-102;PMID:23514742; http://dx.doi.org/10.4049/jimmunol.1200742 [30] Berlanda Scorza F, Colucci AM, Maggiore L, Sanzone S, Rossi O, Fer- lenghi I, Pesce I, Caboni M, Norais N, Di Cioccio V, et al.",Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Plos One2012; 7:e35616; PMID:22701551; http://dx.doi.org/10.1371/journal.pone.0035616 [31] Kesty NC, Kuehn MJ.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Vaccine 2009; 27:674854; PMID:19748581; http://dx.doi.org/10.1016/j.vaccine.2009.08.106 [34] Kim J-Y, Doody AM, Chen DJ, Cremona GH, Shuler ML, Putnam D, DeLisa MP.",Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"J Mol Biol 2008; 380:51-66; PMID:18511069; http://dx.doi.org/10.1016/j.jmb.2008.03.076 [35] Chen DJ, Osterrieder N, Metzger SM, Buckles E, Doody AM, DeLisa MP, Putman D. Delivery of foreign antigens by engi- neered outer membrane vesicle vaccines.",OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
AppliedEnviron Microbiol 2014; 80:5854-65; PMID:25038093; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Inf Imm 2009; 77:472-84; PMID:19001078; http://dx.doi.org/ 10.1128/IAI.01139-08 [38] Bartolini E, Ianni E, Frigimelica E, Petracca R, Galli G, Berlanda Scorza F, Norais N, Laera D, Giusti F, Pierleoni A, et al.",Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
JExtracellular Vesicles 2013; 2:20181; PMID:24009891; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Vaccine 2015; 33:2022-9; PMID:25776921; http://dx.doi.org/10.1016/j.vaccine.2015.03.010 [40] Zhang J, De Masi L, John B, Chen W, Schifferli DM.",Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
Microbial Cell Factories 2014; 13:80;PMID:24898796; http://dx.doi.org/10.1186/1475-2859-13-80HUMAN VACCINES & IMMUNOTHERAPEUTICS 1317,Non-OADS,/arxiv_data1/oa_pdf/77/b9/khvi-12-05-1123829.PMC4963069.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 157 â162 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.01.003 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/06/83/main.PMC4963145.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/83/main.PMC4963145.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14,7 8â83 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.01.002 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/dc/40/main.PMC4963146.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/40/main.PMC4963146.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 131 â135 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.01.006 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/c7/4f/main.PMC4963147.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/4f/main.PMC4963147.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 101 â107 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.01.005 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/1c/6d/main.PMC4963148.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/6d/main.PMC4963148.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 115 â122 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.01.004 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/fb/98/main.PMC4963155.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/98/main.PMC4963155.pdf
World J Urol 2015. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fb/98/main.PMC4963155.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 163 â170 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.03.004 2090-598X Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/13/e6/main.PMC4963157.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 143 â146 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.04.003 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/ed/36/main.PMC4963158.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/36/main.PMC4963158.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 123 â130 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.04.004 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/d4/cb/main.PMC4963160.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/cb/main.PMC4963160.pdf
Availableat: < http://www.fda.gov/Radiation-EmittingProducts/Radia- tionSafety/RadiationDoseReduction/ucm2007191.htm > [ac- cessed April 2016].,OADS,/arxiv_data1/oa_pdf/d4/cb/main.PMC4963160.pdf
"Production and hosting by Elsevier1Ex-fellow of McGill University and University of Toronto, Canada.Arab Journal of Urology (2016) 14, 156 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.03.001 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/ec/5c/main.PMC4963161.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/5c/main.PMC4963161.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14,7 5â77 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.03.002 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/c1/0c/main.PMC4963162.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/0c/main.PMC4963162.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 108 â114 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.02.004 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/87/0f/main.PMC4963164.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/0f/main.PMC4963164.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14,9 4â100 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.03.003 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/4c/dd/main.PMC4963165.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/dd/main.PMC4963165.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 147 â155 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.02.003 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/ad/da/main.PMC4963166.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/da/main.PMC4963166.pdf
World J Urol 2015. http://dx.doi.org/10.1007/s00345-015-1639-8 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/ad/da/main.PMC4963166.pdf
Asian J Surg 2015. http://dx.doi.org/10.1016/j.asjsur.2015.03.010 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/ad/da/main.PMC4963166.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14,8 4â93 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.04.002 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/d4/ac/main.PMC4963167.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/ac/main.PMC4963167.pdf
Thedevice was introduced by Global Life Technologiesand has received media coverage in the Urology Times magazine ( http://business.highbeam.com/137412/arti- cle-1G1-200116245/external-support-device-alternative- ed-medications )[60].,Non-OADS,/arxiv_data1/oa_pdf/d4/ac/main.PMC4963167.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 136 â142 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.03.005 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/27/6a/main.PMC4963168.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/6a/main.PMC4963168.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 171 â177 Arab Journal of Urology (Ofï¬cial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.04.001 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/d1/74/main.PMC4963169.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/74/main.PMC4963169.pdf
This  is  an  open access article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/1a/main.PMC4963244.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.06.047 2210-2612/Â© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/9a/1a/main.PMC4963244.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.ijscr.2016.06.047 .",OADS,/arxiv_data1/oa_pdf/9a/1a/main.PMC4963244.pdf
This  is  an  open  access  article  under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/d7/main.PMC4963245.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.07.013 2210-2612/Published by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/b8/d7/main.PMC4963245.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/d7/main.PMC4963245.pdf
"9 (March  (1))  (2009)  1â7,  http://dx.doi.org/10.1007/s10238-008-0011-3 ,  Epub 2008  Sep 26.",Non-OADS,/arxiv_data1/oa_pdf/b8/d7/main.PMC4963245.pdf
"93  (September  (9))  (2013)  970â982,  http://dx.doi.org/ 10.1038/labinvest.2013.92 , Epub 2013  Aug  5.",Non-OADS,/arxiv_data1/oa_pdf/b8/d7/main.PMC4963245.pdf
"Claudio,  Omega-3  eicosapentaenoic acid  decreases  CD133  colon  cancer  stem-like  cell  marker  expression  while increasing  sensitivity  to  chemotherapy,  PLoS  One  8  (July  (7))  (2013)  e69760, http://dx.doi.org/10.1371/journal.pone.0069760 ,  Print  2013.",Non-OADS,/arxiv_data1/oa_pdf/b8/d7/main.PMC4963245.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/72/main.PMC4963246.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.06.043 2210-2612/Â© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/ae/72/main.PMC4963246.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ed/main.PMC4963249.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ed/main.PMC4963249.pdf
http://dx.doi.org/10.1016/j.eucr.2016.06.004Urology Case Reports 8 (2016) 49 e51,Non-OADS,/arxiv_data1/oa_pdf/11/ed/main.PMC4963249.pdf
MALDI-TOF MS spectrum The MALDI-TOF MS spectrum of âLachnoclostridium bouches- durhonense âis available online ( http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database ).,OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC4963250.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.06.015,Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC4963250.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,6 9 â70 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/19/fb/main.PMC4963250.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Educational gradientsAsian immigrantsSelf-rated health 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/84/main.PMC4963251.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.07.001 2211-3355/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/84/main.PMC4963251.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/84/main.PMC4963251.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ed/84/main.PMC4963251.pdf
This is an ope n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/c9/main.PMC4963256.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.07.003 2214-4269/Â© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/a4/c9/main.PMC4963256.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/c9/main.PMC4963256.pdf
Physician investigators in the NIH-funded Urea Cycle Disorders Consortium ( http://www.rarediseasesnetwork.org/ ucdc/index.htm ) and all users in the Wolters-Kluwer database who had written â¥20 prescriptions for sodium phenylbutyrate (NaPBA) tab- lets or â¥3 6 prescriptions for NaPBA powder in the last 2 years were in-vited to participate.,Non-OADS,/arxiv_data1/oa_pdf/a4/c9/main.PMC4963256.pdf
"When she experienced breakthrough seizures ,the dose of Lamotrigene was increased to 175mg twice a day in weekly increments .However ,this failed to control her seizures ,Carbamazepine was added for a brief period , which had to be discontinued due to increased fatigue and it was duringthis period at 7months after presentation when she complained of head- aches along with breakthrough seizures that Topiramate was added cau-tiously .As pointed we are aware that Topiramate could have both positive and negative effects in individuals with mitochondrial disorders , hence the dose was kept low .We were guided by the effectiveness of Topiramate in another patient with MELAS who had chronic headaches.We were also concerned about the side effects of Topiramate in terms of weight loss ,and cognitive functions .Hence the decision to keep her onMolecular Genetics and Metabolism Reports 8 (2016) 41 â42 http://dx.doi.org/10.1016/j.ymgmr.2016.07.002 2214-4269/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9a/e1/main.PMC4963257.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/e1/main.PMC4963257.pdf
To view  please visit the journal online (http://dx.doi.org/10.1136/gutjnl-2015-310612) For numbered affiliations see  end of article.,Non-OADS,/arxiv_data1/oa_pdf/13/52/gutjnl-2015-310612.PMC4963301.pdf
"The second-stage rep-lication included 2419 cases and 2384 controls, which werederived from Beijing, Hubei and Shandong province.Gastric cancer cases tested for expression of the lncRNA asso- ciated with the GW AS SNPs came from our UGI CancerGenetic Studies (URL: http://dceg.cancer.gov/about/staff-directory/biographies/O-Z/taylor-philip).",Non-OADS,/arxiv_data1/oa_pdf/13/52/gutjnl-2015-310612.PMC4963301.pdf
"31 URLS GTEx, http://www.gtexportal.org/;GTEx MUC1 expression, http://www.gtexportal.org/home/gene/ MUC1 GLU, https://code.google.com/p/glu-genetics/; IMPUTE2 software (V .2.2.2), http://mathgen.stats.ox.ac.uk/impute/impute_v2.html;LocusZoom, http://csg.sph.umich.edu/locuszoom/;PLINK, http://pngu.mgh.harvard.edu/~purcell/plink/;SHAPEIT software (V .2), https://mathgen.stats.ox.ac.uk/genetics_software/shapeit/shapeit.html;SNPTEST software (V .2.2), https://mathgen.stats.ox.ac.uk/genetics_software/snptest/snptest.htmlUCSC liftOver tool, http://hgdownload.cse.ucsc.edu/downloads.html Author af ï¬liations 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA 2Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Gaithersburg, Maryland, USA 3Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, School of Public Health, Nanjing Medical University, Nanjing, People âs Republic of China 4Department of Epidemiology and Biostatistics, and the Ministry of Education Key Lab of Environment and Health, School of Public Health, Tongji Medical College,Huazhong University of Science and Technology, Wuhan, People âs Republic of China 5State Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, People âs Republic of China 6Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, People âs Republic of China 7Clinical Medical Testing Laboratory, Northern Jiangsu People âs Hospital and Clinical Medical College of Yangzhou University, Yangzhou, People âs Republic of China 8Department of Genetic Toxicology, the Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing,People âs Republic of China 9Shanxi Cancer Hospital, Taiyuan, Shanxi, P.R.",Non-OADS,/arxiv_data1/oa_pdf/13/52/gutjnl-2015-310612.PMC4963301.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Ferlay Jea.,Non-OADS,/arxiv_data1/oa_pdf/13/52/gutjnl-2015-310612.PMC4963301.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/40/ce/10549_2016_Article_3889.PMC4963434.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.570 Breast Cancer Res Treat (2016) 158:563â572 123",Non-OADS,/arxiv_data1/oa_pdf/13/b3/10549_2016_Article_3896.PMC4963436.pdf
Retrieved from http://www.nccn.org/professionals/physician_gls/ f_guidelines.asp#supportive 17.,Non-OADS,/arxiv_data1/oa_pdf/13/b3/10549_2016_Article_3896.PMC4963436.pdf
"secrete toxins that exacerbate psoriasis, and it has been hypothesized that the presence of C. albicans in the gut can stimulate production of superantigens, causing non-speciï¬c T-cell activation and production of cytokinesEnhanced content To view enhanced content for this article, please go to http://www.medengine.com/Redeem/0AD4F0604E37A968 .",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/40257_2016_Article_206.PMC4963441.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/40257_2016_Article_206.PMC4963441.pdf
Available at: http://www.merckmanuals.,Non-OADS,/arxiv_data1/oa_pdf/f0/d1/40257_2016_Article_206.PMC4963441.pdf
Avail- able at: http://www.sciencephoto.com/ .,Non-OADS,/arxiv_data1/oa_pdf/f0/d1/40257_2016_Article_206.PMC4963441.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f2/61/10549_2016_Article_3897.PMC4963452.pdf
Statistical analysis was done using Partek software (http://partek.com ).,OADS,/arxiv_data1/oa_pdf/c6/f5/10549_2016_Article_3892.PMC4963453.pdf
STR proï¬les were compared to (1) known ATCC ï¬ngerprints (ATCC.org); (2) the Cell Line IntegratedMolecular Authentication database (CLIMA) version 0.1.200808 ( http://bioinformatics.istge.it/clima/ )[17]; and (3) the MD Anderson ï¬ngerprint database.,OADS,/arxiv_data1/oa_pdf/c6/f5/10549_2016_Article_3892.PMC4963453.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.References 1.",Non-OADS,/arxiv_data1/oa_pdf/c6/f5/10549_2016_Article_3892.PMC4963453.pdf
"Acknowledgement Authors hearty thank to Dr. L. P. Gite, Project coordina - tor, All India Coordinated Research Project on Ergonomics  and Safety in Agriculture, ICAR, New Delhi for full finan - cial support and valuable guidance.References  1) Rice Production (2014) http://worldnaturetrues.blogspot.",Non-OADS,/arxiv_data1/oa_pdf/44/71/indhealth-54-315.PMC4963544.pdf
"2) Annual report (2011) Department of Agriculture and Coop - eration Ministry of Agriculture, http://www.agricoop.nic.in/ Annual%20report2010-11/AR.pdf .",Non-OADS,/arxiv_data1/oa_pdf/44/71/indhealth-54-315.PMC4963544.pdf
7) TSI Incorporated Health and Safety Instruments (1999)  http://www.kenelec.com.au/sitebuilder/products/files/819/ respicon.pdf .,Non-OADS,/arxiv_data1/oa_pdf/44/71/indhealth-54-315.PMC4963544.pdf
http://www.su.se/polopoly_ fs/1.51750.1321891474!/P2456_AN.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/02/indhealth-54-324.PMC4963545.pdf
European Trans - port Research Review; http://dx.doi.org/10.1007/s12544- 010-0035-0.,Non-OADS,/arxiv_data1/oa_pdf/07/3e/indhealth-54-337.PMC4963546.pdf
"http://anzeninfo.mhlw.go.jp/user/ anzen/tok/anst00.htm Accessed May 22, 2015 (in Japanese).",Non-OADS,/arxiv_data1/oa_pdf/53/cf/indhealth-54-354.PMC4963548.pdf
"2) The Bureau of Labor Statistics of the U.S. Department of  Labor (2014) Census of Fatal Occupational Injuries Charts,  1992 â 2013 (revised data), http://www.bls.gov/iif/oshwc/ cfoi/cfch0012.pdf .",OADS,/arxiv_data1/oa_pdf/53/cf/indhealth-54-354.PMC4963548.pdf
"2012-103  http://www.cdc.gov/niosh/docs/2012-103/  Accessed  December 22, 2014.",OADS,/arxiv_data1/oa_pdf/53/cf/indhealth-54-354.PMC4963548.pdf
"http://www.cdc.gov/niosh/docs/2011-109/  Accessed  December 22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/53/cf/indhealth-54-354.PMC4963548.pdf
"http://www.mhlw.go.jp/new-info/kobetu/roudou/ gyousei/anzen/101006-1.html  Accessed April 10, 2012 (in  Japanese).",Non-OADS,/arxiv_data1/oa_pdf/53/cf/indhealth-54-354.PMC4963548.pdf
MiRNAs target gene prediction and functional analysis We	selected	a	series	of	abundantly	 and	differentially 	 expressed	 miRNAs	to	query	for	their	Gene	Ontology	 Enrichment	 categories	 using	the	Visualization	 and	Inte- grated	Discovery	 (DAVID)	V6.7	bioinformatics	 resources	 (http://david.abcc.ncifcrf.gov/ )23).,OADS,/arxiv_data1/oa_pdf/f3/70/indhealth-54-361.PMC4963549.pdf
"The	target	mRNAs	 of	these	miRNAs	were	determined	 based	on	miRWalk	 (http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/ ),	 which is a comprehensive database that provides infor - mation on predicted as well as validated binding sites  on	their	target	genes	miRNA	from	Human,	Mouse	and	 Rat.",OADS,/arxiv_data1/oa_pdf/f3/70/indhealth-54-361.PMC4963549.pdf
"[Medline]  [Cross - Ref]  2) India National Health Policy., 2006 http://mohfw.nic.in/  3) Bentley TA, Parker RJ, Ashby L, Moore DJ, Tappin DC  (2002) The role of the New Zealand forest industry injury  surveillance system in a strategic ergonomics, safety and  health research programme.",Non-OADS,/arxiv_data1/oa_pdf/a6/9f/indhealth-54-377.PMC4963551.pdf
"Four cases which showed brown pigmentation histopathologically, were further analyzed by Berlin Blue and Victoria Blue staining, immunohistochemistry for anti - Received: 11 December 2015, Accepted: 1 March 2016 Published online in J-STAGE: 25 March 2016 *Corresponding author: Y Yamakawa   (e-mail: yoshika.yamakawa@astellas.com) Â©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/db/49/tox-29-181.PMC4963612.pdf
"This report presents up-to-date results including non-proliferative and proliferative findings of the thyroid and parathyroid gland and can serve as a historical Received: 19 January 2016, Accepted: 7 March 2016 Published online in J-STAGE: 4 April 2016 *Corresponding Author: K Isobe (e-mail: kaori.isobe@crl.com) Â©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/4b/20/tox-29-201.PMC4963613.pdf
"2011, from Charles River Laboratories website: http://www.criver.com/files/pdfs/rms/wistarhan/rm_rm_r_wis - tar_han_tox_data_2011.aspx.",OADS,/arxiv_data1/oa_pdf/4b/20/tox-29-201.PMC4963613.pdf
"2013, from Charles River Laboratories web - site: http://www.criver.com/files/pdfs/rms/cd/rm_rm_r_ cd_rat_tox_data_2013.aspx.",OADS,/arxiv_data1/oa_pdf/4b/20/tox-29-201.PMC4963613.pdf
"2010, from Charles River Laboratories website: http://www.criver.com/files/pdfs/rms/cd1/rm_rm_r_cd1_  mouse_tox_data_2010.aspx.",Non-OADS,/arxiv_data1/oa_pdf/4b/20/tox-29-201.PMC4963613.pdf
"Repetition of modified cell division Received: 18 February 2016, Accepted: 10 March 2016 Published online in J-STAGE: 1 April 2016 *Corresponding author: M Tsuchitani  (e-mail: Tsuchitani.Minoru@mp.medience.co.jp) Â©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/9d/f1/tox-29-147.PMC4963614.pdf
"Information re - sources on swine in biomedical research [electronic re - source]: 1990â2000, from United States Department of Agriculture, Agricultural Research Service, National Ag - ricultural library, and Animal Welfare Information Center website: http://pubs.nal.usda.gov/information-resources-swine-biomedical-research-2000.",Non-OADS,/arxiv_data1/oa_pdf/9d/f1/tox-29-147.PMC4963614.pdf
"This study aimed to clarify the histopathological and  electrocardiographic features of myocardial lesions induced by CA4DP and to discuss the relation between myocardial Received: 10 February 2016, Accepted: 6 April 2016 Published online in J-STAGE: 23 April 2016 *Corresponding Author: R Tochinai  (e-mail: ryota-tochinai@yakult.co.jp) Â©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/77/4e/tox-29-163.PMC4963615.pdf
"In addition, a mouse monoclonal antibody against pan-cytokeratin was used (Lu-Received: 24 January 2016, Accepted: 28 April 2016 Published online in J-STAGE: 31 May 2016 *Corresponding author: M Heinrichs  (e-mail: dr.martin.heinrichs@gmx.de) Â©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/50/4b/tox-29-195.PMC4963616.pdf
"When estrus Received: 8 March 2016, Accepted: 7 April 2016 Published online in J-STAGE: 16 May 2016 *Corresponding author: J Sato  (e-mail: Satou.Junko@ms.medience.co.jp) Â©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/6f/69/tox-29-155.PMC4963617.pdf
"Received: 9 February 2016, Accepted: 18 March 2016 Published online in J-STAGE: 21 April 2016 *Corresponding Author: T Ide (e-mail: tetsuya.ide@astellas.com) Â©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/7a/f3/tox-29-191.PMC4963618.pdf
http://data.unaids.org/ pub/EPISlides/2007/2007_epiupdate_en.pdf (accessed 1 August 2015).,OADS,/arxiv_data1/oa_pdf/9b/f4/CD006419.PMC4963621.pdf
April 2014. http://www.who.int/mediacentre/factsheets/fs366/en/ (accessed February 2015).,Non-OADS,/arxiv_data1/oa_pdf/9b/f4/CD006419.PMC4963621.pdf
"For reprints and permission queries, plea se visit SAGEâs Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/40/96/10.1177_2325967116657815.PMC4963625.pdf
http://aaos2015.conferencespot.,Non-OADS,/arxiv_data1/oa_pdf/40/96/10.1177_2325967116657815.PMC4963625.pdf
https://www.isakos.com/ meetings/2013congress/on site/AbstractView?EventID Â¼7751.,Non-OADS,/arxiv_data1/oa_pdf/40/96/10.1177_2325967116657815.PMC4963625.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/e7/91/10.1177_2058460116658686.PMC4963626.pdf
"For reprints and permission queries, plea se visit SAGEâs Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/df/6c/10.1177_2325967116657810.PMC4963627.pdf
Supplementary material The supplementary material is available at http://vmj.sagepub.com References  1.,Non-OADS,/arxiv_data1/oa_pdf/72/af/10.1177_1358863X16645853.PMC4963800.pdf
"325Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Journal of Pathology and Translational Medicine 2016; 50: 325 http://dx.doi.org/10.4132/jptm.2015.09.11.râ RETRACTION â Notice of Retraction: Therapeutic Effects of Umbilical Cord Blood   Derived Mesenchymal Stem Cell-Conditioned Medium   on Pulmonary Arterial Hypertension in Rats Jae Chul Lee1,2,3 Â· Choong Ik Cha3 Â· Dong-Sik Kim2 Â· Soo Young Choe1 1Department of Biology, School of Life Sciences, Chungbuk National University, Cheongju;   2Department of Surgery, Brain Korea 21 PLUS Project for Medical Sciences and HBP Surgery and Liver Transplantation, Korea University College of Medicine, Seoul;  3Department of Anatomy, Seoul National University College of Medicine, Seoul, Korea J Pathol Transl Med 2015; 49(6): 472-480. http://dx.doi.org/10.4132/jptm.2015.09.11 Editors, Journal of Pathology and Translational Medicine Several issues related to the authorship, research materials, and protocols have been raised with the above article published in the  Journal of Pathology and Translational Medicine (2015; 49: 472-80).1 The first author of the article has duely admitted that he is  mainly responsible for the misconduct.",Non-OADS,/arxiv_data1/oa_pdf/b0/c5/jptm-2015-09-11-r.PMC4963961.pdf
"318pISSN 2383-7837 eISSN 2383-7845 Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Gastric Mixed Adenoneuroendocrine Carcinoma with Squamous   Differentiation: A Case Report Han-Ik Bae Â· Chaeyoon Lee1 Â· Young-Min Jo Â· Ohkyung Kwon1 Â· Wansik Yu1 Â· Mee-Seon Kim2 Â· An Na Seo Department of Pathology, Kyungpook National University Hospital, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Daegu;   1Department of Surgery, Gastric Cancer Center, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Daegu;   2Department of Pathology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, KoreaJournal of Pathology and Translational Medicine 2016; 50: 318-321 http://dx.doi.org/10.4132/jptm.2015.10.17â BRIEF CASE REPORT â The occurrence of gastric mixed adenoneuroendocrine carci - noma (MANEC) is relatively rare, although a few cells of gastric  adenocarcinoma frequently show neuroendocrine differentiation.1  We herein present one of only a few reported cases of gastric  MANEC with trilineage histologic differentiation, composed of  adenocarcinoma, large cell neuroendocrine carcinoma (NEC),  and squamous cell carcinoma (SqCC).",Non-OADS,/arxiv_data1/oa_pdf/22/d3/jptm-2015-10-17.PMC4963962.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.10.17MANEC with Trilineage Differentiation   â¢     319 ponent revealed negativity, whereas the adenocarcinoma compo - nent showed complete membranous staining of strong intensity  in primary gastric cancer and in its corresponding metastatic  regional lymph nodes (Fig.",Non-OADS,/arxiv_data1/oa_pdf/22/d3/jptm-2015-10-17.PMC4963962.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.10.17320     â¢  Bae H-I, et al.",OADS,/arxiv_data1/oa_pdf/22/d3/jptm-2015-10-17.PMC4963962.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.10.17MANEC with Trilineage Differentiation   â¢     321 2.,Non-OADS,/arxiv_data1/oa_pdf/22/d3/jptm-2015-10-17.PMC4963962.pdf
"312pISSN 2383-7837 eISSN 2383-7845 Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Carney Complex with Multiple Cardiac Myxomas, Pigmented Nodular   Adrenocortical Hyperplasia, Epithelioid Blue Nevus, and   Multiple Calcified Lesions of the Testis: A Case Report Hyunchul Kim Â· Hyun-Yee Cho Â· Jeong Nam Lee1 Â· Kook-Yang Park2 Departments of Pathology, 1Surgery, and 2Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, Incheon, KoreaJournal of Pathology and Translational Medicine 2016; 50: 312-314 http://dx.doi.org/10.4132/jptm.2015.11.12â BRIEF CASE REPORT â In 1985, Carney et al.1 reported a syndrome composed of  myxoid tumors, endocrine overactivity, and pigmented skin le - sions.",Non-OADS,/arxiv_data1/oa_pdf/44/66/jptm-2015-11-12.PMC4963963.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.11.12A Case of Carney Complex   â¢     313 blue nevus.,Non-OADS,/arxiv_data1/oa_pdf/44/66/jptm-2015-11-12.PMC4963963.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.11.12314     â¢  Kim H, et al.",OADS,/arxiv_data1/oa_pdf/44/66/jptm-2015-11-12.PMC4963963.pdf
"306pISSN 2383-7837 eISSN 2383-7845 Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Pathology and Translational Medicine 2016; 50: 306-308 http://dx.doi.org/10.4132/jptm.2015.11.15â BRIEF CASE REPORT â Corresponding Author Chul Hwan Kim, MD Department of Pathology, Korea University Anam Hospital, 73 Inchon-ro, Seongbuk-gu,  Seoul 02841, Korea  Tel: +82-2-920-5595, Fax: +82-2-920-6576, E-mail: chkap@korea.ac.kr Received:  September 17, 2015  Revised:  October 13, 2015 Accepted:  November 15, 2015Intramuscular Tenosynovial Giant Cell Tumor, Diffuse-Type Yoo Jin Lee Â· Youngjin Kang Â· Jiyoon Jung Â· Seojin Kim Â· Chul Hwan Kim Department of Pathology, Korea University Anam Hospital, Seoul, Korea Tenosynovial giant cell tumors (TSGCT), a group of tumors  that originate in tendon sheaths, joints, bursae, or adjacent soft  tissue, were first described in 1941 by Jaffe et al.1 Diffuse-type  TSGCT are known to be located in the periarticular soft tissue,  while pure intramuscular tumors are rare.",Non-OADS,/arxiv_data1/oa_pdf/51/64/jptm-2015-11-15.PMC4963964.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.11.15Intramuscular Tenosynovial Giant Cell Tumor   â¢     307 as extra-articular extension of a primary intra-articular process.,Non-OADS,/arxiv_data1/oa_pdf/51/64/jptm-2015-11-15.PMC4963964.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.11.15308     â¢  Lee YJ, et al.",OADS,/arxiv_data1/oa_pdf/51/64/jptm-2015-11-15.PMC4963964.pdf
"322pISSN 2383-7837 eISSN 2383-7845 Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Primary Cutaneous Adenoid Cystic Carcinoma Arising in Umbilicus Seok Joo Lee Â· Woo Ick Yang Â· Sang Kyum Kim Department of Pathology, Yonsei University College of Medicine, Seoul, KoreaJournal of Pathology and Translational Medicine 2016; 50: 322-324 http://dx.doi.org/10.4132/jptm.2015.11.24â BRIEF CASE REPORT â Primary cutaneous adenoid cystic carcinoma (PCACC) is a  rare adnexal tumor, first described by Boggio in 1975.1 Fewer  than 70 cases have been reported in the English literature.",Non-OADS,/arxiv_data1/oa_pdf/99/2d/jptm-2015-11-24.PMC4963965.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.11.24Adenoid Cystic Carcinoma Arising in Umbilicus   â¢     323 tumor originates from the apocrine glands.,Non-OADS,/arxiv_data1/oa_pdf/99/2d/jptm-2015-11-24.PMC4963965.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.11.24324     â¢  Lee SJ, et al.",OADS,/arxiv_data1/oa_pdf/99/2d/jptm-2015-11-24.PMC4963965.pdf
"315Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Tailgut Cyst in a Neonate: A Case Report Ji Hyen Lee Â· Yun Suk Lee Â· So Yeon Shim Â· Su Jin Cho Â· Eun Ae Park Â· Soon Sup Chung1 Â· Sanghui Park2 Departments of Pediatrics, 1Surgery, and 2Pathology, Ewha Womans University School of Medicine, Seoul, KoreaJournal of Pathology and Translational Medicine 2016; 50: 315-317 http://dx.doi.org/10.4132/jptm.2015.11.27â BRIEF CASE REPORT â A tailgut cyst is a congenital anomaly located in the retrorec - tal space.",Non-OADS,/arxiv_data1/oa_pdf/99/34/jptm-2015-11-27.PMC4963966.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.11.27316     â¢  Lee JH, et al.",OADS,/arxiv_data1/oa_pdf/99/34/jptm-2015-11-27.PMC4963966.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.11.27Rare Case of Tailgut Cyst in a Neonate   â¢     317 sweat glands were found, similar to dermoid cysts.",Non-OADS,/arxiv_data1/oa_pdf/99/34/jptm-2015-11-27.PMC4963966.pdf
"300pISSN 2383-7837 eISSN 2383-7845 Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Isolated Mass-Forming IgG4-Related Cholangitis as an Initial   Clinical Presentation of Systemic IgG4-Related Disease Seokhwi Kim Â· Hyunsik Bae    Misun Choi Â· Binnari Kim    Jin Seok Heo1 Â· Ho Seong Kim2    Seung Hee Choi3 Â· Kee-Taek Jang Departments of Pathology and Translational  Genomics, 1Surgery, 2Nuclear Medicine,   and 3Radiology, Samsung Medical Center,   Sungkyunkwan University School of Medicine,   Seoul, KoreaIgG4-related disease (IgG4-RD) may involve multiple organs.",Non-OADS,/arxiv_data1/oa_pdf/e4/50/jptm-2015-12-01.PMC4963967.pdf
"Key Words:  IgG4-related disease; Bile ducts; Mass-forming; CholangiocarcinomaReceived:  November 13, 2015 Revised:  November 26, 2015 Accepted:  December 1, 2015 Corresponding Author Kee-Taek Jang, MD Department of Pathology and Translational   Genomics, Samsung Medical Center,   Sungkyunkwan University School of Medicine,   81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel: +82-2-3410-2763 Fax: +82-2-3410-0025 E-mail: kt12.jang@samsung.comJournal of Pathology and Translational Medicine 2016; 50: 300-305 http://dx.doi.org/10.4132/jptm.2015.12.01â CASE STUDY â IgG4-related disease (IgG4-RD) may involve multiple or - gans including pancreas, head and neck region, kidney, lung,  retroperitoneum, and lymph node.1 Histologically, it is charac - terized by lymphoplasmacytic infiltration, storiform fibrosis and/ or obliterative phlebitis with IgG4 immunohistochemical reac - tivity in plasma cells.2 In addition to histologic findings, serum  IgG4 level is often elevated in patients with IgG4-RD.3,4 It is  not difficult to diagnose IgG4-RD if an involved organ shows  diffuse enlargement with an elevated serum IgG4 level.",Non-OADS,/arxiv_data1/oa_pdf/e4/50/jptm-2015-12-01.PMC4963967.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.12.01Mass-Forming IgG4-Related Cholangitis   â¢     301 sion at hilar bile duct.,Non-OADS,/arxiv_data1/oa_pdf/e4/50/jptm-2015-12-01.PMC4963967.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.12.01302     â¢  Kim S, et al.",OADS,/arxiv_data1/oa_pdf/e4/50/jptm-2015-12-01.PMC4963967.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.12.01Mass-Forming IgG4-Related Cholangitis   â¢     303 Fig.,Non-OADS,/arxiv_data1/oa_pdf/e4/50/jptm-2015-12-01.PMC4963967.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.12.01304     â¢  Kim S, et al.",OADS,/arxiv_data1/oa_pdf/e4/50/jptm-2015-12-01.PMC4963967.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.12.01Mass-Forming IgG4-Related Cholangitis   â¢     305 gitis: a comparative histological and immunophenotypic study  with primary sclerosing cholangitis on liver biopsy material.,Non-OADS,/arxiv_data1/oa_pdf/e4/50/jptm-2015-12-01.PMC4963967.pdf
"309Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 IgG4-Related Sclerosing Mesenteritis Seok Joo Lee Â· Cheol Keun Park Â· Woo Ick Yang Â· Sang Kyum Kim Department of Pathology, Yonsei University Medical Center, Seoul, KoreaJournal of Pathology and Translational Medicine 2016; 50: 309-311 http://dx.doi.org/10.4132/jptm.2015.12.03â BRIEF CASE REPORT â Sclerosing mesenteritis (SM) is a rare disease first described  by Sulla1 in 1924 under the name âretractile mesenteritis.â SM  shows fibrosis with fat necrosis and chronic inflammation on  microscopic examination.2 In particular, if the histologic and  immunologic features are associated with IgG4-related disease  (IgG4-RD), the condition is defined as IgG4-related sclerosing  mesenteritis (IgG4-RSM).3 Here, we report a case of a 70-year- old woman, who presented with a palpable intra-abdominal mass  and vague abdominal pain, and was finally diagnosed with IgG4- RSM based on histology and immunohistochemistry.",Non-OADS,/arxiv_data1/oa_pdf/2d/f1/jptm-2015-12-03.PMC4963968.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.12.03310     â¢  Lee SJ, et al.",OADS,/arxiv_data1/oa_pdf/2d/f1/jptm-2015-12-03.PMC4963968.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.12.03IgG4-Related Sclerosing Mesenteritis   â¢     311 of SM with IgG4 testing, and 11 out of 18 cases in total met the  criteria for IgG4-RSM.",Non-OADS,/arxiv_data1/oa_pdf/2d/f1/jptm-2015-12-03.PMC4963968.pdf
"270pISSN 2383-7837 eISSN 2383-7845 Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Stromal Expression of MicroRNA-21 in Advanced Colorectal   Cancer Patients with Distant Metastases Kyu Sang Lee1 Â· Soo Kyung Nam1  Jiwon Koh2 Â· Duck-Woo Kim3  Sung-Bum Kang3 Â· Gheeyoung Choe1,2  Woo Ho Kim2 Â· Hye Seung Lee1 1Department of Pathology, Seoul National   University Bundang Hospital, Seongnam;   2Department of Pathology, Seoul National   University College of Medicine, Seoul;   3Department of Surgery, Seoul National   University Bundang Hospital, Seongnam, KoreaBackground:  The aim of this study was to determine the regional heterogeneity and clinicopatho - logical significance of microRNA-21 (miR-21) in advanced colorectal cancer (CRC) patients with  distant metastasis.",Non-OADS,/arxiv_data1/oa_pdf/27/7b/jptm-2016-03-19.PMC4963969.pdf
"Key Words:  Colorectal neoplasms; MicroRNA-21; Neoplasm metastasis; Genetic heterogeneityReceived:  February 12, 2016 Revised:  March 15, 2016 Accepted:  March 18, 2016 Corresponding Author Hye Seung Lee, PhD Department of Pathology, Seoul National University  Bundang Hospital, 82 Gumi-ro 173beon-gil,  Bundang-gu, Seongnam 13620, Korea Tel: +82-31-787-7714 Fax: +82-31-787-4012 E-mail: hye2@snu.ac.kr Journal of Pathology and Translational Medicine 2016; 50: 270-277 http://dx.doi.org/10.4132/jptm.2016.03.19â ORIGINAL ARTICLE â MicroRNAs (miRNAs) are small (18â25 nucleotides), endog - enous, non-coding RNAs that act as post-transcriptional mod - ulators of all cellular processes, including proliferation, differen - tiation, and apoptosis.1 Alterations in miRNA expression are  associated with the deregulation of oncogenes and tumor sup - pressor genes.2 The discovery that miRNA expression is deregu - lated in cancer suggests the potential of miRNA as biomarkers  for cancer.3 Therefore, targeting miRNAs is regarded as a poten - tial therapeutic strategy and may be a promising diagnostic tool.",Non-OADS,/arxiv_data1/oa_pdf/27/7b/jptm-2016-03-19.PMC4963969.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.19miR-21 in Advanced Colorectal Cancer   â¢     271 role of CAFs through miR-21 expression in CRC.,Non-OADS,/arxiv_data1/oa_pdf/27/7b/jptm-2016-03-19.PMC4963969.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.19272     â¢  Lee KS, et al.",OADS,/arxiv_data1/oa_pdf/27/7b/jptm-2016-03-19.PMC4963969.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.19miR-21 in Advanced Colorectal Cancer   â¢     273 observed in 37 (21.8%), a score of 1 in 16 (9.4%), a score of 2 in  56 (32.9%), a score of 3 in 46 (27.1%), and a score of 4 in 15  (8.8%) patients with CRC.",Non-OADS,/arxiv_data1/oa_pdf/27/7b/jptm-2016-03-19.PMC4963969.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.19274     â¢  Lee KS, et al.",OADS,/arxiv_data1/oa_pdf/27/7b/jptm-2016-03-19.PMC4963969.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.19miR-21 in Advanced Colorectal Cancer   â¢     275 posed that high expression of miR-21 might predict poor sur - vival in patients with CRC.20-24 However, elevated miR-21 level  and poor prognosis correlated only in a subgroup of patients  with stage II CRC.21-24 Interestingly, our results contradict those  of previous miR-21 expression studies.",Non-OADS,/arxiv_data1/oa_pdf/27/7b/jptm-2016-03-19.PMC4963969.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.19276     â¢  Lee KS, et al.",OADS,/arxiv_data1/oa_pdf/27/7b/jptm-2016-03-19.PMC4963969.pdf
"Acknowledgments This research was supported by a grant of the Korea Health  Technology R&D Project through the Korea Health Industry  Development Institute (KHIDI), funded by the Ministry of  Health & Welfare, Republic of Korea (grant number: HI14C1813,  https://www.khidi.or.kr/eps).",Non-OADS,/arxiv_data1/oa_pdf/27/7b/jptm-2016-03-19.PMC4963969.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.19miR-21 in Advanced Colorectal Cancer   â¢     277 pression analysis.,Non-OADS,/arxiv_data1/oa_pdf/27/7b/jptm-2016-03-19.PMC4963969.pdf
"278pISSN 2383-7837 eISSN 2383-7845 Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Detection of Tumor Multifocality Is Important for Prediction of Tumor   Recurrence in Papillary Thyroid Microcarcinoma:   A Retrospective Study and Meta-Analysis Jung-Soo Pyo Â· Jin Hee Sohn   Guhyun Kang1 Department of Pathology, Kangbuk Samsung  Hospital, Sungkyunkwan University School of  Medicine, Seoul; 1Department of Pathology, Inje  University Sanggye Paik Hospital, Inje University  College of Medicine, Seoul, KoreaBackground:  The clinicopathological characteristics and conclusive treatment modality for multifo - cal papillary thyroid microcarcinoma (mPTMC) have not been fully established.",Non-OADS,/arxiv_data1/oa_pdf/78/d8/jptm-2016-03-29.PMC4963970.pdf
"Key Words:  Papillary thyroid microcarcinoma; Multifocal; Incidental; Retrospective studies; Meta- analysisReceived:  March 3, 2016 Revised:  March 29, 2016 Accepted:  March 29, 2016 Corresponding Author Jin Hee Sohn, MD Department of Pathology, Kangbuk Samsung  Hospital, Sungkyunkwan University School of  Medicine, 29 Saemunan-ro, Jongno-gu, Seoul  03181, Korea  Tel: +82-2-2001-2391 Fax: +82-2-2001-2398 E-mail: jhpath.sohn@samsung.comJournal of Pathology and Translational Medicine 2016; 50: 278-286 http://dx.doi.org/10.4132/jptm.2016.03.29â ORIGINAL ARTICLE â Papillary thyroid microcarcinoma (PTMC) measuring 1 cm  or less in diameter is the most common variant of papillary thy - roid carcinoma (PTC).",Non-OADS,/arxiv_data1/oa_pdf/78/d8/jptm-2016-03-29.PMC4963970.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.29Multifocal Papillary Microcarcinoma   â¢     279 MC), while the extent of surgical resection for multifocal PTMC  (mPTMC) remains controversial.11 If incidental mPTMC is con - sidered, the true rate of mPTMC could be higher than previously  reported.",Non-OADS,/arxiv_data1/oa_pdf/78/d8/jptm-2016-03-29.PMC4963970.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.29280     â¢  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/78/d8/jptm-2016-03-29.PMC4963970.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.29Multifocal Papillary Microcarcinoma   â¢     281 0.519 and p = .019).,Non-OADS,/arxiv_data1/oa_pdf/78/d8/jptm-2016-03-29.PMC4963970.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.29282     â¢  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/78/d8/jptm-2016-03-29.PMC4963970.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.29Multifocal Papillary Microcarcinoma   â¢     283 and nodal metastasis (40.3% to 64.1%).23-25,28,29 In addition, a  recent meta-analysis showed that total thyroidectomy was sig - nificantly correlated with lower recurrence and mortality rates  in PTMC.30 Patients who underwent total thyroidectomy showed  a higher incidence of tumor multifocality than patients who  underwent lobectomy (p < .001).",Non-OADS,/arxiv_data1/oa_pdf/78/d8/jptm-2016-03-29.PMC4963970.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.29284     â¢  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/78/d8/jptm-2016-03-29.PMC4963970.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.29Multifocal Papillary Microcarcinoma   â¢     285 picious nodules smaller than 0.3 cm reported preoperatively.,Non-OADS,/arxiv_data1/oa_pdf/78/d8/jptm-2016-03-29.PMC4963970.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.29286     â¢  Pyo J-S, et al.",OADS,/arxiv_data1/oa_pdf/78/d8/jptm-2016-03-29.PMC4963970.pdf
"251Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Aquaporin 1 Is an Independent Marker of Poor Prognosis   in Lung Adenocarcinoma Sumi Yun1,2* Â· Ping-Li Sun3*   Yan Jin4 Â· Hyojin Kim1  Eunhyang Park1 Â· Soo Young Park1  Kyuho Lee1 Â· Kyoungyul Lee5  Jin-Haeng Chung1 1Department of Pathology, Seoul National   University Bundang Hospital, Seongnam;  2Department of Pathology, Soonchunhyang   University Hospital, Seoul, Korea; 3Department  of Pathology, Second Hospital of Jilin University,  Changchun; 4Department of Pathology, Fudan  University, Shanghai Cancer Center, Shanghai,  China; 5Department of Pathology, Kangwon  National University Hospital,   Chuncheon, KoreaBackground:  Aquaporin 1 (AQP1) overexpression has been shown to be associated with uncon - trolled cell replication, invasion, migration, and tumor metastasis.",Non-OADS,/arxiv_data1/oa_pdf/e6/75/jptm-2016-03-30.PMC4963971.pdf
"Key Words:  Aquaporin 1; Adenocarcinoma; Tissue array analysis; Invasion; Epithelial-mesenchymal  transition Received:  February 15, 2016 Revised:  March 27, 2016 Accepted:  March 29, 2016 Corresponding Author Jin-Haeng Chung, MD, PhD Department of Pathology, Seoul National University  Bundang Hospital, 82 Gumi-ro 173beon-gil,  Bundang-gu, Seongnam 13620, Korea  Tel: +82-31-787-7713 Fax: +82-31-787-4012  E-mail: chungjh@snu.ac.kr *Sumi Yun and Ping-Li Sun contributed equally to  this work.Journal of Pathology and Translational Medicine 2016; 50: 251-257 http://dx.doi.org/10.4132/jptm.2016.03.30â ORIGINAL ARTICLE â Non-small cell lung cancer (NSCLC) is one of the major causes  of cancer-related deaths, and the treatment of NSCLC remains  challenging.",Non-OADS,/arxiv_data1/oa_pdf/e6/75/jptm-2016-03-30.PMC4963971.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.30252     â¢  Yun S, et al.",OADS,/arxiv_data1/oa_pdf/e6/75/jptm-2016-03-30.PMC4963971.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.30Overexpression of Aquaporin 1 in Lung Cancer   â¢     253 (25/413) of cases, respectively.",Non-OADS,/arxiv_data1/oa_pdf/e6/75/jptm-2016-03-30.PMC4963971.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.30254     â¢  Yun S, et al.",OADS,/arxiv_data1/oa_pdf/e6/75/jptm-2016-03-30.PMC4963971.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.30Overexpression of Aquaporin 1 in Lung Cancer   â¢     255 factors associated with shorter PFS in lung adenocarcinoma.,Non-OADS,/arxiv_data1/oa_pdf/e6/75/jptm-2016-03-30.PMC4963971.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.30256     â¢  Yun S, et al.",OADS,/arxiv_data1/oa_pdf/e6/75/jptm-2016-03-30.PMC4963971.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.03.30Overexpression of Aquaporin 1 in Lung Cancer   â¢     257 15.,Non-OADS,/arxiv_data1/oa_pdf/e6/75/jptm-2016-03-30.PMC4963971.pdf
"287Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Morphometric Analysis of Thyroid Follicular Cells with Atypia   of Undetermined Significance Youngjin Kang Â· Yoo Jin Lee   Jiyoon Jung Â· Youngseok Lee   Nam Hee Won Â· Yang Seok Chae Department of Pathology, Korea University Anam  Hospital, Seoul, KoreaBackground:  Atypia of undetermined significance (AUS) is a category that encompasses a het - erogeneous group of thyroid aspiration cytology.",Non-OADS,/arxiv_data1/oa_pdf/10/00/jptm-2016-04-04.PMC4963972.pdf
"Key Words:  Atypia of undetermined significance; Morphometric analysis; ThyroidReceived:  January 15, 2016 Revised:  April 2, 2016 Accepted:  April 4, 2016 Corresponding Author Yang Seok Chae, MD Department of Pathology, Korea University Anam  Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul 02841,  Korea Tel: +82-2-920-5595 Fax: +82-2-920-6576 E-mail: chaeys21@korea.ac.krJournal of Pathology and Translational Medicine 2016; 50: 287-293 http://dx.doi.org/10.4132/jptm.2016.04.04â ORIGINAL ARTICLE â Thyroid fine-needle aspiration (FNA) is widely used as an ef - fective first-line screening test to differentiate thyroid lesions1-4  and the Bethesda System for Reporting Thyroid Cytopathology  is used as a standard to interpret FNA specimens.",Non-OADS,/arxiv_data1/oa_pdf/10/00/jptm-2016-04-04.PMC4963972.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.04288     â¢  Kang Y, et al.",OADS,/arxiv_data1/oa_pdf/10/00/jptm-2016-04-04.PMC4963972.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.04Morphometric Analysis of AUS   â¢     289 A C E GB D F H Fig.,Non-OADS,/arxiv_data1/oa_pdf/10/00/jptm-2016-04-04.PMC4963972.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.04290     â¢  Kang Y, et al.",OADS,/arxiv_data1/oa_pdf/10/00/jptm-2016-04-04.PMC4963972.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.04Morphometric Analysis of AUS   â¢     291 findings for thyroid specimens.,Non-OADS,/arxiv_data1/oa_pdf/10/00/jptm-2016-04-04.PMC4963972.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.04292     â¢  Kang Y, et al.",OADS,/arxiv_data1/oa_pdf/10/00/jptm-2016-04-04.PMC4963972.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.04Morphometric Analysis of AUS   â¢     293 16.,Non-OADS,/arxiv_data1/oa_pdf/10/00/jptm-2016-04-04.PMC4963972.pdf
"258pISSN 2383-7837 eISSN 2383-7845 Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma:  Clinicopathologic Analysis of Six Cases Soomin Ahn1 Â· Soo Hyun Hwang1  Joungho Han1 Â· Yoon-La Choi1  Se-Hoon Lee2 Â· Jin Seok Ahn2  Keunchil Park2 Â· Myung-Ju Ahn2  Woong-Yang Park3,4 1Department of Pathology and Translational  Genomics, 2Division of Hematology and   Oncology, Department of Medicine,   3Department of Molecular Cell Biology,   Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul; 4Samsung  Genomic Institute, Samsung Medical Center,  Seoul, KoreaBackground:  Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are con - sidered the first line treatment for a subset of EGFR -mutated non-small cell lung cancer (NSCLC)  patients.",Non-OADS,/arxiv_data1/oa_pdf/1e/82/jptm-2016-04-19.PMC4963973.pdf
"Key Words:  Lung neoplasms; Receptor, epidermal growth factor; Tyrosine kinase inhibitor; Small  cell lung carcinoma; AdenocarcinomaReceived:  February 24, 2016 Revised:  April 6, 2016 Accepted:  April 18, 2016 Corresponding Author Joungho Han, MD Department of Pathology and Translational  Genomics, Samsung Medical Center,   Sungkyunkwan University School of Medicine,   81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea  Tel: +82-2-3410-2765 Fax: +82-2-3410-0025 E-mail: hanjho@skku.eduJournal of Pathology and Translational Medicine 2016; 50: 258-263 http://dx.doi.org/10.4132/jptm.2016.04.19â ORIGINAL ARTICLE â Currently, lung cancer is classified into two broad histological  subgroups: non-small-cell lung cancer (NSCLC) and small cell  lung cancer (SCLC).",Non-OADS,/arxiv_data1/oa_pdf/1e/82/jptm-2016-04-19.PMC4963973.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.19Transformation to Small Cell Lung Cancer   â¢     259 tions.,Non-OADS,/arxiv_data1/oa_pdf/1e/82/jptm-2016-04-19.PMC4963973.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.19260     â¢  Ahn S, et al.",OADS,/arxiv_data1/oa_pdf/1e/82/jptm-2016-04-19.PMC4963973.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.19Transformation to Small Cell Lung Cancer   â¢     261 Sample information and pathologic features are summarized in  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/82/jptm-2016-04-19.PMC4963973.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.19262     â¢  Ahn S, et al.",OADS,/arxiv_data1/oa_pdf/1e/82/jptm-2016-04-19.PMC4963973.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.19Transformation to Small Cell Lung Cancer   â¢     263 lar drivers and cells of origin.,Non-OADS,/arxiv_data1/oa_pdf/1e/82/jptm-2016-04-19.PMC4963973.pdf
"264pISSN 2383-7837 eISSN 2383-7845 Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Significance of Parafibromin Expression in Laryngeal   Squamous Cell Carcinomas Inju Cho Â· Mija Lee Â· Sharon Lim   Ran Hong Department of Pathology, Chosun University  School of Medicine, Gwangju, KoreaBackground:  Parafibromin is a product of the tumor suppressor gene that has been studied as a  potential indicator of tumor aggressiveness in the parathyroid, breast, colorectum, and stomach.",Non-OADS,/arxiv_data1/oa_pdf/20/55/jptm-2016-04-24.PMC4963974.pdf
"Key Words:  Parafibromin; Carcinoma, squamous cell; Epithelial-mesenchymal transitionReceived:  December 30, 2015 Revised:  April 15, 2016 Accepted:  April 24, 2016 Corresponding Author Ran Hong, MD, PhD Department of Pathology,   Chosun University School of Medicine,   309 Pilmun-daero, Dong-gu,   Gwangju 61452, Korea Tel: +82-62-230-6356 Fax: +82-62-234-4584 E-mail: nanih@chosun.ac.krJournal of Pathology and Translational Medicine 2016; 50: 264-269 http://dx.doi.org/10.4132/jptm.2016.04.24â ORIGINAL ARTICLE â Laryngeal cancer is one of the most common malignancies in  the head and neck area and the 11th most common cancer world - wide, with a high mortality rate and poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/20/55/jptm-2016-04-24.PMC4963974.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.24Parafibromin in Laryngeal SCCs   â¢     265 of the gastric glands, and the pars intermedia of the hypophy - sis.11 Hyperparathyroidism-jaw-tumors-syndrome and sporadic  parathyroid carcinoma show loss of nuclear immunoreactivity of  parafibromin.12 Selvarajan et al.13 showed inverse correlations  between parafibromin expression and tumor size, pathologic st- age, and lymphovascular invasion of breast carcinomas.",OADS,/arxiv_data1/oa_pdf/20/55/jptm-2016-04-24.PMC4963974.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.24266     â¢  Cho I, et al.",OADS,/arxiv_data1/oa_pdf/20/55/jptm-2016-04-24.PMC4963974.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.24Parafibromin in Laryngeal SCCs   â¢     267 a subset of cases showed parafibromin immunoreactivity at the  periphery of the tumor cell nest (Fig.,Non-OADS,/arxiv_data1/oa_pdf/20/55/jptm-2016-04-24.PMC4963974.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.24268     â¢  Cho I, et al.",OADS,/arxiv_data1/oa_pdf/20/55/jptm-2016-04-24.PMC4963974.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.04.24Parafibromin in Laryngeal SCCs   â¢     269 Current opinion in diagnosis and treatment of laryngeal carcino - ma.,Non-OADS,/arxiv_data1/oa_pdf/20/55/jptm-2016-04-24.PMC4963974.pdf
"294pISSN 2383-7837 eISSN 2383-7845 Â© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical Significance of an HPV DNA Chip Test with Emphasis   on HPV-16 and/or HPV-18 Detection in Korean Gynecological Patients Min-Kyung Yeo1,2 Â· Ahwon Lee1  Soo Young Hur3 Â· Jong Sup Park3 1Department of Hospital Pathology, College  of Medicine, The Catholic University of Korea,  Seoul; 2Department of Pathology, Chungnam  National University School of Medicine, Daejeon;  3Department of Obstetrics and Gynecology,  Seoul St. Maryâs Hospital, College of Medicine,  The Catholic University of Korea, Seoul, KoreaBackground:  Human papillomavirus (HPV) is a major risk factor for cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/1e/56/jptm-2016-05-09.PMC4963975.pdf
"Key Words:  Human papillomavirus; DNA chip; Hybrid capture 2; Cervical intraepithelial neoplasia;  Cervical carcinomaReceived:  January 26, 2016 Revised:  April 6, 2016 Accepted:  May 9, 2016 Corresponding Author Ahwon Lee, MD  Department of Hospital Pathology,   College of Medicine, The Catholic University   of Korea, 222 Banpo-daero, Seocho-gu,   Seoul 06591, Korea Tel: +82-2-2258-1621 Fax: +82-2-2258-1627 E-mail: klee@catholic.ac.krJournal of Pathology and Translational Medicine 2016; 50: 294-299 http://dx.doi.org/10.4132/jptm.2016.05.09â ORIGINAL ARTICLE â Human papillomavirus (HPV) is a DNA tumor virus that is  an essential causative factor for cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/1e/56/jptm-2016-05-09.PMC4963975.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.05.09HPV DNA Chip Test with HPV-16 and/or HPV-18 Detection   â¢     295 grade squamous intraepithelial lesions (HSILs).,Non-OADS,/arxiv_data1/oa_pdf/1e/56/jptm-2016-05-09.PMC4963975.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.05.09296     â¢  Yeo M-K, et al.",OADS,/arxiv_data1/oa_pdf/1e/56/jptm-2016-05-09.PMC4963975.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.05.09HPV DNA Chip Test with HPV-16 and/or HPV-18 Detection   â¢     297 chip test, 229 cases (84.2%) were also HR-HPV (+) based on  HC2 test.",OADS,/arxiv_data1/oa_pdf/1e/56/jptm-2016-05-09.PMC4963975.pdf
"http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.05.09298     â¢  Yeo M-K, et al.",OADS,/arxiv_data1/oa_pdf/1e/56/jptm-2016-05-09.PMC4963975.pdf
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2016.05.09HPV DNA Chip Test with HPV-16 and/or HPV-18 Detection   â¢     299 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/56/jptm-2016-05-09.PMC4963975.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/a5/01/10.1177_2058460116657688.PMC4963986.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/fa/04/10.1177_2058460116659098.PMC4963987.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/b1/rjw131.PMC4964030.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/4f/rjw128.PMC4964044.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/46/rjw115.PMC4964049.pdf
http://womensenews.org/story/ medicine/110120/hospital-maternity-wards-are-closing- across-us.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://healthexec.com/top- ics/policy/gop-budget-proposal-has-drastic-changes-and- steep-cuts-healthcare?nopaging=1.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.ahrq.gov/sites/default/files/publica- tions/files/2013nhdr.pdf.,OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://aspe.hhs.gov/poverty/11poverty.shtml.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
https://www.aap.org/en-us/about-the-aap/aap-press-room/pages/AAP-Updates-Schedule-of-Screening-and-Assessments- for-Well-Child-Visits.aspx#sthash.qcBBSKSF.dpuf.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://kff.org/other/state-indicator/expenses-per-inpatient-day/.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
CPI detailed report: data for  May 2015. http://www.bls.gov/cpi/.,OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.bls.gov/oes/current/oes291171.htm.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.beckershospitalreview.com/finance/obama-s-budget-for-2015-10-points-for-hospi-tals-know.html.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.beckershospitalreview.com/hospital-management-administration/daughters-of-charity-to-cut-services-at-2-california-hospitals.html.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.npr.org/sections/health-shots/2015/04/29/402875028/floridas-legislature-quits- early-at-impasse-over-medicaid-expansion.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.urban.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.physiciansfoundation.org/ uploads/default/2014_Physicians_Foundation_Biennial_Physician_Survey_Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.forbes.com/sites/merrillmatthews/2015/01/05/doctors-face-a-huge-medi-care-and-medicaid-pay-cut-in-2015/.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.nytimes.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.cbpp.org/research/new-medicaid-citizenship-documentation-requirement-is-taking-a-toll-states-report.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.stltoday.com/news/special-reports/mohealth/long-line- for-medicaid-leaves-many-unsure-about-eligibility/,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.nydailynews.com/new-york/foundling-hospital-mother-child-programputs- pregnant-teens-road-success-mothers-article-1.1168085.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
http://www.pwc.com/us/en/health-industries/ publications/healthcare-unwired.jhtml.,Non-OADS,/arxiv_data1/oa_pdf/e6/5b/10.1177_2333794X16660234.PMC4964150.pdf
"Defining research, 2013, http://www.hra.nhs.uk/resources/before-you-apply/is-it-research/  21.",Non-OADS,/arxiv_data1/oa_pdf/14/03/10.1177_2050312116659604.PMC4964151.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).T rends in Hearing 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/f0/78/10.1177_2331216516658239.PMC4964154.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4c/22/bmjgast-2016-000096.PMC4964159.pdf
doi:10.1136/ vetreco-2016-000172 â¸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ vetreco-2016-000172).,Non-OADS,/arxiv_data1/oa_pdf/cb/07/vetreco-2016-000172.PMC4964160.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011271).,Non-OADS,/arxiv_data1/oa_pdf/f0/6e/bmjopen-2016-011271.PMC4964163.pdf
http://hiru.mcmaster.ca/hiru/HIRU_Hedges_ MEDLINE_Strategies.aspx 27.,Non-OADS,/arxiv_data1/oa_pdf/f0/6e/bmjopen-2016-011271.PMC4964163.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2015- 000240).,Non-OADS,/arxiv_data1/oa_pdf/48/5f/rmdopen-2015-000240.PMC4964164.pdf
2015. http://www.eular.org/education_ training.cfm (accessed 18 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/48/5f/rmdopen-2015-000240.PMC4964164.pdf
2013. http://www.uems.eu/ (accessed 18 Oct2015).,Non-OADS,/arxiv_data1/oa_pdf/48/5f/rmdopen-2015-000240.PMC4964164.pdf
2015. http://ec.europa.eu/eurostat/tgm/ table.do?tab=table&init=1&language=en&pcode=tps00155&plugin=1(accessed 22 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/48/5f/rmdopen-2015-000240.PMC4964164.pdf
See: Âhttp://creativecommons.org/licenses/by-nc/2.0/ Âhttp://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3d/c8/bmjqir-u211608-w4680.PMC4964165.pdf
National Institute of Clinical Excellence (revised 2012) Clinical Knowledge Summaries [Available online: http://cks.nice.org.uk/red-eye] 6.,Non-OADS,/arxiv_data1/oa_pdf/3d/c8/bmjqir-u211608-w4680.PMC4964165.pdf
The Royal National Institute of the Blind (2013) Sight loss UK 2013 [Available online: https://www.rnib.org.uk/sites/default/files/Sight_loss_UK_2013.pdf] 9.,Non-OADS,/arxiv_data1/oa_pdf/3d/c8/bmjqir-u211608-w4680.PMC4964165.pdf
The Royal College of General Practitioners (revised 2015) Eye Health [Available online: http://www.rcgp.org.uk/eyehealth] 10.,Non-OADS,/arxiv_data1/oa_pdf/3d/c8/bmjqir-u211608-w4680.PMC4964165.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011459).,Non-OADS,/arxiv_data1/oa_pdf/31/ba/bmjopen-2016-011459.PMC4964166.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.g08gb.,OADS,/arxiv_data1/oa_pdf/31/ba/bmjopen-2016-011459.PMC4964166.pdf
2015. http://www.un.org/millenniumgoals/2015_MDG_Report/pdf/MDG 2015 rev ( July 1).pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/31/ba/bmjopen-2016-011459.PMC4964166.pdf
http://www.un.org/en/ga/70/resolutions.shtml 3.,Non-OADS,/arxiv_data1/oa_pdf/31/ba/bmjopen-2016-011459.PMC4964166.pdf
2015. http://who.int/life-course/partners/global-strategy/globalstrategyreport2016-2030-lowres.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/31/ba/bmjopen-2016-011459.PMC4964166.pdf
2015. http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-2015/en/10.,Non-OADS,/arxiv_data1/oa_pdf/31/ba/bmjopen-2016-011459.PMC4964166.pdf
http://www.who.int/reproductivehealth/publications/monitoring/9789241547734/en/ 18.,Non-OADS,/arxiv_data1/oa_pdf/31/ba/bmjopen-2016-011459.PMC4964166.pdf
https://nrhm-mis.nic.in/hmisreports/frmstandard_reports.aspx 22.,Non-OADS,/arxiv_data1/oa_pdf/31/ba/bmjopen-2016-011459.PMC4964166.pdf
2015. http://apps.who.int/iris/bitstream/10665/161442/1/WHO_RHR_15.02_eng.pdf?ua=1 23.,OADS,/arxiv_data1/oa_pdf/31/ba/bmjopen-2016-011459.PMC4964166.pdf
"http://www.censusindia.gov.in/2011-Common/Sample_Registration_System.html 8 Strehlow MC, et al.BMJ Open 2016; 6:e011459.",OADS,/arxiv_data1/oa_pdf/31/ba/bmjopen-2016-011459.PMC4964166.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ vetreco-2016-000173).,Non-OADS,/arxiv_data1/oa_pdf/95/74/vetreco-2016-000173.PMC4964167.pdf
Analyses of this type do not require individual ethical permission as they are viewed as audit (see http://www.hra.nhs.uk/research-community/before-you-apply/ determine-whether-your-study-is-research/).,Non-OADS,/arxiv_data1/oa_pdf/ff/30/bmjopen-2016-012078.PMC4964168.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ff/30/bmjopen-2016-012078.PMC4964168.pdf
http://www.oecd.org/els/health-systems/Focus-on-Health-Making-Mental-Health-Count.pdf 3. WHO.,Non-OADS,/arxiv_data1/oa_pdf/13/96/bmjopen-2016-011579.PMC4964169.pdf
http://www.who.int/mental_health/publications/action_plan/en/ 4.,Non-OADS,/arxiv_data1/oa_pdf/13/96/bmjopen-2016-011579.PMC4964169.pdf
2015. http://www.nivel.nl/en/dossier/nivel-primary-care-database (accessed 22 Dec2015).,Non-OADS,/arxiv_data1/oa_pdf/13/96/bmjopen-2016-011579.PMC4964169.pdf
https://www.lhv.nl/actueel/nieuws/huisarts-vangnet-voor-patienten-met-psychische-problemen(accessed 22 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/13/96/bmjopen-2016-011579.PMC4964169.pdf
http://www.nivel.nl/node/3166 (accessed 18 Feb 2016).23.,Non-OADS,/arxiv_data1/oa_pdf/13/96/bmjopen-2016-011579.PMC4964169.pdf
"Dutch Civil Law, Article 7:458. http://www.dutchcivillaw.com/ civilcodebook077.htm (accessed 22 Dec 2015).",Non-OADS,/arxiv_data1/oa_pdf/13/96/bmjopen-2016-011579.PMC4964169.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:e010158corr1.,Non-OADS,/arxiv_data1/oa_pdf/39/3f/bmjopen-2015-010158corr1.PMC4964170.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011630).,Non-OADS,/arxiv_data1/oa_pdf/3d/06/bmjopen-2016-011630.PMC4964173.pdf
"For comparison, we searched Scopus (http://www.scopus.com/ search/form.url; retrieved on 15 July 2015) for total citation counts of the T100 articles.",OADS,/arxiv_data1/oa_pdf/3d/06/bmjopen-2016-011630.PMC4964173.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/rmdopen-2016-000272).,Non-OADS,/arxiv_data1/oa_pdf/6f/50/rmdopen-2016-000272.PMC4964174.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/de/9b/bmjopen-2015-010651.PMC4964175.pdf
2005. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078932.pdf 81.,Non-OADS,/arxiv_data1/oa_pdf/de/9b/bmjopen-2015-010651.PMC4964175.pdf
"ICH Harmonised Tripartite Guideline, Clinical SafetyData Management: Definitions and Standards for ExpeditedReporting E2A, 1994. https://www.ich.org/fileadmin/Public_ Web_Site/ICH_Products/Guidelines/Efficacy/E2A/Step4/E2A_ Guideline.pdf 84.",Non-OADS,/arxiv_data1/oa_pdf/de/9b/bmjopen-2015-010651.PMC4964175.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010751).,Non-OADS,/arxiv_data1/oa_pdf/54/b0/bmjopen-2015-010751.PMC4964176.pdf
"Washington DC: U.S. Environmental Protection Agency, EPA/600/R-08/139F, 2009 http://cfpub.epa.gov/ncea/risk/recordisplay.cfm?deid=216546&CFID=39659091&CFTOKEN=38401757 (accessed Dec 2015).",OADS,/arxiv_data1/oa_pdf/54/b0/bmjopen-2015-010751.PMC4964176.pdf
"Washington DC: U.S. Environmental Protection Agency, EPA/600/R-14/006.http://cfpub.epa.gov/ncea/isa/recordisplay.cfm?deid=288043(accessed Dec 2015).",OADS,/arxiv_data1/oa_pdf/54/b0/bmjopen-2015-010751.PMC4964176.pdf
"2013. http://www.euro.who.int/en/ health-topics/environment-and-health/air-quality/publications/2013/review-of-evidence-on-health-aspects-of-air-pollution-revihaap- project-final-technical-report, (accessed Dec 2015).",Non-OADS,/arxiv_data1/oa_pdf/54/b0/bmjopen-2015-010751.PMC4964176.pdf
2011. http://www.hpa.,Non-OADS,/arxiv_data1/oa_pdf/54/b0/bmjopen-2015-010751.PMC4964176.pdf
2009. http://webarchive.nationalarchives.gov.uk/20140505104658/http://www.comeap.org.uk/documents/statements/39-page/linking/86-quantification-of-the-effects-of-long-term-exposure-to-nitrogen-dioxide (accessed Dec 2015).,OADS,/arxiv_data1/oa_pdf/54/b0/bmjopen-2015-010751.PMC4964176.pdf
"Report to the United Kingdom Department of Health, 2007. https://www.gov.uk/government/publications/quantitative-systematic-review-of-short-term-associations-between-ambient-air-pollution-particulate-matter-ozone-nitrogen-dioxide-sulphur-dioxide-and-carbon-monoxide-and-mortality-and-morbidity (accessed Jun 2015).14.",Non-OADS,/arxiv_data1/oa_pdf/54/b0/bmjopen-2015-010751.PMC4964176.pdf
"The Cochrane Collaboration, 2015. http://handbook.cochrane.org/(accessed Apr 2015).",OADS,/arxiv_data1/oa_pdf/54/b0/bmjopen-2015-010751.PMC4964176.pdf
2006. http://www.gov.uk/government/collections/comeap-reports (accessed Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/54/b0/bmjopen-2015-010751.PMC4964176.pdf
"Washington DC: U.S. Environmental Protection Agency, EPA/600/R-08/071, 2008. http://cfpub.epa.gov/ncea/isa/recordisplay.cfm?deid=194645, (accessed Dec 2015).",OADS,/arxiv_data1/oa_pdf/54/b0/bmjopen-2015-010751.PMC4964176.pdf
"http://yosemite.epa.gov/sab/sabproduct.nsf/15E4619D3CD3409A85257CF30069387D/$File/EPA-CASAC-14-002+unsigned.pdf,(accessed Apr 2015).",OADS,/arxiv_data1/oa_pdf/54/b0/bmjopen-2015-010751.PMC4964176.pdf
See: Âhttp://creativecommons.org/licenses/by-nc/2.0/ Âhttp://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/1f/bmjqir-u215456-w4946.PMC4964177.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2016-000262).,Non-OADS,/arxiv_data1/oa_pdf/ea/03/rmdopen-2016-000262.PMC4964179.pdf
"TWJH reports that the department of rheumatology has mutual projects with a number of EFPIA members (see http://www.BTCURE.com), plus grants from the Dutch arthritis foundation, the Dutch NIH and the EU.",Non-OADS,/arxiv_data1/oa_pdf/ea/03/rmdopen-2016-000262.PMC4964179.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011584).,Non-OADS,/arxiv_data1/oa_pdf/8b/67/bmjopen-2016-011584.PMC4964180.pdf
"Data analysis All analyses will be performed blind to participantgroup.Analysis of MRI data Structural MRI scans will be processed using BET and FAST , both packages of the publicly available image pro-cessing software FSL 5.0 (http://www.fmrib.ox.ac.uk/ fsl/tbss/index.html) to identify grey matter (GM) and white matter (WM), and CSF components on theimage.",Non-OADS,/arxiv_data1/oa_pdf/8b/67/bmjopen-2016-011584.PMC4964180.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012125).,Non-OADS,/arxiv_data1/oa_pdf/c2/c7/bmjopen-2016-012125.PMC4964181.pdf
http://www.who.int/globalchange/publications/WMO_WHO_Heat_Health_Guidance_2015.pdf (accessed 26 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/c7/bmjopen-2016-012125.PMC4964181.pdf
http://www.ses.sa.gov.au/site/community_safety/heatsafe/extreme_heat_plan.jsp (accessed 26 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/c7/bmjopen-2016-012125.PMC4964181.pdf
http://www.redcross.org.au/ telecross-redi.aspx (accessed 26 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/c7/bmjopen-2016-012125.PMC4964181.pdf
http://www.sahealth.sa.gov.au/wps/wcm/ connect/public+content/sa+health+internet/protecting+public+health/emergency+management/extreme+heat (accessed 26 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/c7/bmjopen-2016-012125.PMC4964181.pdf
The IPAQguidelines for data management (http://www.ipaq.ki.se) were followed.,Non-OADS,/arxiv_data1/oa_pdf/1c/48/openhrt-2016-000484.PMC4964183.pdf
2013. http://www.health.gov.au/internet/main/publishing.nsf/Content/health-pubhlth-strateg-phys-act-guidelines âapaadult (accessed Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/1c/48/openhrt-2016-000484.PMC4964183.pdf
2008. http://www.health.gov/paguidelines/pdf/paguide.pdf (accessed Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/1c/48/openhrt-2016-000484.PMC4964183.pdf
2011. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213740/dh_128145.pdf (accessed Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/1c/48/openhrt-2016-000484.PMC4964183.pdf
2013. http://www.abs.gov.au/ausstats/abs@.nsf/mf/2033.0.55.001 (accessed Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/1c/48/openhrt-2016-000484.PMC4964183.pdf
"Adelaide: South Australian Department ofHealth, 2009. https://health.adelaide.edu.au/pros/docs/reports/general/qol_population_profile_population_norms_sf36_2009.pdf (accessed 1 Mar 2016).",Non-OADS,/arxiv_data1/oa_pdf/1c/48/openhrt-2016-000484.PMC4964183.pdf
2013. http://www.abs.,Non-OADS,/arxiv_data1/oa_pdf/1c/48/openhrt-2016-000484.PMC4964183.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011836).,Non-OADS,/arxiv_data1/oa_pdf/37/19/bmjopen-2016-011836.PMC4964184.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010836).,Non-OADS,/arxiv_data1/oa_pdf/c2/dd/bmjopen-2015-010836.PMC4964186.pdf
"Competing interests All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: SP has received personal fees from: Novo Nordisk, Sanofi Aventis, Janssen, Bristol Myers Squibb, Astazeneca, Roche; NS has had some funding from Astrazeneca for a clinical trial and personal fees from Boehringer Ingelheimand Janssen.",Non-OADS,/arxiv_data1/oa_pdf/c2/dd/bmjopen-2015-010836.PMC4964186.pdf
"Data sharing statement Applications to use the data should be directed to the data custodians, see http://www.informationgovernance.scot.nhs.uk/ for further information.",Non-OADS,/arxiv_data1/oa_pdf/c2/dd/bmjopen-2015-010836.PMC4964186.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c2/dd/bmjopen-2015-010836.PMC4964186.pdf
2010. http://www.sign.ac.uk/pdf/ sign115.pdf (accessed 06 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/dd/bmjopen-2015-010836.PMC4964186.pdf
2013. http://www.sci-diabetes.scot.nhs.uk/ (accessed 06 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/dd/bmjopen-2015-010836.PMC4964186.pdf
http://22fa0f74501b902c9f11-8b3fbddfa1e1fab453a8e75cb14f3396.r26.cf3.rackcdn.com/simd_448749_v7_20121217.pdf(accessed 06 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/dd/bmjopen-2015-010836.PMC4964186.pdf
2014. https://www.nice.org.uk/guidance/ph53/resources/weight-management-lifestyle-services-for-overweight-or-obese-adults-1996416726469 (accessed06 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/dd/bmjopen-2015-010836.PMC4964186.pdf
http://www.sign.ac.uk/pdf/sign116.pdf(accessed 06 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/dd/bmjopen-2015-010836.PMC4964186.pdf
2013. http://www.hscic.gov.uk/catalogue/PUB16076/HSE2013-Ch10-Adult-anth-meas.pdf(accessed 06 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/dd/bmjopen-2015-010836.PMC4964186.pdf
2014-2018. https://www.diabetes.org.uk/Research/ Our-research-projects/Scotland/The-DiRECT-route-to-Type-2-remission/ (accessed 06 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c2/dd/bmjopen-2015-010836.PMC4964186.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011985).,Non-OADS,/arxiv_data1/oa_pdf/29/5b/bmjopen-2016-011985.PMC4964187.pdf
Competing interests All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/5b/bmjopen-2016-011985.PMC4964187.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Schwartz RA.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/bcr-2016-216073.PMC4964191.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012107).,Non-OADS,/arxiv_data1/oa_pdf/57/66/bmjopen-2016-012107.PMC4964199.pdf
Competing interests All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare no support from any organisation for the submitted work; no financial relationships with any organisation that might have an interest in the submitted work in the previous 3 years; no other relationships or activitiesthat could appear to have influenced the submitted work.,Non-OADS,/arxiv_data1/oa_pdf/57/66/bmjopen-2016-012107.PMC4964199.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/57/66/bmjopen-2016-012107.PMC4964199.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010197).,Non-OADS,/arxiv_data1/oa_pdf/1c/31/bmjopen-2015-010197.PMC4964200.pdf
"Competing interests All authors have read and understood BMJ policy on declaration of interests and have completed the ICMJE uniform disclosure at http://www.icmje.org/coi_disclosure.pdf and declare financial support for thesubmitted work from GlaxoSmithKline and the following interests: IC reports receiving lecturing and consulting fees from Medtronic, Bayer AG, GlaxoSmithKline, Eli Lilly & Co, NovoNordisk A/S, Sanofi-Aventis, Novartis, Astra Zeneca and MSD.",Non-OADS,/arxiv_data1/oa_pdf/1c/31/bmjopen-2015-010197.PMC4964200.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1c/31/bmjopen-2015-010197.PMC4964200.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/1c/31/bmjopen-2015-010197.PMC4964200.pdf
http://ec.europa.eu/ health/documents/community-register/2013/20130201125120/anx_125120_es.pdf (accessed 29 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/1c/31/bmjopen-2015-010197.PMC4964200.pdf
http://www.ema.europa.eu/ docs/es_ES/document_library/EPAR_-_Product_Information/human/000698/WC500051845.pdf (accessed 29 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/1c/31/bmjopen-2015-010197.PMC4964200.pdf
http://ec.europa.eu/ health/documents/community-register/2011/20110617103730/anx_103730_es.pdf (accessed 29 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/1c/31/bmjopen-2015-010197.PMC4964200.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011919).,Non-OADS,/arxiv_data1/oa_pdf/21/84/bmjopen-2016-011919.PMC4964202.pdf
2014.http://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000080278.pdf (accessed24 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/21/84/bmjopen-2016-011919.PMC4964202.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010484).,Non-OADS,/arxiv_data1/oa_pdf/78/80/bmjopen-2015-010484.PMC4964204.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/78/80/bmjopen-2015-010484.PMC4964204.pdf
US Health and Human Services Office for Human Research Protections.http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/ucm119074.htm (accessed 5 Apr 2016).,OADS,/arxiv_data1/oa_pdf/78/80/bmjopen-2015-010484.PMC4964204.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011930).,Non-OADS,/arxiv_data1/oa_pdf/5f/c8/bmjopen-2016-011930.PMC4964205.pdf
2014. http://fukushima.grs.de/sites/default/files/NISA-IAEA-Fukushima_2011-06-08.pdf#search=%27Report+of+Japanese+Government+to+IAEA+Ministerial+Conference+on+Nuclear+SafetyAccident+at+TEPCO%E2%80%99s+Fukushima+Nuclear+Power+Stations%27 (accessed 13 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/5f/c8/bmjopen-2016-011930.PMC4964205.pdf
http://www.unscear.org/docs/reports/2013/13-85418_Report_2013_Annex_A.pdf (accessed 13 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/5f/c8/bmjopen-2016-011930.PMC4964205.pdf
http://www.reconstruction.go.jp/topics/main-cat2/sub-cat2-1/20160226_hinansha.pdf (accessed 13 Mar 2016).,OADS,/arxiv_data1/oa_pdf/5f/c8/bmjopen-2016-011930.PMC4964205.pdf
https://www.pref.fukushima.lg.jp/sec/21045b/kenkocyosa-kentoiinkai-22.html (accessed 13 Mar 2016).,OADS,/arxiv_data1/oa_pdf/5f/c8/bmjopen-2016-011930.PMC4964205.pdf
http://radioactivity.nsr.go.jp/map/ja/area.html (accessed13 Mar 2016).,OADS,/arxiv_data1/oa_pdf/5f/c8/bmjopen-2016-011930.PMC4964205.pdf
See: Âhttp://creativecommons.org/licenses/by-nc/2.0/ Âhttp://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/37/5d/bmjqir-u210402-w4210.PMC4964208.pdf
"2012. http://www.kingsfund.org.uk/sites/files/kf/field/field_publication_file/long-term-conditions-mental-health-cost-comorbidities-naylor-feb12.pdf Choudhury-Peters D, Dain V. BMJ Quality Improvement Reports 2016; 5:u210402.w4210.",Non-OADS,/arxiv_data1/oa_pdf/37/5d/bmjqir-u210402-w4210.PMC4964208.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012105).,Non-OADS,/arxiv_data1/oa_pdf/44/0d/bmjopen-2016-012105.PMC4964210.pdf
https://sites.google.,Non-OADS,/arxiv_data1/oa_pdf/ae/05/bmjopen-2015-010013.PMC4964211.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ae/05/bmjopen-2015-010013.PMC4964211.pdf
2015. http://data.worldbank.org/indicator/SH.STA.MMRT (accessed 12 Jan 2106).,Non-OADS,/arxiv_data1/oa_pdf/ae/05/bmjopen-2015-010013.PMC4964211.pdf
2013. http://www.ncss.com (accessed 31 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/ae/05/bmjopen-2015-010013.PMC4964211.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011227).,Non-OADS,/arxiv_data1/oa_pdf/d6/b0/bmjopen-2016-011227.PMC4964214.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7f/93/bmjdrc-2016-000246.PMC4964215.pdf
To view please visit the journal (http://dx.doi.org/10.1136/lupus-2016- 000161).,Non-OADS,/arxiv_data1/oa_pdf/b4/ae/lupus-2016-000161.PMC4964216.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b4/ae/lupus-2016-000161.PMC4964216.pdf
2011. http://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf 7.,OADS,/arxiv_data1/oa_pdf/b4/ae/lupus-2016-000161.PMC4964216.pdf
"Washington DC: U.S. Department of Health and Human Services, 2011. https://www.healthypeople.gov 47.",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/lupus-2016-000161.PMC4964216.pdf
"Presently, HbA1c is expressed in National Glycohemoglobin StandardizationProgram (NGSP) and IFCC standards (http://www.ngsp.",Non-OADS,/arxiv_data1/oa_pdf/1e/c2/bmjdrc-2016-000209.PMC4964219.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ rmdopen-2015-000239).,Non-OADS,/arxiv_data1/oa_pdf/f0/31/rmdopen-2015-000239.PMC4964220.pdf
See: Âhttp://creativecommons.org/licenses/by-nc/2.0/ Âhttp://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0c/31/bmjqir-u209186-w3750.PMC4964229.pdf
May 2014. http://www.acutemedicine.org.uk/wp-content/uploads/2014/11/Plenary-5-1030-Wrong-Place-Anytime-Why-Boarding-is-Bad-for-Patients-Hospitals-and-Healthcare-Systems.pdf (accessed November 19th 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/31/bmjqir-u209186-w3750.PMC4964229.pdf
https://www.rcpe.ac.uk/policy-standards/pressures-acute-medical-specialities (accessed September 3rd 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/31/bmjqir-u209186-w3750.PMC4964229.pdf
http://www.bbc.co.uk/news/uk-scotland-23482451 (accessed November 19th 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/31/bmjqir-u209186-w3750.PMC4964229.pdf
http://www.shiftingthebalance.scot.nhs.uk/initiatives/sbc-initiatives/emergency-access-delivery-programme/winter-planning/ (accessed September3rd 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/31/bmjqir-u209186-w3750.PMC4964229.pdf
https://www.bma.org.uk/news/2013/december/bma-plans-to-tackle-winter-pressures (accessed June 3rd 2016).,Non-OADS,/arxiv_data1/oa_pdf/0c/31/bmjqir-u209186-w3750.PMC4964229.pdf
http://www.gov.scot/ Topics/Health/Quality-Improvement-Performance/UnscheduledCare(accessed November 19th 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/31/bmjqir-u209186-w3750.PMC4964229.pdf
http://www.health.org.uk/sites/default/files/ImprovingPatientFlowAcrossPathwaysAndOrganisations.pdf(accessed November 19th 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/31/bmjqir-u209186-w3750.PMC4964229.pdf
http://attendee-io-production.s3.amazonaws.com/events/52c453cac76ab7b722000013/posters/8ab14ed3-56a7-4468-aa9a-4e6e5688f6cf/Boarder%20Patient%20-%20equal%20care%20from%20primary%20team.pdf (accessed November 24th 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/31/bmjqir-u209186-w3750.PMC4964229.pdf
See: Âhttp://creativecommons.org/licenses/by-nc/2.0/ Âhttp://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/bmjqir-u210787-w4336.PMC4964230.pdf
"See: Âhttp://creativecommons.org/licenses/by-nc/2.0/ Âhttp://creativecommons.org/licenses/by-nc/2.0/legalcodeFigure 3 4 Locke A, Kamo N. BMJ Quality Improvement Reports 2016; 5:u211816.w4748.",Non-OADS,/arxiv_data1/oa_pdf/73/b8/bmjqir-u211816-w4748.PMC4964234.pdf
Availablefrom: http://wahealthalliance.org/wp-content/uploads.php?link-year=2015&link-month=12&link=community_checkup_report_2015.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/73/b8/bmjqir-u211816-w4748.PMC4964234.pdf
Geneva: World Health Organization; 2003 [cited 2016 Mar 13].Available from: http://www.who.int/mental_health/media/investing_mnh.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/73/b8/bmjqir-u211816-w4748.PMC4964234.pdf
Available from: http://kff.org/medicaid/report/mental-health-financing-in-the-united-states/ 4.,Non-OADS,/arxiv_data1/oa_pdf/73/b8/bmjqir-u211816-w4748.PMC4964234.pdf
Available from: http://us.milliman.com/insight/research/health/pdfs/Chronic-conditions-and-comorbid-psychological-disorders/ 5.,Non-OADS,/arxiv_data1/oa_pdf/73/b8/bmjqir-u211816-w4748.PMC4964234.pdf
Available from:https://www.nice.org.uk/guidance/cg90.,Non-OADS,/arxiv_data1/oa_pdf/73/b8/bmjqir-u211816-w4748.PMC4964234.pdf
Available from: https://www.england.nhs.uk/mentalhealth/parity/ 8.,Non-OADS,/arxiv_data1/oa_pdf/73/b8/bmjqir-u211816-w4748.PMC4964234.pdf
Available from: http://www.ncqa.org/ hedis-quality-measurement/hedis-learning-collaborative/ hedis-depression-measures 10.,Non-OADS,/arxiv_data1/oa_pdf/73/b8/bmjqir-u211816-w4748.PMC4964234.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011326).,Non-OADS,/arxiv_data1/oa_pdf/ea/77/bmjopen-2016-011326.PMC4964235.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012362).,Non-OADS,/arxiv_data1/oa_pdf/60/c3/bmjopen-2016-012362.PMC4964236.pdf
Competing interests All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on requestfrom the corresponding author) and declare: LAM and LF are full-time employees of Pfizer and own stocks and/or options in Pfizer Inc. Provenance and peer review Not commissioned; externally peer reviewed.,OADS,/arxiv_data1/oa_pdf/60/c3/bmjopen-2016-012362.PMC4964236.pdf
2007. http://www.gpo.gov/fdsys/pkg/PLAW-110publ85/pdf/ PLAW-110publ85.pdf.,Non-OADS,/arxiv_data1/oa_pdf/60/c3/bmjopen-2016-012362.PMC4964236.pdf
2010. http://www.efpia.eu/ uploads/Modules/Documents/20100610_joint_position_publication_10jun2010.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/60/c3/bmjopen-2016-012362.PMC4964236.pdf
2013. http://www.pfizer.com/research/research_ clinical_trials/registration_disclosure_authorship (accessed 15 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/60/c3/bmjopen-2016-012362.PMC4964236.pdf
2016. http://www.amgen.com/science/clinical-trials/clinical-data-transparency-practices/ (accessed 10 Apr 2016).,OADS,/arxiv_data1/oa_pdf/60/c3/bmjopen-2016-012362.PMC4964236.pdf
http://www.icmje.org/urm_main.html (accessed24 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/60/c3/bmjopen-2016-012362.PMC4964236.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011613).,Non-OADS,/arxiv_data1/oa_pdf/e0/9c/bmjopen-2016-011613.PMC4964238.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e0/9c/bmjopen-2016-011613.PMC4964238.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009641).,Non-OADS,/arxiv_data1/oa_pdf/a8/1c/bmjopen-2015-009641.PMC4964239.pdf
"Best practice referral pathways for general practitioners, 2012.https://www.gov.uk/government/publications/direct-access-to-diagnostic-tests-for-cancer-best-practice-referral-pathways-for-general-practitioners (accessed Mar 2015).",Non-OADS,/arxiv_data1/oa_pdf/a8/1c/bmjopen-2015-009641.PMC4964239.pdf
2014. https://www.iarc.fr/en/publications/pdfs-online/epi/sp164/CI5volX_Full.pdf36.,Non-OADS,/arxiv_data1/oa_pdf/a8/1c/bmjopen-2015-009641.PMC4964239.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011945).,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bmjopen-2016-011945.PMC4964241.pdf
2012. http://www.alzheimer.ca/~/media/Files/national/Media-releases/asc_factsheet_new_data_09272012_en.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bmjopen-2016-011945.PMC4964241.pdf
"U.S. Census Bureau , Washington DC, USA, 2014. https://www.census.gov/prod/2014pubs/p25-1140.pdf.",OADS,/arxiv_data1/oa_pdf/e3/b2/bmjopen-2016-011945.PMC4964241.pdf
"Catalogue no.98-311-X2011001, 2012. http://www12.statcan.gc.ca/census-recensement/2011/as-sa/98-311-x/98-311-x2011001-eng.pdf 23.",OADS,/arxiv_data1/oa_pdf/e3/b2/bmjopen-2016-011945.PMC4964241.pdf
http://dx.doi.org/10.1093/ geront/gnv074 41.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bmjopen-2016-011945.PMC4964241.pdf
2016. http://www.asha.org/public/hearing/Hearing-Screening 56.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bmjopen-2016-011945.PMC4964241.pdf
http://opto.ca/sites/default/ files/resources/documents/cjo_volume_74_no_3_canadian_research_contributions_to_low_vision_rehabilitation.pdf 58.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bmjopen-2016-011945.PMC4964241.pdf
2001. http://www.rand.org/pubs/monograph_reports/MR1269.html 62.,Non-OADS,/arxiv_data1/oa_pdf/e3/b2/bmjopen-2016-011945.PMC4964241.pdf
Further information on the ethical committee may beobtained from the website http://www.shds.in Provenance and peer review Not commissioned; externally peer reviewed.,Non-OADS,/arxiv_data1/oa_pdf/11/33/bmjopen-2015-010085.PMC4964242.pdf
"Noncommunicable Diseases (NCD) Country Profiles, 2011. http://www.who.int/nmh/countries/ind_en.pdf 6.",Non-OADS,/arxiv_data1/oa_pdf/11/33/bmjopen-2015-010085.PMC4964242.pdf
Incentives for abstinence Monetary reward for abstinence will be given through vouchers (Kadeos http://www.ed enred.fr/besoin/avantages- aux-salaries/produit/ticket-kadeos/) that can be redeemed in many different shops and superstores; they cannot be used to buy tobacco or alcohol products.,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
"â¸Assessment of intrauterine growth restriction calcu- lated by AUDIPOG (http://www.augipog.net), anational network of intrauterine growth data.",OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
This research complies with the law of 6 January 1978 article 54 and was declared to the Commission nationale de l âinforma- tique et des libertÃ©s (CNIL) (https://www.formulaires.,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
"Sponsor: Assistance public-HÃ´pitaux de Paris (APHP) http://www.aphp.fr, DÃ©partement de laRecherche Clinique et DÃ©veloppement (study number: P140106).",Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
2012. http://www.sante.gouv.fr/rapport-de-yves-bur- proposition-pour-une-nouvelle-politique-de-lutte-contre-le-tabac.htm 4.,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
http://societe-francaise-de-tabacologie.com/dl/ CourComptes-tabagisme2012.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
OFDT Note 2015-04. http://www.ofdt.fr/BDD/publications/docs/eisxpkv9.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
http://www.sante.gouv.fr/IMG/pdf/Les_ naissances_en_2010_et_leur_evolution_depuis_2003.pdf (accessed5 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
"Institut national de la statistique et des Ã©tudes Ã©conomiques, Insee âPopulation âStatistiques d âÃ©tat civil sur les naissances en 2010. http://www.insee.fr/fr/themes/document.asp?ref_id=sd20101(accessed 1 Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
http://ansm.sante.fr/S-informer/Presse-Communiques-Points-presse/Traitements-de-Substituts- Nicotiniques-TSN-et-femmes-enceintes/%28language%29/fre-FR (accessed 9 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
"http://www.nice.org.uk/ 10 Berlin N, et al.BMJ Open 2016; 6:e011669.",Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
http://www.ahrq.gov/professionals/clinicians-providers/guidelinesrecommendations/tobacco/clinicians/ update/treating_tobacco_use08.pdf (accessed 9 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10-fr.pdf 65.,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
http://www.inpes.sante.fr/30000/pdf/2014/Essentiel_GrossesseArretTabac.pdf (accessed 3 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
https://www.uvm.edu/medicine/behaviorandhealth/?Page=minnws.,Non-OADS,/arxiv_data1/oa_pdf/8c/1a/bmjopen-2016-011669.PMC4964243.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.nr6bf.,OADS,/arxiv_data1/oa_pdf/4a/7b/bmjopen-2016-011747.PMC4964244.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012285).,Non-OADS,/arxiv_data1/oa_pdf/63/97/bmjopen-2016-012285.PMC4964247.pdf
2015. https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/10/d08pb-intra-pumps-trtmnt.pdf (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/63/97/bmjopen-2016-012285.PMC4964247.pdf
2013. https://www.england.nhs.uk/wp-content/uploads/2013/04/d04-p-c.pdf (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/63/97/bmjopen-2016-012285.PMC4964247.pdf
2015. https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/10/d08pa-intrathecal-pumps-oct15.pdf (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/63/97/bmjopen-2016-012285.PMC4964247.pdf
2015. http://www.crd.york.ac.uk/crdweb/searchstrategies.asp (accessed 17Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/63/97/bmjopen-2016-012285.PMC4964247.pdf
2015. http://www.sign.ac.uk/methodology/filters.html (accessed 17 Dec2015).,Non-OADS,/arxiv_data1/oa_pdf/63/97/bmjopen-2016-012285.PMC4964247.pdf
"Chichester: John Wiley &Sons, 2011. http://handbook.cochrane.org/chapter_15/15_10_chapter_information.htm 6 Duarte RV, et al.BMJ Open 2016; 6:e012285.",OADS,/arxiv_data1/oa_pdf/63/97/bmjopen-2016-012285.PMC4964247.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011564).,Non-OADS,/arxiv_data1/oa_pdf/1f/0c/bmjopen-2016-011564.PMC4964248.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011959).,Non-OADS,/arxiv_data1/oa_pdf/27/60/bmjopen-2016-011959.PMC4964252.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/27/60/bmjopen-2016-011959.PMC4964252.pdf
http://www.stats.gov.cn/tjsj/ndsj/2013/ indexch.htm 24.,OADS,/arxiv_data1/oa_pdf/5f/76/bmjopen-2016-011388.PMC4964254.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012363).,Non-OADS,/arxiv_data1/oa_pdf/20/8e/bmjopen-2016-012363.PMC4964303.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/20/8e/bmjopen-2016-012363.PMC4964303.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008281).,Non-OADS,/arxiv_data1/oa_pdf/80/de/bmjopen-2015-008281.PMC4964313.pdf
"Sao Paulo 2016;58:48 http://dx.doi.org/10.1590/S1678-9946201658048 ORIGINAL ARTICLE In situ  CUTANEOUS CELLULAR IMMUNE RESPONSE IN DOGS NATURALLY AFFECTED BY  VISCERAL LEISHMANIASIS Claudio Nazaretian ROSSI(1), Thaise Yumie TOMOKANE(2), Luis FÃ¡bio da Silva BATISTA(3), Mary MARCONDES(4),   Carlos Eduardo LARSSON(1) & MÃ¡rcia Dalastra LAURENTI(2) SUMMARY Thirty-eight dogs naturally affected by visceral leishmaniasis were recruited in AraÃ§atuba, SÃ£o Paulo  State, Brazil â an endemic  area for visceral leishmaniasis.",Non-OADS,/arxiv_data1/oa_pdf/de/e8/0036-4665-rimtsp-58-00048.PMC4964317.pdf
"Sao Paulo 2016;58:49 http://dx.doi.org/10.1590/S1678-9946201658049 ORIGINAL ARTICLE CUTANEOUS TUBERCULOSIS: A 26-YEAR RETROSPECTIVE STUDY IN AN ENDEMIC AREA OF  TUBERCULOSIS, VITÃRIA,  ESPÃRITO SANTO,  BRAZIL Karla SPELTA(1) & Lucia M. DINIZ(1,2) SUMMARY Background : Tuberculosis is a serious health problem in Brazil so that the knowledge on the aspects of cutaneous tuberculosis  is medically important.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/0036-4665-rimtsp-58-00049.PMC4964318.pdf
Available from: http://www.who.int/tb/publications/global_report/en/ index.html    2.,OADS,/arxiv_data1/oa_pdf/ee/ee/0036-4665-rimtsp-58-00049.PMC4964318.pdf
Available from: http://portalsaude.saude.gov.br/images/pdf/2014/ novembro/24/panorama-tuberculose-brasil-out14-web.pdf  3.,Non-OADS,/arxiv_data1/oa_pdf/ee/ee/0036-4665-rimtsp-58-00049.PMC4964318.pdf
Available from: http://www.who.int/tb/publications/global_report/2010/ en/  48.,Non-OADS,/arxiv_data1/oa_pdf/ee/ee/0036-4665-rimtsp-58-00049.PMC4964318.pdf
"Sao Paulo 2016;58:50 http://dx.doi.org/10.1590/S1678-9946201658050 ORIGINAL ARTICLE SAND FLY SPECIES COMPOSITION (DIPTERA: PSYCHODIDAE: PHLEBOTOMINAE) IN THE  MUNICIPALITY OF CANTAGALO , AN AREA WITH SPORADIC CASES OF HUMAN CUTANEOUS  LEISHMANIASIS IN  RIO DE JANEIRO  STATE , BRAZIL Quezia Nunes PERES-DIAS(1), Claudete Diniz OLIVEIRA(2), Marcos Barbosa de SOUZA(1), AntÃ´nio de Medeiros MEIRA(1) & Ciro Benigno VILLANOV A(1) SUMMARY The municipality of Cantagalo  is an area with sustained transmission of American Cutaneous Leishmaniasis (ACL).",Non-OADS,/arxiv_data1/oa_pdf/bf/5e/0036-4665-rimtsp-58-00050.PMC4964319.pdf
Available from: http://www.saude.gov.,Non-OADS,/arxiv_data1/oa_pdf/bf/5e/0036-4665-rimtsp-58-00050.PMC4964319.pdf
Available from: http://www.cidades.ibge.gov.br/xtras/perfil.,OADS,/arxiv_data1/oa_pdf/bf/5e/0036-4665-rimtsp-58-00050.PMC4964319.pdf
"Sao Paulo 2016;58:51 http://dx.doi.org/10.1590/S1678-9946201658051 ORIGINAL ARTICLE DETECTION OF INTESTINAL PARASITES IN THE ENVIRONMENTS OF A PUBLIC SCHOOL IN   THE TOWN OF DIAMANTINA , MINAS GERAIS  STATE, BRAZIL  EdvÃ¢nia Beatriz dos Santos PEREIRA(1), SÃ¢mara Lauren Cunha RODRIGUES(1), Gustavo Henrique BAHIA-DE-OLIVEIRA(2),   Suedali Villas BÃ´as COELHO(3) & Ricardo Andrade BARATA(1) SUMMARY  Intestinal parasites are a major public health problem in developing countries, most prevalent in areas where sanitation is poor and  the populationâs hygiene is inadequate.",Non-OADS,/arxiv_data1/oa_pdf/f2/a9/0036-4665-rimtsp-58-00051.PMC4964320.pdf
"Sao Paulo 2016;58:52 http://dx.doi.org/10.1590/S1678-9946201658052 ORIGINAL ARTICLE CLINICAL CHARACTERISTICS, OUTCOMES AND RISK FACTORS FOR DEATH AMONG CRITICALLY  ILL PATIENTS WITH HIV-RELATED ACUTE KIDNEY INJURY Leonardo Duarte Sobreira LUNA(1), Douglas de Sousa SOARES(1), Geraldo Bezerra da SILV A JUNIOR(2), Malena Gadelha CA V ALCANTE(3),   Lara Raissa Cavalcante MALVEIRA(1), Gdayllon Cavalcante MENESES(3), Eanes Delgado Barros PEREIRA(2) & Elizabeth De Francesco DAHER(1,2) SUMMARY Background: The aim of this study is to describe clinical characteristics, outcomes and risk factors for death among patients with  HIV-related acute kidney injury (AKI) admitted to an intensive care unit (ICU).",Non-OADS,/arxiv_data1/oa_pdf/79/77/0036-4665-rimtsp-58-00052.PMC4964321.pdf
Available from: http://www.unaids.org/en/media/unaids/ contentassets/documents/factsheet/2014/20140716_FactSheet_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/79/77/0036-4665-rimtsp-58-00052.PMC4964321.pdf
"Sao Paulo 2016;58:53 http://dx.doi.org/10.1590/S1678-9946201658053 ORIGINAL ARTICLE CIPROFLOXACIN RESISTANCE PATTERN AMONG BACTERIA ISOLATED FROM PATIENTS WITH  COMMUNITY-ACQUIRED URINARY TRACT INFECTION Ana Carolina Costa REIS(1), Susana Regia da Silva SANTOS(1), Siane Campos de SOUZA(1,2), Milena GÃ³es SALDANHA(2),   Thassila Nogueira PITANGA(3) & Ricardo Riccio OLIVEIRA(3) SUMMARY Objective:  To identify the main bacterial species associated with community-acquired urinary tract infection (UTI) and to assess  the pattern of ciprofloxacin susceptibility among bacteria isolated from urine cultures.",Non-OADS,/arxiv_data1/oa_pdf/76/71/0036-4665-rimtsp-58-00053.PMC4964322.pdf
Available from: http://www.anvisa.gov.br/sngpc/ Documentos2012/RDC%2020%202011.pdf?jornal=%E2%80%A6  Received: 23 December 2015 Accepted: 25 February 2016,Non-OADS,/arxiv_data1/oa_pdf/76/71/0036-4665-rimtsp-58-00053.PMC4964322.pdf
"Sao Paulo 2016;58:54 http://dx.doi.org/10.1590/S1678-9946201658054 ORIGINAL ARTICLE PREVALENCE AND RISK FACTORS OF SCHISTOSOMIASIS AMONG HAUSA   COMMUNITIES IN KANO  STATE, NIGERIA Salwa DA WAKI(1), Hesham Mahyoub AL-MEKHLAFI(1,2), Init ITHOI(1), Jamaiah IBRAHIM(1), Awatif Mohammed ABDULSALAM(1), Abdulhamid AHMED(3),   Hany SADY(1), Wahib Mohammed ATROOSH(1), Mona Abdullah AL-AREEQI(1), Fatin Nur ELYANA(1), Nabil Ahmed NASR(1) & Johari SURIN(1) SUMMARY Schistosomiasis remains one of the most prevalent neglected tropical diseases especially in Nigeria which has the greatest number  of infected people worldwide.",Non-OADS,/arxiv_data1/oa_pdf/c8/aa/0036-4665-rimtsp-58-00054.PMC4964323.pdf
"Sao Paulo 2016;58:55 http://dx.doi.org/10.1590/S1678-9946201658055 ORIGINAL ARTICLE EXPERIMENTAL SUBCUTANEOUS CYSTICERCOSIS BY Taenia crassiceps  IN   BALB/c AND C57BL/6 MICE Ãria MÃ¡rcia PEREIRA, Sarah Buzaim LIMA, Aline de AraÃºjo FREITAS, Marina Clare VINAUD & Ruy de Souza LINO JUNIOR SUMMARY Human cysticercosis is one of the most severe parasitic infections affecting tissues.",Non-OADS,/arxiv_data1/oa_pdf/c4/80/0036-4665-rimtsp-58-00055.PMC4964324.pdf
Available from: http://apps.who.int/iris/ bitstream/10665/164359/1/9789241508643_eng.pdf  2.,OADS,/arxiv_data1/oa_pdf/c4/80/0036-4665-rimtsp-58-00055.PMC4964324.pdf
Available from:  http://www.who.int/mediacentre/factsheets/fs376/en/  3.,Non-OADS,/arxiv_data1/oa_pdf/c4/80/0036-4665-rimtsp-58-00055.PMC4964324.pdf
"Sao Paulo 2016;58:56 http://dx.doi.org/10.1590/S1678-9946201658056 CASE REPORT Bartonella  henselae  AS A PUTATIVE CAUSE OF CONGENITAL CHOLESTASIS Paulo Eduardo Neves Ferreira VELHO(1), Maria Ãngela BELLOMO-BRANDÃO(2), Marina Rovani DRUMMOND(1),   Renata Ferreira MAGALHÃES(1), Gabriel HESSEL(2), Maria de Lourdes BARJAS-CASTRO(1), CecÃ­lia AmÃ©lia Fazzio ESCANHOELA(3),   Gilda Maria Barbaro DEL NEGRO(4) & Thelma Suely OKAY(5) SUMMARY Severe anemia and cholestatic hepatitis are associated with bartonella infections.",Non-OADS,/arxiv_data1/oa_pdf/a6/a6/0036-4665-rimtsp-58-00056.PMC4964325.pdf
"Sao Paulo 2016;58:57 http://dx.doi.org/10.1590/S1678-9946201658057 CASE REPORT CHYLOTHORAX IN PARACOCCIDIOIDOMYCOSIS FlÃ¡via Fonseca FERNANDES(1), Victor Oliveira ALVES(1), Tarquino Erastides Gavilanes SÃNCHEZ(2),   Wagner Diniz de PAULA(3) & Alfredo Nicodemos Cruz SANTANA(4) SUMMARY A previously healthy, 52-year-old woman presented with a nine months history of low fever and weight loss (> 30 kg).",Non-OADS,/arxiv_data1/oa_pdf/59/d3/0036-4665-rimtsp-58-00057.PMC4964326.pdf
"Sao Paulo 2016;58:58 http://dx.doi.org/10.1590/S1678-9946201658058 BRIEF COMMUNICATION ASSOCIATION OF EPSTEIN-BARR VIRUS (EBV) BUT NOT HUMAN PAPILLOMAVIRUS (HPV) WITH  GINGIVITIS AND/OR PERIODONTITIS IN TRANSPLANTED INDIVIDUALS Camila Freze BAEZ(1), Flavia SA V ASSI-RIBAS(2), Wilker Menezes da ROCHA(2), StÃ©phanie G. S. ALMEIDA(2), Marianna T. V .",Non-OADS,/arxiv_data1/oa_pdf/03/69/0036-4665-rimtsp-58-00058.PMC4964327.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012001).,Non-OADS,/arxiv_data1/oa_pdf/1b/a2/bmjopen-2016-012001.PMC4964621.pdf
"3, 785 â793 http://dx.doi.org/10.1080/21645515.2015.1085143",Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Vaccine 2012; 30:1244-54;PMID:22212128; http://dx.doi.org/10.1016/j.vaccine.2011.12.092 [2] Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD.",Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
Vaccine 2009;27 Suppl 5:F46-9; PMID:19931719; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"J Infect Dis 2009; 200 Suppl 1:S167-73; PMID:19817597; http://dx.doi.org/ 10.1086/605039 [6] Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al.",OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"N Engl J Med 2006; 354:11-22; PMID:16394298; http://dx.doi.org/10.1056/NEJMoa052434 [7] Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al.",OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"N Engl J Med 2006; 354:23-33; PMID:16394299; http://dx.doi.org/10.1056/NEJMoa052664 [8] Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, Pitan F, Cunliffe N. Vaccines for preventing rotavirusdiarrhoea: vaccines in use.",Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"PloS One 2013; 8:e68169; PMID:23840828; http://dx.doi.org/10.1371/journal.pone.0068169 [10] Dennehy PH, Bertrand HR, Silas PE, Damaso S, Friedland LR, Abu- Elyazeed R. Coadministration of RIX4414 oral human rotavirus vac- cine does not impact the immune response to antigens contained in routine infant vaccines in the United States.",Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Pediatrics 2008; 122:e1062-6; PMID:18977955; http://dx.doi.org/10.1542/peds.2008-1059 [11] Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Thollot F, Garcia-Corbeira P, Damaso S, Han HH, Bouckenooghee A. Immunogenicity and safety of the human rotavirus vaccine Rotarixco-administered with routine infant vaccines following the vaccina- tion schedules in Europe.",Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Vaccine 2010; 28:5272-9; PMID:20538094; http://dx.doi.org/10.1016/j.vaccine.2010.05.057 [12] Steele AD, De Vos B, Tumbo J, Reynders J, Scholtz F, Bos P, de Beer MC, Van der Merwe CF, Delem A. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.",Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Vaccine 2010; 28:6542-8;PMID:18786585; http://dx.doi.org/10.1016/j.vaccine.2008.08.034 [13] Li RC, Huang T, Li Y, Luo D, Tao J, Fu B, Si G, Nong Y, Mo Z, Liao X, et al.",OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
HumVaccin Immunother 2014; 10:1-8; PMID:24832715; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Vaccine 2009; 27:1333-9; PMID:19162114; http://dx.doi.org/10.1016/j.vaccine.2008.12.059 [15] Madhi SA, Kirsten M, Louw C, Bos P, Aspinall S, Bouckenooghe A, Neuzil KM, Steele AD.",Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Vaccine 2012; 30 Suppl 1:A44-51; PMID:22520136;http://dx.doi.org/10.1016/j.vaccine.2011.08.080 [16] Patel M, Steele AD, Parashar UD.",Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"In ï¬uence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines.Vaccine 2012; 30 Suppl 1:A30-5; PMID:22520134; http://dx.doi.org/ 10.1016/j.vaccine.2011.11.093 [17] Steele AD, Reynders J, Scholtz F, Bos P, de Beer MC, Tumbo J, Van der Merwe CF, Delem A, De Vos B.",Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"J Infect Dis 2010; 202 Suppl:S93-100; PMID:20684724; http://dx.doi.org/10.1086/653550 [18] Tregnaghi MW, Abate HJ, Valencia A, Lopez P, Da Silveira TR, Riv- era, L, Medina DMR, Saez-Llorens X, Ayala SEG, De Leon T, et al.",OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Vaccine 2011; 29:6335-41; PMID:21640780; http://dx.doi.org/10.1016/j.vaccine.2011.05.017 [20] Kim JS, Bae CW, Lee KY, Park MS, Choi YY, Kim KN, Kim JD, Park WS, Sin JB, Kim EA, et al.",OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Humanvaccines & immunotherapeutics 2012; 8:806-12; PMID:22699440; http://dx.doi.org/10.4161/hv.19853 [21] Phua KB, Emmanuel SC, Goh P, Quak SH, Lee BW, Han HH, Ward RL, Bernstein DI, De Vos B, Bock HL.",OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Vaccine 2013; 31:2253-9;PMID:23499605; http://dx.doi.org/10.1016/j.vaccine.2013.03.001 [23] Steele AD, De Vos B, Tumbo J, Reynders J, Scholtz F, Bos P, de Beer MC, Van der Merwe CF, Delem A. Co-administration study in South African infants of a live-attenuated oral human rotavi-rus vaccine (RIX4414) and polio virus vaccines.",Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
Vaccine 2010; 28:6542-8; PMID:18786585; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Hum Vaccin 2009; 5:414-9; PMID:19276664; http://dx.doi.org/10.4161/hv.5.6.8176 [25] Cheuvart B, Neuzil KM, Steele AD, Cunliffe N, Madhi SA, Karkada N, Han HH, Vinals C. Association of serum anti-rotavirus immuno- globulin A antibody seropositivity and protection against severe rota-virus gastroenteritis: analysis of clinical trials of human rotavirusvaccine.",OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Hum Vaccin Immunother 2014; 10:505-11; PMID:24240068; http://dx.doi.org/10.4161/hv.27097 [26] Salinas B, Perez Schael I, Linhares AC, Ruiz Palacios GM, Guerrero ML, Yarzabal JP, Cervantes Y, Clemens C, Damaso S, Hardt K, et al.",OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"Pediatr Infect Dis J 2009; 28:225-32; PMID:19209095; http://dx.doi.org/10.1097/INF.0b013e31819715fa [29] Camargo ME, Silveira L, Furuta JA, Oliveira EP, Germek OA.",OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"J Biol Stand 1983; 11:137-44; PMID:6345548;http://dx.doi.org/10.1016/S0092-1157(83)80038-9[31] Riffelmann M, Thiel K, Schmetz J, Wirsing von Koenig CH.",OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
J Clin Microbiol2010; 48:4459-63; PMID:20943873; http://dx.doi.org/10.1128/ JCM.01371-10 [32] World Health Organization Expanded Programme on Immuniza- tion.,Non-OADS,/arxiv_data1/oa_pdf/88/33/khvi-12-03-1085143.PMC4964624.pdf
"3, 716 â731 http://dx.doi.org/10.1080/21645515.2015.1101197",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
N Engl J Med 2015; 372:1231-9;PMID:25806915; http://dx.doi.org/10.1056/NEJMra1406035 [2] Robinson MC.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Trans R Soc Trop Med Hyg 1955; 49:28-32; PMID:14373834; http://dx.doi.org/10.1016/0035-9203(55)90080-8 [3] Rezza G. Dengue and chikungunya: long-distance spread and outbreaks in naive areas.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Pathog Glob Health 2014; 108:349-55; PMID:25491436; http://dx.doi.org/10.1179/2047773214Y.0000000163 [4] WHO.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"2015; http://www.who.int/ mediacentre/factsheets/fs327/en/ (accessed June 18th, 2015).",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Hyg 1956; 54:177-91; PMID:13346078; http://dx.doi.org/10.1017/S0022172400044442 [6] Moyen N, Thiberville SD, Pastorino B, Nougairede A, Thirion L, Mombouli JV, Dimi Y, Leparc-Goffart I, Capobianchi MR, Lep-foundzou AD, et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PloS one 2014; 9:e115938; PMID:25541718; http://dx.doi.org/10.1371/journal.pone.0115938 [7] Chretien JP, Anyamba A, Bedno SA, Breiman RF, Sang R, Sergon K, Powers AM, Onyango CO, Small J, Tucker CJ, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Epidemiol Infect 2009; 137:534-41; PMID:18694529;http://dx.doi.org/10.1017/S0950268808001167 [9] Mudur G. Failure to control mosquitoes has led to two fever epi- demics in India.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Clin Microbiol Infect 2010; 16:1702-4;PMID:21040155; http://dx.doi.org/10.1111/j.1469-0691.2010.03386.x [11] Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Lan-cet 2007; 370:1840-6; PMID:18061059; http://dx.doi.org/10.1016/ S0140-6736(07)61779-6 [12] Paty MC, Six C, Charlet F, Heuze G, Cochet A, Wiegandt A, Chappert JL, Dejour-Salamanca D, Guinard A, Soler P, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Emerg Infect Dis 2015; 21:557-61; PMID:25816211; http://dx.doi.org/10.3201/eid2104.141723726 M. SCHWAMEIS ET AL.,OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Negl Trop Dis 2014; 8:e2921;PMID:24967777; http://dx.doi.or g/10.1371/journal.pntd.0002921 [15] Tsetsarkin KA, Chen R, Leal G, Forrester N, Higgs S, Huang J, Weaver SC.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Virol J 2010; 7:8; PMID:20078896;http://dx.doi.org/10.1186/1743-422X-7-8 [18] Fros JJ, Liu WJ, Prow NA, Geertsema C, Ligtenberg M, Vanlanding- ham DL, Schnettler E, Vlak JM, Suhrbier A, Khromykh AA, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2010; 84:10877-87;PMID:20686047; http://dx.doi.org/10.1128/JVI.00949-10 [19] Dudha N, Rana J, Rajasekharan S, Gabrani R, Gupta A, Chaudhary VK, Gupta S. Host-pathogen interactome analysis of Chikungunyavirus envelope proteins E1 and E2.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Virus Genes 2015; 50:200-9; PMID:25563600; http://dx.doi.org/10.1007/s11262-014-1161-x [20] Uchime O, Fields W, Kielian M. The role of E3 in pH protection during alphavirus assembly and exit.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2013; 87:10255-62;PMID:23864626; http://dx.doi.org/10.1128/JVI.01507-13 [21] Choi HK, Tong L, Minor W, Dumas P, Boege U, Rossmann MG, Wengler G. Structure of Sindbis virus core protein reveals a chymo-trypsin-like serine proteinase and the organization of the virion.Nature 1991; 354:37-43; PMID:1944569; http://dx.doi.org/10.1038/ 354037a0 [22] Hallengard D, Kakoulidou M, Lulla A, Kummerer BM, Johansson DX, Mutso M, Lulla V, Fazakerley JK, Roques P, Le Grand R, et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2014; 88:2858-66;PMID:24371047; http://dx.doi.org/10.1128/JVI.03453-13 [23] Saisawang C, Sillapee P, Sinsirimongkol K, Ubol S, Smith DR, Ket- terman AJ.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PloS one 2012; 7:e50476; PMID:23209750; http://dx.doi.org/ 10.1371/journal.pone.0050476 [25] Volk SM, Chen R, Tsetsarkin KA, Adams AP, Garcia TI, Sall AA, Nasar F, Schuh AJ, Holmes EC, Higgs S, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2010; 84:6497-504; PMID:20410280; http://dx.doi.org/10.1128/JVI.01603-09 [26] Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector speci ï¬city and epi- demic potential.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
PLoS Pathog 2007; 3:e201; PMID:18069894; http://dx.doi.org/10.1371/journal.ppat.0030201 [27] ECDC.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"2014; http://ecdc.europa.eu/en/health topics/vectors/mosquitoes/Pages/aedes-albopictus.aspx (accessed July 10th, 2015) [28] Ribeiro JM, Rossignol PA, Spielman A.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"BMC Genomics 2007; 8:6; PMID:17204158; http://dx.doi.org/10.1186/1471-2164-8-6 [30] Maharaj PD, Widen SG, Huang J, Wood TG, Thangamani S. Dis- covery of mosquito saliva microRNAs during CHIKV infection.PLoS Negl Trop Dis 2015; 9:e0003386; PMID:25612225; http://dx.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"InfectGenet Evol 2013; 17:210-5; PMID:23583544; http://dx.doi.org/10.1016/j.meegid.2013.04.005 [32] Schneider BS, Higgs S. The enhancement of arbovirus transmis- sion and disease by mosquito saliva is associated with modula-tion of the host immune response.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Trans R Soc Trop Med Hyg 2008; 102:400-8; PMID:18342898; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Biol Chem 2006; 281:1935- 42; PMID:16301315; http://dx.doi.org/10.1074/jbc.M510359200 [34] Thangamani S, Higgs S, Ziegler S, Vanlandingham D, Tesh R, Wikel S. Host immune response to mosquito-transmitted chikun-gunya virus differs from that elicited by needle inoculated virus.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PloS one 2010; 5:e12137; PMID:20711354; http://dx.doi.org/ 10.1371/journal.pone.0012137 [35] Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Gui- vel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Exp Med 2010; 207:429-42; PMID:20123960;http://dx.doi.org/10.1084/jem.20090851 [36] Her Z, Malleret B, Chan M, Ong EK, Wong SC, Kwek DJ, Tolou H, Lin RT, Tambyah PA, Renia L, et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Immunol 2010; 184:5903-13; http://dx.doi.org/10.4049/ jimmunol.0904181 [37] Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhas- sine F, Rudnicka D, Sol-Foulon N, Le Roux K, Prevost MC, Fsihi H,et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Pathog 2007; 3:e89; PMID:17604450; http://dx.doi.org/10.1371/ journal.ppat.0030089 [38] Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel-Ben- hassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
PLoS Pathog2008; 4:e29; PMID:18282093; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Microbesand infection / Institut Pasteur 2009; 11:1186-96; PMID:19737625; http://dx.doi.org/10.1016/j.micinf.2009.09.003 [40] Chow A, Her Z, Ong EK, Chen JM, Dimatatac F, Kwek DJ, Bark- ham T, Yang H, Renia L, Leo YS, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Infect Dis2011; 203:149-57; PMID:21288813; http://dx.doi.org/10.1093/infdis/jiq042 [41] Gasque P, Couderc T, Lecuit M, Roques P, Ng LF.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vector Borne Zoonotic Dis 2015; 15:241-9; PMID:25897810; http://dx.doi.org/10.1089/vbz.2014.1710 [42] Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Infect Dis 2011; 204:115-23; PMID:21628665; http://dx.doi.org/10.1093/infdis/jiq006 [43] Schwartz O, Albert ML.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Nat Rev Microbiol 2010; 8:491-500; PMID:20551973; http://dx.doi.org/10.1038/nrmicro2368 [44] Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Clin Investig 2010; 120:894-906; PMID:20179353; http://dx.doi.org/10.1172/JCI40104 [45] Selvamani SP, Mishra R, Singh SK.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
PloS one 2014; 9:e103624; PMID:25083878; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Infect Dis 2012; 206:455-7: 7-9; http://dx.doi.org/10.1093/infdis/jis368 [48] Brandler S, Ruf ï¬e C, Combredet C, Brault JB, Najburg V, Prevost MC, Habel A, Tauber E, Despres P, Tangy F. A recombinant mea-sles vaccine expressing chikungunya virus-like particles is stronglyimmunogenic and protects mice from lethal challenge with chikun- gunya virus.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Virology 2008; 371:185-95;PMID:17949772; http://dx.doi.org/10.1016/j.virol.2007.09.028 [50] Pal P, Dowd KA, Brien JD, Edeling MA, Gorlatov S, Johnson S, Lee I, Akahata W, Nabel GJ, Richter MK, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Pathog 2013; 9:e1003312; PMID:23637602; http://dx.doi.org/10.1371/journal.ppat.1003312 [51] Couderc T, Khandoudi N, Grandadam M, Visse C, Gangneux N, Bagot S, Prost JF, Lecuit M. Prophylaxis and therapy for Chikungu-nya virus infection.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Infect Dis 2009; 200:516-23; PMID:19572805; http://dx.doi.org/10.1086/600381 [52] Rudd PA, Wilson J, Gardner J, Larcher T, Babarit C, Le TT, Anraku I, Kumagai Y, Loo YM, Gale M, Jr., et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
J Virol 2012; 86:9888-98; PMID:22761364; http://dx.doi.org/ 10.1128/JVI.00956-12 [53] Munoz-Jordan JL.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Mol Cell 2006; 22:561-9;PMID:16762830; http://dx.doi.org/10.1016/j.molcel.2006.05.012 [55] Morrison J, Aguirre S, Fernandez-Sesma A. Innate immunity eva- sion by Dengue virus.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Viruses 2012; 4:397-413; PMID:22590678;http://dx.doi.org/10.3390/v4030397 [56] Rodriguez-Madoz JR, Belicha-Villanueva A, Bernal-Rubio D, Ashour J, Ayllon J, Fernandez-Sesma A. Inhibition of the type I interferon response in human dendritic cells by dengue virus infec-tion requires a catalytically active NS2B3 complex.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2010; 84:9760-74; PMID:20660196; http://dx.doi.org/10.1128/JVI.01051-10 [57] Hoang LT, Lynn DJ, Henn M, Birren BW, Lennon NJ, Le PT, Duong KT, Nguyen TT, Mai LN, Farrar JJ, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2010; 84:12982-94;PMID:20943967; http://dx.doi.org/10.1128/JVI.01224-10 [58] Ramirez-Ronda CH, Garcia CD.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Viruses 2015; 7:3204-25;PMID:26102580; http://dx.doi.org/10.3390/v7062770 [60] Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Cell 2009; 139:1243-54; PMID:20064371; http://dx.doi.org/10.1016/j.cell.2009.12.017 [61] Zhu X, He Z, Yuan J, Wen W, Huang X, Hu Y, Lin C, Pan J, Li R, Deng H, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Cell Microbiol 2015; 17:105-18; PMID:25131332; http://dx.doi.org/10.1111/cmi.12339 [62] Fink K, Ng C, Nkenfou C, Vasudevan SG, van Rooijen N, Schul W. Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Eur J Immunol 2009; 39:2809-21; PMID:19637226; http://dx.doi.org/10.1002/eji.200939389[63] Kalantri SP, Joshi R, Riley LW.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Negl Trop Dis 2015; 9:e0003764; PMID:25951202; http://dx.doi.org/10.1371/journal.pntd.0003764 [65] Staikowsky F, Talarmin F, Grivard P, Souab A, Schuffenecker I, Le Roux K, Lecuit M, Michault A.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Med Virol 2014; 86:1393-401; PMID:24523146; http://dx.doi.org/10.1002/jmv.23875 [67] Gerardin P, Fianu A, Michault A, Mussard C, Boussaid K, Rollot O, Grivard P, Kassab S, Bouquillard E, Borgherini G, et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Arthritis Res Ther 2013; 15:R9;PMID:23302155; http://dx.doi.org/10.1186/ar4137 [68] Simon F, Parola P, Grandadam M, Fourcade S, Oliver M, Brouqui P, Hance P, Kraemer P, Ali Mohamed A, de Lamballerie X, et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Medicine 2007; 86:123- 37; PMID:17505252; http://dx.doi.org/10.1097/MD/0b013e31806010a5 [69] Taubitz W, Cramer JP, Kapaun A, Pfeffer M, Drosten C, Dobler G, Burchard GD, Loscher T. Chikungunya fever in travelers: clinicalpresentation and course.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Clin Infect Dis 2007; 45:e1-4; PMID:17554689; http://dx.doi.org/10.1086/518701 [70] Mohan A. Chikungunya fever: clinical manifestations & manage- ment.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2014; 88:2414-25; PMID:24335291; http://dx.doi.org/10.1128/JVI.02716-13 [72] Josseran L, Paquet C, Zehgnoun A, Caillere N, Le Tertre A, Solet JL, Ledrans M. Chikungunya disease outbreak, Reunion Island.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"EmergInfect Dis 2006; 12:1994-5; PMID:17354339; http://dx.doi.org/ 10.3201/eid1212.060710 [73] Renault P, Solet JL, Sissoko D, Balleydier E, Larrieu S, Filleul L, Lassalle C, Thiria J, Rachou E, de Valk H, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Negl Trop Dis 2013; 7:e2137; PMID:23556021; http://dx.doi.org/10.1371/journal.pntd.0002137 [75] Simon F, Javelle E, Gasque P. Chikungunya Virus Infections.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"N Engl J Med 2015; 373:93-4; PMID:26132957; http://dx.doi.org/ 10.1056/NEJMc1505501 [76] Chen W, Foo SS, Sims NA, Herrero LJ, Walsh NC, Mahalingam S. Arthritogenic alphaviruses: new insights into arthritis and bone pathology.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Trends Microbiol 2015; 23:35-43; PMID:25449049; http://dx.doi.org/10.1016/j.tim.2014.09.005 [77] Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, de Monredon J, Roger JC, El Amrani M, Yvin JL, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PloS one 2007; 2: e527; PMID:17565380; http://dx.doi.org/10.1371/journal.pone.0000527 [78] Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Immunol 2010;184:5914-27; http://dx.doi.org/10.4049/jimmunol.0900255 [79] Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Lancet Infect Dis 2007; 7:319-27;PMID:17448935; http://dx.doi.org/10.1016/S1473-3099(07)70107-X728 M. SCHWAMEIS ET AL.,OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Biosci 2008; 33:443-9; PMID:19208970; http://dx.doi.org/10.1007/s12038-008-0063-2 [81] Chevillon C, Briant L, Renaud F, Devaux C. The Chikungunya threat: an ecological and evolutionary pe rspective.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Trends Microbiol 2008; 16:80-8; PMID:18191569; http://dx.do i.org/10.1016/j.tim.2007.12.003 [82] Magurano F, Zammarchi L, Baggieri M, Fortuna C, Farese A, Benedetti E, Fiorentini C, Rezza G, Nicoletti L, Bartoloni A. Chikungunya from the Caribbean: the importance of appropri-ate laboratory tests to con ï¬r mt h ed i a g n o s i s .V e c t o rB o r n eZ o o - notic Dis 2015; 15:258-60; PMID:25897812; http://dx.doi.org/ 10.1089/vbz.2014.1724 [83] Foissac M, Javelle E, Ray S, Guerin B, Simon F. Post-Chikungunya rheumatoid arthritis, Saint Martin.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Emerg Infect Dis 2015; 21:530-2; PMID:25695499; http://dx.doi.org/10.3201/eid2103.141397 [84] Kam YW, Lee WW, Simarmata D, Harjanto S, Teng TS, Tolou H, Chow A, Lin RT, Leo YS, Renia L, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2012; 86:13005-15; PMID:23015702; http://dx.doi.org/10.1128/JVI.01780-12 [85] Panning M, Grywna K, van Esbroeck M, Emmerich P, Drosten C. Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Emerg Infect Dis 2008; 14:416-22; PMID:18325256; http://dx.doi.org/10.3201/eid1403.070906 [86] Pierro A, Rossini G, Gaibani P, Finarelli AC, Moro ML, Landini MP, Sambri V. Persistence of anti-chikungunya virus-speci ï¬c antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"New Microbes New Infect 2015; 7:23-5;PMID:26106482; http://dx.doi.org/10.1016/j.nmni.2015.04.002 [87] Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, Arvin-Berod C, Paganin F. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island.Clin Infect Dis 2008; 47:469-75; PMID:18611153; http://dx.doi.org/ 10.1086/590003 [88] de Andrade DC, Jean S, Clavelou P, Dallel R, Bouhassira D. Chronic pain associated with the Chikungunya Fever: long lasting burden ofan acute illness.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
BMC Infect Dis 2010; 10:31; PMID:20170492; http://dx.doi.org/10.1186/1471-2334-10-31 [89] WHO.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"2008; http://www.wpro.who.int/mvp/topics/ntd/Clinical_Mgnt_Chikungunya_WHO_SEARO.pdf (accessed August 25th, 2015) [90] Briolant S, Garin D, Scaramozzino N, Jouan A, Crance JM.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Antiviral Res 2004; 61:111-7; PMID:14670584; http://dx.doi.org/10.1016/j.antiviral.2003.09.005 [91] Rothan HA, Bahrani H, Mohamed Z, Teoh TC, Shankar EM, Rahman NA, Yusof R. A combination of doxycycline and ribavirin alleviated chikungunya infection.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PloS one 2015; 10:e0126360; PMID:25970853; http://dx.doi.org/10.1371/journal.pone.0126360 [92] De Lamballerie X, Boisson V, Reynier JC, Enault S, Charrel RN, Flahault A, Roques P, Le Grand R. On chikungunya acute infection and chloroquine treatment.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vector Borne Zoonotic Dis 2008; 8:837-9; PMID:18620511; http://dx.doi.org/10.1089/vbz.2008.0049 [93] Ganu MA, Ganu AS.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Joint Bone Spine 2009; 76:654-7; PMID:19945329; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Negl Trop Dis 2015; 9:e0003603; PMID:25760632;http://dx.doi.org/10.1371/journal.pntd.0003603[97] Delang L, Segura Guerrero N, Tas A, Querat G, Pastorino B, Froeyen M, Dallmeier K, Jochmans D, Herdewijn P, Bello F, et al.Mutations in the chikungunya virus non-structural proteins causeresistance to favipiravir (T-705), a broad-spectrum antiviral.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Biochem Biophys Res Commun 2008; 376:718-22;PMID:18805396; http://dx.doi.org/10.1016/j.bbrc.2008.09.040 [99] Lam S, Chen KC, Ng MM, Chu JJ.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PloS one 2012; 7:e46396; PMID:23056297;http://dx.doi.org/10.1371/journal.pone.0046396 [100] Fong RH, Banik SS, Mattia K, Barnes T, Tucker D, Liss N, Lu K, Sel- varajah S, Srinivasan S, Mabila M, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2014; 88:14364- 79; PMID:25275138; http://dx.doi.org/10.1128/JVI.01943-14 [101] Warter L, Lee CY, Thiagarajan R, Grandadam M, Lebecque S, Lin RT, Bertin-Maghit S, Ng LF, Abastado JP, Despres P, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Pathog 2011; 7:e1002390;PMID:22144891; http://dx.doi.org/10.1371/journal.ppat.1002390 [103] Fric J, Bertin-Maghit S, Wang CI, Nardin A, Warter L. Use of human monoclonal antibodies to treat Chikungunya virus infec- tion.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Infect Dis 2013; 207:319-22; PMID:23125446; http://dx.doi.org/10.1093/infdis/jis674 [104] Masrinoul P, Puiprom O, Tanaka A, Kuwahara M, Chaichana P, Ikuta K, Ramasoota P, Okabayashi T. Monoclonal antibody target-ing chikungunya virus envelope 1 protein inhibits virus release.Virology 2014; 464-465:111-7; PMID:25063884 [105] Goh LY, Hobson-Peters J, Prow NA, Gardner J, Bielefeldt-Ohmann H, Pyke AT, Suhrbier A, Hall RA.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Clin Immunol 2013; 149:487-97; PMID:24239837; http://dx.doi.org/10.1016/j.clim.2013.10.004 [106] Selvarajah S, Sexton NR, Kahle KM, Fong RH, Mattia KA, Gardner J, Lu K, Liss NM, Salvador B, Tucker DF, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Negl Trop Dis 2013; 7:e2423;PMID:24069479; http://dx.doi.or g/10.1371/journal.pntd.0002423 [107] Goh LY, Hobson-Peters J, Prow NA, Gardner J, Bielefeldt-Ohmann H, Suhrbier A, Hall RA.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Monoclonal antibodies speci ï¬c for the cap- sid protein of chikungunya virus suitable for multiple applications.J Gen Virol 2015; 96:507-12; PMID:25480927; http://dx.doi.org/10.1099/jgv.0.000002 [108] Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJ.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Nat Rev Drug Discov 2010; 9:325-38; PMID:20305665; http://dx.doi.org/10.1038/nrd3003 [109] CDC.,OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"2015; http://www.cdc.gov/chikungunya/pdfs/CHIKV_VectorCon trol.pdf (accessed July 9th, 2015) [110] Lang J, Wood SC.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Emerg Infect Dis 1999; 5:749-56; PMID:10603207; http://dx.doi.org/10.3201/eid0506.990602 [111] Kumar CJ, Baboo CA, Krishnan BU, Kumar A, Joy S, Jose T, Philip A, Sambasivaiah K, Hegde BM.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Trans R Soc Trop Med Hyg 2010; 104:133-8;PMID:19709705; http://dx.doi.org/10.1016/j.trstmh.2009.07.014HUMAN VACCINES & IMMUNOTHERAPEUTICS 729,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Negl Trop Dis 2011; 5:e1197; PMID:21695162; http://dx.doi.or g/10.1371/journal.pntd.0001197 [114] Vazquez-Prokopec GM, Chaves LF, Ritchie SA, Davis J, Kitron U.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Negl Trop Dis 2010; 4:e858; PMID:21049010; http://dx.doi.org/ 10.1371/journal.pntd.0000858 [115] Roy CJ, Adams AP, Wang E, Plante K, Gorchakov R, Seymour RL, Vinet-Oliphant H, Weaver SC.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"US Mili- tary contributions to the global response to pandemic chikungunya.Vaccine 2012; 30:6713-20; PMID:22940380; http://dx.doi.org/10.1016/j.vaccine.2012.08.025 [117] Wang E, Volkova E, Adams AP, Forrester N, Xiao SY, Frolov I, Weaver SC.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vaccine 2008; 26:5030-9; PMID:18692107; http://dx.doi.org/ 10.1016/j.vaccine.2008.07.054 [118] Wang D, Suhrbier A, Penn-Nicholson A, Woraratanadharm J, Gardner J, Luo M, Le TT, Anraku I, Sakalian M, Einfeld D, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vaccine 2011; 29:2803- 9; PMID:21320541; http://dx.doi.org/10.1016/j.vaccine.2011.01.108 [119] Chattopadhyay A, Wang E, Seymour R, Weaver SC, Rose JK.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2013; 87:395-402; PMID:23077320; http://dx.doi.org/10.1128/ JVI.01860-12 [120] Garcia-Arriaza J, Cepeda V, Hallengard D, Sorzano CO, Kummerer BM, Liljestrom P, Esteban M. A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice againstchikungunya infection.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2014; 88:3527-47; PMID:24403588;http://dx.doi.org/10.1128/JVI.03418-13 [121] Hallengard D, Lum FM, Kummerer BM, Lulla A, Lulla V, Garcia- Arriaza J, Fazakerley JK, Roques P, Le Grand R, Merits A, et al.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol2014; 88:13333-43; PMID:25210177; http://dx.doi.org/10.1128/ JVI.01926-14 [122] Tretyakova I, Hearn J, Wang E, Weaver S, Pushko P. DNA vaccine ini- tiates replication of live attenuated chikungunya virus in vitro and elic- its protective immune response in mice.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Infect Dis 2014; 209:1882- 90; PMID:24585894; http://dx.doi.org/10.1093/infdis/jiu114 [123] Khan M, Dhanwani R, Rao PV, Parida M. Subunit vaccine formula- tions based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing anti- bodies in mice.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Virus Res 2012; 167:236-46; PMID:22610133;http://dx.doi.org/10.1016/j.virusres.2012.05.004 [124] Kumar M, Sudeep AB, Arankalle VA.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vaccine 2012; 30:6142-9;PMID:22884660; http://dx.doi.org/10.1016/j.vaccine.2012.07.072 [125] Tiwari M, Parida M, Santhosh SR, Khan M, Dash PK, Rao PV.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PloS one 2014; 9:e94401; PMID:24713807; http://dx.doi.org/10.1371/journal.pone.0094401 [127] Ramsauer K, Schwameis M, Firbas C, Mullner M, Putnak RJ, Thomas SJ, Despres P, Tauber E, Jilma B, Tangy F. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chi- kungunya vaccine: a randomised, double-blind, placebo-controlled,active-comparator, ï¬rst-in-man trial.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Lancet Infect Dis 2015;15:519-27; PMID:25739878; http://dx.doi.org/10.1016/S1473-3099 (15)70043-5 [128] Harrison VR, Eckels KH, Bartelloni PJ, Hampton C. Production and evaluation of a formalin-killed Chikungunya vaccine.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Lancet 2014; 384:2046-52;PMID:25132507; http://dx.doi.org/10.1016/S0140-6736(14)61185-5 [134] Tsetsarkin K, Higgs S, McGee CE, De Lamballerie X, Charrel RN, Van- landingham DL.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vector Borne Zoonotic Dis 2006; 6:325-37; PMID:17187566; http://dx.doi.org/10.1089/vbz.2006.6.325 [135] Plante K, Wang E, Partidos CD, Weger J, Gorchakov R, Tsetsarkin K, Borland EM, Powers AM, Seymour R, Stinchcomb DT, et al.Novel chikungunya vaccine candidate with an IRES-based attenua- tion and host range alteration mechanism.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Pathog 2011; 7: e1002142; PMID:21829348; http://dx.doi.org/10.1371/journal.ppat.1002142 [136] Chu H, Das SC, Fuchs JF, Suresh M, Weaver SC, Stinchcomb DT, Partidos CD, Osorio JE.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Vaccine 2013; 31:3353-60; PMID:23727003; http://dx.doi.org/10.1016/j.vaccine.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vaccine 2012; 30:4638-43; PMID:22583812;http://dx.doi.org/10.1016/j.vaccine.2012.04.099 [138] Metz SW, Martina BE, van den Doel P, Geertsema C, Osterhaus AD, Vlak JM, Pijlman GP.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vaccine 2013; 31:6092-6;PMID:24099875; http://dx.doi.org/10.1016/j.vaccine.2013.09.045 [139] Akahata W, Yang ZY, Andersen H, Sun S, Holdaway HA, Kong WP, Lewis MG, Higgs S, Rossmann MG, Rao S, et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Nat Med 2010; 16:334-8; PMID:20111039; http://dx.doi.org/10.1038/nm.2105 [140] Metz SW, Gardner J, Geertsema C, Le TT, Goh L, Vlak JM, Suhrbier A, Pijlman GP.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Negl Trop Dis 2013; 7:e2124; PMID:23516657; http://dx.doi.org/10.1371/journal.pntd.0002124 [141] Brandler S, Lucas-Hourani M, Moris A, Frenkiel MP, Combredet C, Fevrier M, Bedouelle H, Schwartz O, Despres P, Tangy F. Pediatric measles vaccine expressing a dengue antigen induces durable sero- type-speci ï¬c neutralizing antibodies to dengue virus.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Negl Trop Dis 2007; 1:e96; PMID:18160988; http://dx.doi.org/10.1371/journal.pntd.0000096 [142] Brandler S, Ruf ï¬e C, Najburg V, Frenkiel MP, Bedouelle H, Despres P, Tangy F. Pediatric measles vaccine expressing a dengue tetrava-lent antigen elicits neutralizing antibodies against all four dengue730 M. SCHWAMEIS ET AL.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
Vaccine 2010; 28:6730-9; PMID:20688034; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
J Infect Dis 2005; 191:207-14; PMID:15609230; http://dx.doi.org/10.1086/426824 [144] Hilleman MR. Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vaccine 2001; 20:651-65; PMID:11738730; http://dx.doi.org/10.1016/S0264-410X(01)00384-X [145] Wong-Chew RM, Beeler JA, Audet S, Santos JI.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Med Virol 2003; 70:276-80;PMID:12696117; http://dx.doi.org/10.1002/jmv.10390 [146] Rager-Zisman B, Bazarsky E, Skibin A, Chamney S, Belmaker I, Shai I, Kordysh E, Grif ï¬n DE.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vaccine 2003; 21:2580-8; PMID:12744894; http://dx.doi.org/10.1016/S0264-410X(03)00053-7 [147] Seymour RL, Adams AP, Leal G, Alcorn MD, Weaver SC.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Negl Trop Dis 2015; 9:e0003800; PMID:26115459; http://dx.doi.org/10.1371/journal.pntd.0003800 [148] Petrovsky N, Aguilar JC.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PloS one 2011; 6:e24384; PMID:21915319; http://dx.doi.org/10.1371/journal.pone.0024384 [150] Pellegrino P, Clementi E, Radice S. On vaccine âs adjuvants and autoimmunity: Current evidence and future perspectives.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Biotechnol J 2015; 10:659-70; PMID:25692281; http://dx.doi.org/10.1002/biot.201400427 [154] Metz SW, Pijlman GP.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
J Invertebr pathol 2011;107 Suppl:S16-30; PMID:21784227; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
J Inver- tebr pathol 2011; 107 Suppl:S42-8; PMID:21784230; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
J Gen Virol 1986; 67 (Pt 11):2539-42; PMID:3783130; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2000; 74:8376-81; PMID:10954537; http://dx.doi.org/10.1128/JVI.74.18.8376-8381.2000 [158] Weaver SC, Osorio JE, Livengood JA, Chen R, Stinchcomb DT.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Expert Rev Vaccines2012; 11:1087-101; PMID:23151166; http://dx.doi.org/10.1586/ erv.12.84 [159] Dowdle WR, Coleman MT, Mostow SR, Kaye HS, Schoenbaum SC.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Postgrad Med J 1973; 49:159-63; PMID:4803439; http://dx.doi.org/ 10.1136/pgmj.49.569.159[160] Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, Orenstein WA.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Infect Dis 1990; 162:1036-42; PMID:2230231; http://dx.doi.org/10.1093/infdis/162.5.1036 [161] Ahola T, Courderc T, Ng LF, Hallengard D, Powers A, Lecuit M ,E s t e b a nM ,M e r i t sA ,R o q u e sP ,L i l j e s t r o mP .T h e r a p e u t i c sand vaccines against chikungu nya virus.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vector Borne Zoonotic Dis 2015; 15:250-7; PMID:25897811; http://dx.doi.org/10.1089/ vbz.2014.1681 [162] Fischer M, Staples JE, Arboviral Diseases Branch NCfE, Zoonotic Infectious Diseases CDC.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Vaccine 1986; 4:157-62; PMID:3020820;http://dx.doi.org/10.1016/0264-410X(86)90003-4 [164] Piper A, Ribeiro M, Smith KM, Briggs CM, Huitt E, Nanda K, S p e a r sC J ,Q u i l e sM ,C u l l e nJ ,T h o m a sM E ,e ta l .C h i k u n g u n y a virus host range E2 transmembrane deletion mutants induceprotective immunity against challenge in C57BL/6J mice.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2013; 87:6 748-57; PMID:23552427; http://dx.doi.org/10.1128/ JVI.03357-12 [165] Nakao E, Hotta S. Immunogenicity of puri ï¬ed, inactivated chikun- gunya virus in monkeys.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"PLoS Negl Trop Dis 2011; 5:e928; PMID:21264351; http://dx.doi.org/10.1371/journal.pntd.0000928 [168] Bao H, Ramanathan AA, Kawalakar O, Sundaram SG, Tingey C, Bian CB, Muruganandam N, Vijayachari P, Sardesai NY,Weiner DB, et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Viralimmunology 2013; 26:75-83; PMID:23409931; http://dx.doi.org/ 10.1089/vim.2012.0061 [169] Akahata W, Nabel GJ.",Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"J Virol 2012; 86:8879-83; PMID:22647698; http://dx.doi.org/10.1128/JVI.00370-12 [170] Billeter MA, Naim HY, Udem SA.",OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
PLoS Negl Trop Dis 2014; 8:e2719; PMID:3930508; http://dx.doi.org/10.1371/journal.pntd.0002719HUMAN VACCINES & IMMUNOTHERAPEUTICS 731,Non-OADS,/arxiv_data1/oa_pdf/a9/e7/khvi-12-03-1101197.PMC4964651.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com Â© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowAbstract Background:  Classification and regression tree analysis involves the creation  of a decision tree by recursive partitioning of a dataset into more homogeneous  subgroups.",Non-OADS,/arxiv_data1/oa_pdf/5c/7a/SNI-7-73.PMC4964664.pdf
"Surg Neurol Int  2016;7:73. http://surgicalneurologyint.com/Aneurysmal-subarachnoid-hemorrhage-prognostic- decision-making-algorithm-using-classification-and-regression-tree-analysis/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/5c/7a/SNI-7-73.PMC4964664.pdf
"Surgical Neurology International 2016, 7:73  http://www.surgicalneurologyint.com/content/7/1/73decision making, a prediction tool is useful as an adjunct  to complement clinical opinion and judgment.",Non-OADS,/arxiv_data1/oa_pdf/5c/7a/SNI-7-73.PMC4964664.pdf
"Surgical Neurology International 2016, 7:73  http://www.surgicalneurologyint.com/content/7/1/73with percentage dif ferences between the two decision  trees ranging from 1.3 to 7.8%.",Non-OADS,/arxiv_data1/oa_pdf/5c/7a/SNI-7-73.PMC4964664.pdf
"Surgical Neurology International 2016, 7:73  http://www.surgicalneurologyint.com/content/7/1/734.",Non-OADS,/arxiv_data1/oa_pdf/5c/7a/SNI-7-73.PMC4964664.pdf
"Surgical Neurology International 2016, 7:73  http://www.surgicalneurologyint.com/content/7/1/73Table  1 shows a clinical prognostic decisionâmaking  algorithm for aneurysmal SAH patients with prognostic  subgroups based on the classification and regression tree  derived from the Tirilazad database.",OADS,/arxiv_data1/oa_pdf/5c/7a/SNI-7-73.PMC4964664.pdf
"Surgical Neurology International 2016, 7:73  http://www.surgicalneurologyint.com/content/7/1/73of the clinical trials of Tirilazad, there have been  advances in the surgical treatment and neurocritical  care management of aneurysmal SAH patients.",Non-OADS,/arxiv_data1/oa_pdf/5c/7a/SNI-7-73.PMC4964664.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/9d/a8/JCIS-6-27.PMC4964665.pdf
"6, 1566 â1588 http://dx.doi.org/10.1080/21645515.2015.1125055",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
Available at https://www.healthypeople.gov/2020/topics-objec tives/topic/immunization-and-infectious-diseases/objectives.,Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"J Pediatr Psych 2010; 35(7):704-15; http://dx.doi.org/10.1093/jpepsy/jsp108 [20] Holman D, Bernard V, Roland K, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"JAMA Pediatr 2014; 168(1):76-82; PMID:24276343; http://dx.doi.org/10.1001/jamapediatrics.2013.2752 [21] Walhart T. Parents, adolescents, children and the human papilloma- virus vaccine: a review.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Int Nurs Rev 2012; 59:305-11;PMID:22897180; http://dx.doi.org/10.1111/j.1466-7657.2012.00991.x [22] Niccolai L, Hansen C. Practice- and community-based interventions to increase human papillomavirus vaccine coverage: a systematicreview.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
JAMA Pediatr 2015; 169(7):686-92; PMID:26010507; http://dx.doi.org/10.1001/jamapediatrics.2015.0310 [23] Community Preventive Services Task Force.,Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Pediatrics2012; 129:1056-63; PMID:22566425; http://dx.doi.org/10.1542/peds.2011-2641 [26] Dempsey A, Schaffer S. Human papillomavirus vaccination rates and state mandates for tetanus-containing vaccines.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Am J Public Health 2014; 104(8):1526-33; PMID:24922144; http://dx.doi.org/10.2105/AJPH.2014.301910 [28] Chao C, Preciado M, Slezak J, Xu L. A randomized intervention of reminder letter for human papillomavirus vaccine series completion.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"J Adolescent Health 2015; 56:85-90; http://dx.doi.org/10.1016/j.jadohealth.2014.08.014 [29] Kharbanda E, Stockwell M, Fox H, Andres R, Lara M, Rickert V. Text message reminders to promote human papillomavirus vaccination.Vaccine 2011; 29:2537-41; PMID:21300094; http://dx.doi.org/10.1016/j.vaccine.2011.01.065 [30] Patel A, Stern L, Unger Z, Debevec E, Roston A, Hanover R, Morfesis J.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Pediatrics 2012; 129 (6):1437-45; http://dx.doi.org/10.1542/peds.2011-1714 [32] Szilagyi PG, Albertin C, Humiston SG, Rand CM, Schaffer S, Brill H, Stankaitis J, Yoo, BK, Blumkin AK, Stokley S. A randomized trial of the effect of centralized reminder/recall on immunizations and pre- ventive care visits for adolescents.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Acad Pediatr 2013; 13(3):204-13;PMID:23510607; http://dx.doi.org/10.1016/j.acap.2013.01.002 [33] Bar-Shain D, Stager M, Runkle A, Leon J, Kaelber D. Direct messag- ing to parents/guardians to improve adolescent immunizations.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"JAdolescent Health 2015; 56:S21-26; http://dx.doi.org/10.1016/j.jadohealth.2014.11.023 [34] Morris J, Wang W, Wang L, Peddecord KM, Sawyer M. Comparison of reminder methods in selected adolescents with records in animmunization registry.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"J Adolescent Health 2015; 56:S27-32; http://dx.doi.org/10.1016/j.jadohealth.2015.01.010 [35] Rand CM, Brill H, Albertin C, Humiston SG, Schaffer S, Shone LP, Blumkin AK, Szilagyi PG.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
J Adolescent Health 2015; 56:S17-20; http://dx.doi.org/ 10.1016/j.jadohealth.2014.10.273 [36] Hopfer S. Effects of a narrative HPV vaccine intervention aimed at reaching college women: a randomized controlled trial.,Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Prev Sci 2012; 13:173-82; PMID:21993613; http://dx.doi.org/10.1007/s11121- 011-0254-1 [37] Vanderpool RC, Cohen EL, Crosby RA, Jones MG, Bates, W, Casey BR, Collins T. â1-2-3 Pap âintervention improves HPV vaccine series completion among Appalachian women.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"J Com- mun 2013; 63:95-115; PMID:26560123; http://dx.doi.org/10.1111/jcom.12001 [38] Kempe A, Barrow J, Stokley S, Saville A, Glazner JE, Suh C, Federico S, Abrams L, Seewald L, Beaty B, et al.",OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Pediatrics 2012;129:1446-52; http://dx.doi.org/10.1542/peds.2011-2921 [39] Patel D, Zochowski M, Peterman S, Dempsey A, Ernst S, Dalton V. Human papillomavirus vaccine intent and uptake among female col-lege students.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"J Am Coll Health 2012; 60(2):151-61; PMID:22316412;http://dx.doi.org/10.1080/07448481.2011.580028 [40] Cates J, Shafer A, Diehl S, Deal A.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
Soc Mar Q 2011; 17(1):4-26; PMID:21804767; http://dx.doi.org/10.1080/15245004.2010.,OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Arch Pediatr Adol Med 2011; 165(6):547-53; http://dx.doi.org/10.1001/archpediatrics.2011.73 [43] Rickert V, Auslander B, Cox D, Rosenthal S, Rupp R, Zimet G. School-based HPV immunization of young adolescents: effects of two brief health interventions.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Hum Vaccin Immunother 2015; 11(2):315-21; PMID:25692717; http://dx.doi.org/10.1080/21645515.2014.1004022 [44] Ruf ï¬n MT, Plegue MA, Rockwell PG, Young AP, Patel DA, Yeazel MW.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"J Am Board Fam Med 2015; 28(3):324-33; PMID:25957365; http://dx.doi.org/10.3122/jabfm.2015.03.140082 [45] Szilagyi PG, Serwint JR, Humiston SG, Rand CM, Schaffer S, Vincelli P, Dhepyasuwan N, Blumkin A, Albertin C, Curtis CR.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Acad Pediatr 2015; 15:149-57; PMID:25748976; http://dx.doi.org/10.1016/j.acap.2014.10.006 [46] Gilkey MB, Dayton AM, Moss JL, Sparks AC, Grimshaw AH, Bowl- ing JM, Brewer NT.",OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Pediatrics 2014;134:346-53; http://dx.doi.org/10.1542/peds.2013-4257[47] Cassidy B, Braxter B, Charron-Prochownik D, Schlenk E. A quality improvement initiative to increase HPV vaccine rates using an edu-cational and reminder strategy with parents of preteen girls.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"J PediatrHealth Care 2014; 28(2):155-64; PMID:23522561; http://dx.doi.org/ 10.1016/j.pedhc.2013.01.002 [48] Fiks AG, Grundmeier RW, Mayne S, Song L, Feemster K, Karavite D, Hughes CC, Massey J, Keren R, Bell LM, et al.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Pediatrics 2013; 131:1114-24; PMID:23650297; http://dx.doi.org/10.1542/peds.2012-3122 [49] Matheson EC, Derouin A, Gagliano M, Thompson JA, Blood-Sieg- fried J.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"J Pediatr Health Care 2014; 28(4):35-9;PMID:23195652; http://dx.doi.org/10.1016/j.pedhc.2013.09.001 [50] Moss JM, Reiter P, Dayton, A, Brewer NT.",OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Vaccine 2012; 30:4960-3; PMID:22652406; http://dx.doi.org/10.1016/j.vaccine.2012.05.042 [51] Perkins R, Zisblatt L, Legler A, Trucks E, Hanchate A, Sheinfeld Gorin S. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Vaccine 2015; 33:1223-9; PMID:25448095; http://dx.doi.org/10.1016/j.vaccine.2014.11.021 [52] Pahud B, Clard S, Herigon JC, Sherman A, Lynch DA, Hoffman A, Jackson MA.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Hosp Pediatr 2015; 5(1):35-41; PMID:25554757;http://dx.doi.org/10.1542/hpeds.2014-0027 [53] Chung R, Walter E, Kemper A, Dayton A.",OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Keen on teen vaccines: improvement of adolescent vaccine coverage in rural North Carolina.J Adolescent Health 2015; 56:S14-16; http://dx.doi.org/10.1016/j.jadohealth.2014.10.272 [54] Staras S, Vadaparampil S, Livingston M, Thompson L, Sanders A, Shenkmen E. Increasing human papillomavirus vaccine initiationamong publicly insured Florida adolescents.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"J Adolescent Health 2015; 56:S40-46; http://dx.doi.org/10.1016/j.jadohealth.2014.11.024 [55] Bundy DG, Persing NM, Solomon BS, King TM, Murakami P, Thompson RE, Engineer LD, Lehmann CU, Miller MR. TheImmProve Project: Leveraging electronic health record data to pro- mote immunization delivery.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Acad Pediatr 2013; 13(5):458-65; PMID:23726754http://dx.doi.org/10.1016/j.acap.2013.03.004 [56] Daley MF, Kempe A, Pyrzanowski J, Vogt TM, Dickinson LM, Kile D, Fang H, Rinehart DJ, Shlay JC.",OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"J Adolescent Health 2014; 54:282-8; http://dx.doi.org/10.1016/j.jadohealth.2013.12.011 [57] Stubbs B, Panozzo C, Moss J, Reiter P, Whitesell D, Brewer N. Evalu- ation of an intervention providing HPV vaccine in schools.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Am JHealth Behav 2014; 38(1):92-102; PMID:24034684; http://dx.doi.org/10.5993/AJHB.38.1.10 [58] Harper DM, Verdenius I, Harris GD, Barnett AL, Rosemergey BE, Arey AM, Wall J, Malnar GJ.",OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Prev Med 2014; 61:20-5; PMID:24440159; http://dx.doi.org/10.1016/j.ypmed.2014.01.007 [59] Chesson H, Ekwueme D, Saraiya M, Watson M, Lowy D, Markowitz LE.",OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Vaccine 2012; 30(42):6016-9; PMID:22867718; http://dx.doi.org/10.1016/j.vaccine.2012.07.056 [60] Rosenthal S, Weiss T, Zimet G, Ma L, Good M, Vichnin M. Predictors of HPV vaccine uptake among women aged 19 â26: importance of a physician âs recommendation.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Vaccine 2011; 29(5):890-895; PMID:20056186; http://dx.doi.org/10.1016/j.vaccine.2009.12.063 [61] Hofstetter A, Rosenthal S. Health care professional communication about STI vaccines with adolescents and parents.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"Vaccine 2014; 32(14):1616-23; PMID:23791695; http://dx.doi.org/10.1016/j.vaccine.2013.06.035 [62] Hofstetter A, Rosenthal S. Factors impacting HPV vaccination: les- sons for health care professionals.",Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
Exp Rev Vaccines 2014; 13(8):1013-26; http://dx.doi.org/10.1586/14760584.2014.9330761588 E. A. SMULIAN ET AL.,Non-OADS,/arxiv_data1/oa_pdf/d7/a8/khvi-12-06-1125055.PMC4964671.pdf
"3, 757 â762 http://dx.doi.org/10.1080/21645515.2015.1087628",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
Nat Commun 2012; 3:698; PMID:22426219;http://dx.doi.org/10.1038/ncomms1701 [2] Cook MJ.,OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Science 1982; 216:1317-9; PMID:7043737; http://dx.doi.org/10.1126/ science.7043737 [4] Wressnigg N, Pollabauer EM, Aichinger G, Portsmouth D, Low- Baselli A, Fritsch S, Livey I, Crowe BA, Schwendinger M, Br â¬uhl P, et al.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Lancet Infect Dis 2013;13:680-9; PMID:23665341; http://dx.doi.org/10.1016/S1473-3099 (13)70110-5 [5] Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
Lancet 2012; 379:461-73; PMID:21903253; http://dx.doi.org/10.1016/S0140- 6736(11)60103-7 [6] Auwaerter PG.,OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Clin InfectDis 2007; 45:143-8; PMID:17578771; http://dx.doi.org/10.1086/ 518854 [7] Mongodin EF, Casjens SR, Bruno JF, Xu Y, Drabek EF, Riley DR, Cantarel BL, Pagan PE, Hernandez YA, Vargas LC, et al.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"BMC Genomics 2013;14:693; PMID:24112474; http://dx.doi.org/10.1186/1471-2164-14- 693 [8] Tappe J, Jordan D, Janecek E, Fingerle V, Strube C. Revisited: Borre- lia burgdorferi sensu lato infections in hard ticks (Ixodes ricinus) in the city of Hanover (Germany).",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Parasites Vectors 2014; 7:441; PMID:25233844; http://dx.doi.org/10.1186/1756-3305-7-441 [9] Nelder MP, Russell C, Lindsay LR, Dhar B, Patel SN, Johnson S, Moore S, Kristjanson E, Li Y, Ralevski F. Population-based passive tick surveillance and detection of expanding foci of blacklegged ticksIxodes scapularis and the Lyme disease agent Borrelia burgdorferi inOntario, Canada.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"PLoS One 2014; 9:e105358; PMID:25171252; http://dx.doi.org/10.1371/journal.pone.0105358 [10] Rauter C, Hartung T. Prevalence of Borrelia burgdorferi sensu lato genospecies in Ixodes ricinus ticks in Europe: a metaanalysis.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
ApplEnviron Microbiol 2005; 71:7203-16; PMID:16269760; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Clin Infect Dis 2011; 52 Suppl 3:s247-52; http://dx.doi.org/10.1093/cid/ciq115 [12] Lindgren E, Jaenson TG.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Press release of the Centers for Disease Control and Pre- vention, August 13, 2013. http://www.cdc.gov/media/releases/2013/ p0819-lyme-disease.html [14] Muller I, Freitag MH, Poggensee G, Scharnetzky E, Straube E, Schoerner C, Hlobil H, Hagedorn HJ, Stanek G, Schubert-Unkmeir A, et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"ClinDev Immunol 2012; 2012:595427; http://dx.doi.org/10.1155/2012/ 595427 [15] Smith R, Takkinen J. Lyme borreliosis: Europe-wide coordinated sur- veillance and action needed?",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Ticks Tick-Borne Dis 2015; 6:69-74; PMID:25448421;http://dx.doi.org/10.1016/j.ttbdis.2014.09.006 [17] Panelius J, Meri T, Seppala I, Eholuoto M, Alitalo A, Meri S. Outer surface protein E antibody response and its effect on com- plement factor H binding to OspE in Lyme borreliosis.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"MicrobesInfection / Institut Pasteur 2008; 10:135-42; http://dx.doi.org/ 10.1016/j.micinf.2007.10.016 [18] McKisic MD, Barthold SW. T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution oflyme disease.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Infect Immun 2000; 68:5190-7; PMID:10948143; http://dx.doi.org/10.1128/IAI.68.9.5190-5197.2000 [19] Vaz A, Glickstein L, Field JA, McHugh G, Sikand VK, Damle N, Steere AC.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Infect Immun 2001; 69:7437-44; PMID:11705918; http://dx.doi.org/ 10.1128/IAI.69.12.7437-7444.2001 [20] Akin E, McHugh GL, Flavell RA, Fikrig E, Steere AC.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Clin Vaccine Immunol 2012; 19:1218-26; PMID:22718128; http://dx.doi.org/10.1128/CVI.00228-12 [22] Burbelo PD, Issa AT, Ching KH, Cohen JI, Iadarola MJ, Marques A.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Clin Vaccine Immunol 2010; 17:904-9;PMID:20392886; http://dx.doi.org/10.1128/CVI.00476-09 [23] Dessau RB, Moller JK, Kolmos B, Henningsson AJ.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"J Med Microbiol 2015; 64:224-31; PMID:25587083;http://dx.doi.org/10.1099/jmm.0.000009 [24] Jones KL, Seward RJ, Ben-Menachem G, Glickstein LJ, Costello CE, Steere AC.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"J Immunol 2002; 169:3847-53; PMID:12244181; http://dx.doi.org/10.4049/jimmunol.169.7.3847 [26] Schuijt TJ, Hovius JW, van der Poll T, van Dam AP, Fikrig E. Lyme borreliosis vaccination: the facts, the challenge, the future.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Trends Parasitol 2011; 27:40-7; PMID:20594913; http://dx.doi.org/10.1016/j.pt.2010.06.006 [27] Rogovskyy AS, Bankhead T. Variable VlsE is critical for host reinfec- tion by the Lyme disease spirochete.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"PLoS One 2013; 8:e61226; PMID:23593438; http://dx.doi.org/10.1371/journal.pone.0061226 [28] McKisic MD, Redmond WL, Barthold SW.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"J Immu- nol 2000; 164:6096-9; PMID:10843657; http://dx.doi.org/10.4049/jimmunol.164.12.6096 [29] Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, Nowakowski J, Schmid CH, Laukamp S, Buscarino C, et al.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"N Engl J Med 1998; 339:209-15; PMID:9673298; http://dx.doi.org/10.1056/NEJM199807233390401 [30] Sigal LH, Zahradnik JM, Lavin P, Patella SJ, Bryant G, Haselby R, Hilton E, Kunkel M, Adler-Klein D, Doherty T, et al.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"N Engl J Med 1998;339:216-22; PMID:9673299; http://dx.doi.org/10.1056/ NEJM199807233390402 [31] Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Huber BT.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Science 1998; 281:703-6; PMID:9685265; http://dx.doi.org/ 10.1126/science.281.5377.703 [32] Nigrovic LE, Thompson KM.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
Epidemiol Infect 2007; 135:1-8; PMID:16893489; http://dx.doi.org/ 10.1017/S0950268806007096 [33] Willyard C. Resurrecting the âyuppie vaccine.,Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
Nat Med 2014; 20:698- 701; PMID:24999936; http://dx.doi.org/10.1038/nm0714-698 [34] Recommendations for the Use of Lyme Disease Vaccine Recommen- dations of the Advisory Committee on Immunization Practices(ACIP).,Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"J Exp Med 1996; 183:271-5;PMID:8551231; http://dx.doi.org/10.1084/jem.183.1.271 [39] Gipson CL, de Silva AM.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Infect Immun 2005; 73:1644-7; PMID:15731064; http://dx.doi.org/10.1128/IAI.73.3.1644-1647.2005 [40] Wressnigg N, Barrett PN, Pollabauer EM, O âRourke M, Portsmouth D, Schwendinger MG, Crowe BA, Livey I, Dvorak T, Schmitt B, et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Clin Vaccine Immunol 2014; 21:1490-9; PMID:25185574; http://dx.doi.org/10.1128/CVI.00406-14 [41] Stubs G, Fingerle V, Zahringer U, Schumann RR, Rademann J, Schroder NW.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"FEMS Immunol Med Microbiol 2011; 63:140-3; PMID:21635569; http://dx.doi.org/10.1111/j.1574-695X.2011.00827.x [42] Kazimirova M, Stibraniova I.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Frontiers Cellular Infection Microbiol 2013; 3:43; http://dx.doi.org/10.3389/fcimb.2013.00043 [43] Ullmann AJ, Dolan MC, Sackal CA, Fikrig E, Piesman J, Zeidner NS.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"TicksTick-Borne Dis 2013; 4:160-3; PMID:23141105; http://dx.doi.org/ 10.1016/j.ttbdis.2012.08.006 [44] Sprong H, Trentelman J, Seemann I, Grubhoffer L, Rego RO, Hajdusek O, Kop /C19a/C20cek P, /C20S/C19Ä±ma R, Nijhof AM, Anguita J, et al.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Parasit Vectors 2014; 7:77; PMID:24559082; http://dx.doi.org/10.1186/1756-3305-7-77 [45] Wikel SK, Ramachandra RN, Bergman DK, Burkot TR, Piesman J. Infestation with pathogen-free nymphs of the tick Ixodes scapularisinduces host resistance to transmission of Borrelia burgdorferi by ticks.",Non-OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"Vector Borned Zoonotic Dis 2013; 13:203-14; http://dx.doi.org/10.1089/vbz.2012.1003 [47] Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, Welch P, Marcus R, Ag â¬uero-Rosenfeld ME, Dennis DT, et al.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
"NEngl J Med 2001; 345:79-84; PMID:11450675; http://dx.doi.org/ 10.1056/NEJM200107123450201 [48] Adrion ER, Aucott J, Lemke KW, Weiner JP.",OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
PLoSOne 2015; 10:e0116767; PMID:25650808; http://dx.doi.org/ 10.1371/journal.pone.0116767762 P. KAAIJK AND W. LUYTJES,OADS,/arxiv_data1/oa_pdf/b0/8e/khvi-12-03-1087628.PMC4964673.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011076).,Non-OADS,/arxiv_data1/oa_pdf/3f/5c/bmjopen-2016-011076.PMC4964680.pdf
"3, 655 â657 http://dx.doi.org/10.1080/21645515.2015.1084451",Non-OADS,/arxiv_data1/oa_pdf/13/46/khvi-12-03-1084451.PMC4964705.pdf
"Human Vacc Immunother 2014; 10:129-37; http://dx.doi.org/10.4161/hv.26269[2] Lim FS, Phua KB, Lee BW, Quak SH, Teoh YL, Ramakrishnan G, Han HH, Van Der Meeren O, Jacquets JM, Bock HL.",Non-OADS,/arxiv_data1/oa_pdf/13/46/khvi-12-03-1084451.PMC4964705.pdf
"Available at: http://www.who.int/ent ity/immunization /policy/Immuniza tion_routine_table1.pdf?ua=1, accessed on 10 thMarch 2015.",Non-OADS,/arxiv_data1/oa_pdf/13/46/khvi-12-03-1084451.PMC4964705.pdf
"Vaccine 2003; 16:2003-14;http://dx.doi.org/10.1016/S0264-410X(02)00770-3 [5] Dagan R, Igbaria K, Piglansky L, Melamed R, Willems P, Grossi A, Kauf- hold A.",OADS,/arxiv_data1/oa_pdf/13/46/khvi-12-03-1084451.PMC4964705.pdf
"Pediatr Inf Dis J 1997; 16: 1113- 21; http://dx.doi.org/10.1097/00006454-199712000-00004 [6] Halperin SA, King J, Law B, Mills E, Willems P. Safety and immuno- genicity of Haemophilus in ï¬uenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids andinactivated poliovirus vaccine for the ï¬rst four doses.",Non-OADS,/arxiv_data1/oa_pdf/13/46/khvi-12-03-1084451.PMC4964705.pdf
"Clin Inf Dis 1999; 28:995-1001; http://dx.doi.org/10.1086/514741 [7] Lin TY, Wang YH, Chang LY, Chiu CH, Huang YC, Tang H, Bock H. Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated p oliovirus vaccine/Haemophilus inï¬uenzae type B combination vaccine administered to Taiwa- n e s ei n f a n t sa t2 ,4 ,a n d6m o n t h so fa g e .C h a n gG u n gM e dJ2003; 26:315-22; PMID:12934847 [8] Phua KB, Quak SH, Lim FS, Goh P, Teoh YL, Datta SK, Han HH, Bock HL.",Non-OADS,/arxiv_data1/oa_pdf/13/46/khvi-12-03-1084451.PMC4964705.pdf
BioMed Res Int 2014; 2014:541319; PMID:24678509; http://dx.doi.org/10.1155/2014/541319 [10] Le CT.,OADS,/arxiv_data1/oa_pdf/13/46/khvi-12-03-1084451.PMC4964705.pdf
Clin Inf Dis 2001; 33 Suppl 4: S367-71; http://dx.doi.org/10.1086/322575 [11] UNICEF: National EPI Review Report: Review of Expanded Program of Immunization Vietnam 2009.,Non-OADS,/arxiv_data1/oa_pdf/13/46/khvi-12-03-1084451.PMC4964705.pdf
Available at: http://www.unicef.org/vietnam/EPI_NATIONAL_Review_Report_Vietnam_2009_Final.,Non-OADS,/arxiv_data1/oa_pdf/13/46/khvi-12-03-1084451.PMC4964705.pdf
Available at: http://www.nihe.org.vn/new-en/chuong-trinh-tiem-chung-mo-rong-quoc-gia-703261429/1034/General-Information.,Non-OADS,/arxiv_data1/oa_pdf/13/46/khvi-12-03-1084451.PMC4964705.pdf
Human Vacc Immunother 2012; 8:347-54; http://dx.doi.org/10.4161/hv.18630HUMAN VACCINES & IMMUNOTHERAPEUTICS 657,Non-OADS,/arxiv_data1/oa_pdf/13/46/khvi-12-03-1084451.PMC4964705.pdf
"6, 1484 â1490 http://dx.doi.org/10.1080/21645515.2016.1153207",Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
Vaccine 2006; 24 Suppl 1:S1-S15; PMID: 16406226; http://dx.doi.org/10.1016/j.vaccine.2005.09.054 [2] National Advisory Committee on Immunization (NACI).,Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
"http://publications.gc.ca/collections/collection_2008/phac-aspc/HP40-29-2008E.pdf [5] Drolet M, B /C19enard /C19E, Boily MC, Ali H, Baandrup L, Bauer H, Bed- dows S, Brisson J, Brotherton JM, Cummings T, et al.",Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
Lancet Infect Dis 2015; 15:565-80; PMID:25744474; http://dx.doi.org/10.1016/S1473-3099(14)71073-4 [6] Fisher WA.,Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
Vaccine 2012; 30 Suppl 5:F149-56; PMID:23199958; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
Hum Vaccin Immunother 2015; 11:322-9; PMID:25692455. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
Vaccine 2013; 31:757-62; PMID:23246265; http://dx.doi.org/10.1016/j.vaccine.2012.11.090 [10] Ontario Agency for Health Protection and Promotion.,Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
Vaccine 2015; 33:1786-90; PMID:25731789; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
Prev Med 2013; 57:409-13; PMID:23769899; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
"Clin Pediatr 2014; 53:261-9; PMID:24463951; http://dx.doi.org/10.1177/0009922813520070 [16] Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K, Hickman M. Inequalities in the uptake of human papillomavirus vaccination: Asystematic review and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
"Int J Epidemiol 2013; 42:896-908; PMID:23620381; http://dx.doi.org/10.1093/ije/dyt049 [17] Remes O, Smith LM, Alvarado-Llano BE, Colley L, L /C19evesque LE.",OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
JAMA Pediatr 2014; 168:76-82; PMID:24276343; http://dx.doi.org/10.1001/jamapediatrics.2013.2752 [20] Canadian Medical Protective Association.,Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
2014; https://www.cmpa-acpm.ca/-/can-a-child-provide-consent-.,Non-OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
2015; http://www.statcan.gc.ca/imdb-bmdi/5185-eng.htm.,OADS,/arxiv_data1/oa_pdf/c1/32/khvi-12-06-1153207.PMC4964714.pdf
"6, 1435 â1450 http://dx.doi.org/10.1080/21645515.2016.1141158",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
Vaccine 2012; 30 Suppl 5:F12 â23; PMID:23199955; http://dx.doi.org/10.1016/j.vac cine.2012.07.055 [3] Centers for Disease Control Prevention.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
Retrieved from: http://www.cdc.gov/std/hpv/stdfact-hpv-vaccine-hcp.htm [5] United States Food and Drug Administration.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"2014; Retrieved from: http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm426485.htm [6] Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RD, Markowitx L. Human papillomavirus vaccination coverage amongadolescents, 2007-2013, and post-licensure vaccine safety monitor-ing, 2006-2014 - United States.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Pediatr Clin North Am 2016; 63:81 â95; PMID:26613690; http://dx.doi.org/10.1016/j.pcl.2015.08.004 [8] Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, MacNeil J, Markowitz LE, Stokley S. National,regional, state, and selected local area vaccination coverage amongadolescents aged 13 â17 years âUnited States, 2014.",OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
MMWR Morb Mortal Wkly Rep; 64:784 â92; http://dx.doi.org/10.15585/mmwr.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
Inj Prev 1998; 4:89 â 91; PMID:9666358; http://dx.doi.org/10.1136/ip.4.2.89 [12] Pollitt K. Virginity or death!,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
Prev Med 2013; 57:409 â13; PMID:23769899; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Retrieved from: http://www.cbc.ca/news/canada/british-columbia/hpv-vaccine-abstinence-bishop-bc-1.3242076 [15] Smith R, Motiuk D, Henry F, Pettipas G, Bouchard L, Chatlain M. A message to Catholic parents/ guardians and the Catholic educational community 2008.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Available:http://ccsdmedia.s3.amazonaws.com/wp-content/uploads/2014/08/Alberta_Bishops_letter.pdf [16] Waller J, Marlow LA, Wardle J.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Cancer Epidemiol Biomarkers Prev 2006; 15:1257 â 61; PMID:16835320; http://dx.doi.org/10.1158/1055-9965.EPI-06- 0041 [17] Brewer NT, Fazekas KI.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Prev Med 2007; 45:107 â14; PMID:17628649; http://dx.doi.org/10.1016/j.ypmed.2007.05.013 [18] Friedman AL, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regard-ing HPV ï¬ndings from CDC focus group research and implications for practice.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Health Educ Behav 2007; 34:471 â85; PMID:17000622; http://dx.doi.org/10.1177/1090198106292022 [19] Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H. Parental acceptance of the human papillomavirus vaccine.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
J Adolesc Health 2005; 37:248 â51; PMID:16109349; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Women & Health 2007; 45:59 â73; PMID:18019286; http://dx.doi.org/10.1300/J013v45n02_04 [22] Mayer MK, Reiter PL, Zucker RA, Brewer NT.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
Sex Transm Dis 2013; 40:822 â8; PMID:24275737; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Can Med Assoc J 2007; 177:1506 â12; http://dx.doi.org/10.1503/ cmaj.071022 [24] Schuler CL, Reiter PL, Smith JS, Brewer NT.",OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Sex Transm Infect 2011; 87:349 â353; PMID:21357601; http://dx.doi.org/10.1136/ sti.2010.048017 [25] Marlow LAV, Forster AS, Wardle J, Waller J.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"J Adolesc Health 2009; 44:446 â51; PMID:19380091; http://dx.doi.org/ 10.1016/j.jadohealth.2008.09.011 [26] Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, McCann R. Uptake of ï¬rst two doses of human papillomavirus vac- cine by adolescent schoolgirls in Manchester: prospective cohortstudy.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"BMJ 2008; 336:1056 â8; PMID:18436917; http://dx.doi.org/ 10.1136/bmj.39541.534109.BE [27] Etter DJ, Zimet GD, Rickert VI.",OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Curr Opin Obstet Gynecol 2012; 24:305 â10; PMID:22781077; http://dx.doi.org/10.1097/ GCO.0b013e3283567005 [28] Aujo JC, Bakeera-Kitaka S, Kiguli S, Mirembe F. No difference in sexual behavior of adolescent girls following Human Papilloma Virusvaccination: a case study two districts in Uganda; Nakasongola and Luwero.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"BMC Public Health 2014; 14:155; PMID:24520841; http://dx.doi.org/10.1186/1471-2458-14-155 [29] Marchand E, Glenn B, Bastani R. HPV vaccination and sexual behav- ior in a community college sample.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"J Commun Health 2013; 38:1010 â4; http://dx.doi.org/10.1007/s10900-013-9710-0 [30] Mattebo M, Grun N, Rosenblad A, Larsson M, Haggstrom-Nordin E, Dalianis T, Tyden T. Sexual experiences in relation to HPV vaccina- tion status in female high school students in Sweden Eur J Contra-cept Reprod Health Care 2014; 19:86 â92; PMID:24555926; http://dx.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Pediatrics 2014; 133:404 â11; PMID:24488747; http://dx.doi.org/10.1542/peds.2013-2822 [32] Mather T, McCaffery K, Juraskova I.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Vaccine 2012; 30:3196 â201; PMID:22425789; http://dx.doi.org/ 10.1016/j.vaccine.2012.02.081 [33] Ruiz-Sternberg AM, Pinzon-Rondon AM.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Int J Gynaecol Obstet 2014; 126:205 â8; PMID:24996685; http://dx.doi.org/10.1016/j.ijgo.2014.03.033 [34] Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT.",OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Cancer Epidemiol Biomarkers Prev 2015; 24:1673 â9; PMID:26494764; http://dx.doi.org/10.1158/1055- 9965.EPI-15-0326 [35] Zimet GD, Stupiansky NW, Weiss TW, Rosenthal SL, Good MB, Vichnin MD.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
Vac- cine 2011; 29:378 â81; PMID:21111781; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Sex Transm Infect 2012; 88:433 â5; PMID:22522751; http://dx.doi.org/10.1136/sextrans-2011- 050437 [37] Forster AS, Marlow LA, Stephenson J, Wardle J, Waller J.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Vaccine 2012; 30:4939 â44; PMID:22664223; http://dx.doi.org/10.1016/j.vac cine.2012.05.053 [38] Hansen BT, Kjaer SK, Arnheim-Dahlstrom L, Liaw KL, Jensen KE, Thomsen LT, Munk C, Nygard M. Human papillomavirus (HPV)vaccination and subsequent sexual behaviour: evidence from a largesurvey of Nordic women.",OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Vaccine 2014; 32:4945 â53; PMID:25045810; http://dx.doi.org/10.1016/j.vaccine.2014.07.025 [39] Liddon NC, Leichliter JS, Markowitz LE.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Am JPrev Med 2012; 42:44 â52; PMID:22176845; http://dx.doi.org/ 10.1016/j.amepre.2011.09.024 [40] Lutringer-Magnin D, Kalecinski J, Cropet C, Barone G, Ronin V, Regnier V, Leocmach Y, Jacquard AC, Vanhems P, Chauvin F, et al.Prevention of sexually transmitted infections among girls and young women in relation to their HPV vaccination status.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Eur J Public Health 2013; 23:1046 â53; PMID:23430762; http://dx.doi.org/ 10.1093/eurpub/ckt018 [41] Cummings T, Zimet GD, Brown D, Tu W, Yang Z, Fortenberry JD, Shew ML.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Vaccine 2012; 30:5496 â9; PMID:22750043; http://dx.doi.org/10.1016/j.vaccine.2012.06.057 [42] Al Romaih WRR, Srinivas A, Shahtahmasebi S, Omar HA.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
Int J STD AIDS 2013; 24:531 â5; PMID:23970767; http://dx.doi.org/10.1177/0956462412473891 [44] Ratanasiripong NT.,OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"J Sch Nurs 2014; 30:456 â63; PMID:24414172; http://dx.doi.org/10.1177/ 1059840513520042 [45] Rysavy MB, Kresowik JD, Liu D, Mains L, Lessard M, Ryan GL.",OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"J Pediatr Adolesc Gynecol 2014; 27:67 â71; PMID:24405635; http://dx.doi.org/10.1016/j.jpag.2013.08.009 [46] Sadler L, Roberts SA, Hampal G, McManus D, Mandal D, Brabin L. Comparing risk behaviours of human papillomavirus-vaccinated and non-vaccinated women.",OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Womens Reprod Health 2014; 1:43 â55; http://dx.doi.org/10.1080/ 23293691.2014.901804 [48] Sadler L, Roberts SA, Hampal G, McManus D, Mandal D, Brabin L. Comparing risk behaviours of human papillomavirus-vaccinated and non-vaccinated women.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"J Fam Plann Reprod Health Care 2015;41:255 â8; PMID:25605479; http://dx.doi.org/10.1136/jfprhc-2014- 100896 [49] Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
Pediatrics 2012; 130:798 â805; PMID:23071201; http://dx.doi.org/10.1542/peds.2012-1516 [50] Fonseca-Moutinho JA.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
ISRN obstetrics and gynecology 2011; 2011:847684; PMID:21785734; http://dx.doi.org/10.5402/2011/847684 [51] International Agency for Research on Cancer.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"JAMA Int Med 2015; 175:617 â23; http://dx.doi.org/ 10.1001/jamainternmed.2014.7886 [53] Smith LM, Kaufman JS, Strumpf EC, Levesque LE.",OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Can Med Assoc J 2015; 187:E74 â81; http://dx.doi.org/ 10.1503/cmaj.140900 [54] Fortenberry JD, Costa FM, Jessor R, Donovan JE.",OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"JRes Adolesc 1997; 7:307 â29; PMID:12292602; http://dx.doi.org/ 10.1207/s15327795jra0703_4 [55] Kahn JA, Xu J, Zimet GD, Liu N, Gonin R, Dillard ME, Squires K. Risk perceptions after Human Papillomavirus Vaccination in HIV- infected adolescents and young adult women.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"J Adolesc Health 2012; 50:464 â70; PMID:22525109; http://dx.doi.org/10.1016/j.jado health.2011.09.005 [56] Mullins TL, Zimet GD, Rosenthal SL, Morrow C, Ding L, Shew M, Fortenberry JD, Bernstein DI, Kahn JA.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Arch Pediatr Adolesc Med 2012; 166:82 â8; PMID:22213755; http://dx.doi.org/10.1001/arch pediatrics.2011.186 [57] Mullins TLK, Widdice LE, Rosenthal SL, Zimet GD, Kahn JA.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"Vaccine 2015; 33:3907 â12; PMID:26116249; http://dx.doi.org/10.1016/j.vaccine.2015.06.060 [58] Zimet GD, Rosberger Z, Fisher WA, Perez S, Stupiansky NW.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
Prev Med 2013; 57:414 â8; PMID:23732252; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
Pediatrics 2009; 124 Suppl 5:S532 â9; PMID:19948585; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"J Clin Epidemiol 2009; 62:1006 â12; PMID:19631508; http://dx.doi.org/10.1016/j.jclinepi.2009.06.005 [63] Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions.",OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
Available: https://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular risk-reduction/tools/cohortHUMAN VACCINES & IMMUNOTHERAPEUTICS 1449,Non-OADS,/arxiv_data1/oa_pdf/10/cb/khvi-12-06-1141158.PMC4964724.pdf
"6, 1406 â1417 http://dx.doi.org/10.1080/21645515.2016.1168952",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Through the AIDS Malignancy Consortium (https://web.emmes.com/study/amc/public/), a clinical trial was conductedin the United States to assess the safety and immunogenicity of4vHPV of HIV infected men aged 18 or older.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Vaccine 2010; 28:4719-30; PMID:20451636; http://dx.doi.org/10.1016/j.vaccine.2010.04.070 [2] Petrosky E, Bocchini JA, Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE, Centers for Disease C, Prevention.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM11 1263.pdf [4] Human Papillomavirus Bivalent ( types 16 and 18) Vaccine, Recombi- n a n t ,P a c k a g eI n s e r t .A v a i l a b l ea t :h ttp://www.fda.gov/downloads/Bio logicsBloodVaccines/Vaccines /ApprovedProducts/UCM186981.pdf [5] Human Papillomavirus 9-valent Vaccine, Recombinant, Package Insert.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM426457.pdf [6] Agorastos T, Chatzigeorgiou K, Brotherton JM, Garland SM.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Vaccine 2009; 27:7270-81; PMID:19799849;http://dx.doi.org/10.1016/j.vaccine.2009.09.097 [7] Macartney KK, Chiu C, Georgousakis M, Brotherton JM.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Vac- cine 2010; 28:4731-7; PMID:20188681; http://dx.doi.org/10.1016/j.vaccine.2010.02.019 [9] Vichnin M, Bonanni P, Klein NP, Garland SM, Block SL, Kjaer SK, Sings HL, Perez G, Haupt RM, Saah AJ, et al.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"PediatrInfect Dis J 2015; 34:983-91; PMID:26107345; http://dx.doi.org/ 10.1097/INF.0000000000000793 [10] Darden PM, Thompson DM, Roberts JR, Hale JJ, Pope C, Naifeh M, Jacobson RM.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Pediatrics 2013; 131:645- 51; PMID:23509163; http://dx.doi.org/10.1542/peds.2012-2384 [11] Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, MacNeil J, Markowitz LE, Stokley S. National,Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13 â17 Years âUnited States, 2014.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
MMWR Morb Mortal Wkly Rep 2015; 64:784-92; PMID:26225476; http://dx.doi.org/10.15585/mmwr.mm6429a3 [12] DeStefano F. The Vaccine Safety Datalink project.,Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
Pharmacoe- pidemiolDrug Saf 2001; 10:403-6; http://dx.doi.org/10.1002/pds.613 [13] Sukumaran L. Human Papillomavirus (HPV) Vaccine Safety Update.,Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Available at: http://www.cdc.gov/vaccines/acip/meetings/slides-2015-10.html [14] Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izur- ieta HS, Ball R, Miller N, Braun MM, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"JAMA 2009; 302:750-7; PMID:19690307; http://dx.doi.org/10.1001/jama.2009.1201 [15] Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L. Immunization Services Division NCfI, RespiratoryDiseases CDC, et al.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
Available at: http://www.cdc.gov/vaccinesafety/vaccines/hpv/hpv-safety-faqs.html [18] Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (WONDER) search tool for theHUMAN VACCINES & IMMUNOTHERAPEUTICS 1415,Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Available at: http://wonder.cdc.gov/vaers.html [19] Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, Kulldorff M, Lewis E, Fireman B, Daley MF, et al.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Vaccine 2011; 29:8279-84; PMID:21907257; http://dx.doi.org/10.1016/j.vaccine.2011.08.106 [20] McNeil MM, Weintraub ES, Duffy J, Sukumaran L, Jacobsen SJ, Klein NP, Hambidge SJ, Lee GM, Jackson LA, Irving SA, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Safety of quadrivalenthuman papillomavirus vaccine administered routinely to females.Arch Pediatr Adolesc Med 2012; 166:1140-8; PMID:23027469; http://dx.doi.org/10.1001/archpediatrics.2012.1451 [22] Della Corte C, Carlucci A, Francalanci P, Alisi A, Nobili V. Autoim- mune hepatitis type 2 following anti-papillomavirus vaccination in a11-year-old girl.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Mult Scler 2014; 20:762-3; PMID:23970503; http://dx.doi.org/10.1177/1352458513502114 [24] Wildemann B, Jarius S, Hartmann M, Regula JU, Hametner C. Acute disseminated encephalomyelitis following vaccination against human papilloma virus.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"CMAJ 2007; 177:1352-4; PMID:18025425; http://dx.doi.org/10.1503/cmaj.071134 [27] Siegrist CA, Lewis EM, Eskola J, Evans SJ, Black SB.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Vaccine 2012; 30:4585-7; PMID:22580356; http://dx.doi.org/10.1016/j.vaccine.2012.04.103 [29] Chao C, Klein NP, Velicer CM, Sy LS, Slezak JM, Takhar H, Acker- son B, Cheetham TC, Hansen J, Deosaransingh K, et al.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
JIntern Med 2014; 275:398-408; PMID:24206418; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
Autoimmun Rev 2010; 9:771-4; PMID:20601203; http://dx.doi.org/10.1016/j.autrev.2010.06.008 [36] Santoro N. Mechanisms of premature ovarian failure.,Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"J Womens Health Gend Based Med 2000; 9:275- 87; PMID:10787223; http://dx.doi.org/10.1089/152460900318461 [38] Scheller NM, Pasternak B, Svanstrom H, Hviid A. Quadrivalent human papillomavirus vaccine and the risk of venous thromboembo-lism.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"JAMA 2014; 312:187-8; PMID:25005658; http://dx.doi.org/ 10.1001/jama.2014.2198 [39] Naleway AL, Crane B, Smith N, Daley MF, Donahue J, Gee J, Greene SK, Harrington T, Jackson LA, Klein NP, et al.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
Arch Gyne-col Obstet 2012; 285:1719-24; PMID:22246478; http://dx.doi.org/ 10.1007/s00404-011-2208-z [42] European Medicines Agency recommends continued vaccination with Gardasil.,Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/Press_release/2009/11/WC500011828.pdf [43] Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Lancet 2015; 385:2571; PMID:26122153; http://dx.doi.org/10.1016/S0140-6736(15)61152-7 [44] Richards S, Chalkiadis G, Lakshman R, Buttery JP, Crawford NW.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
Arch DisChild 2012; 97:913-5; PMID:22858647; http://dx.doi.org/10.1136/archdischild-2011-301307 [45] Weinbaum CCM.,OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"EBioMed 2015; 2:1014-5; http://dx.doi.org/10.1016/j.ebiom.2015.08.030 [46] Tomljenovic L, Colafrancesco S, Perricone C, Shoenfeld Y. Postural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccina-tion as Part of the âAutoimmune/Auto-in ï¬ammatory Syndrome Induced by Adjuvants: âCase Report and Literature Review.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
Vaccine 2015; 33:2602- 5; PMID:25882168; http://dx.doi.org/10.1016/j.vaccine.2015.03.098 [48] Grubb BP.,Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Circulation 2008; 117:2814-7; PMID:18506020; http://dx.doi.org/10.1161/ CIRCULATIONAHA.107.761643 [49] Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biag- gioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Consensus statement on the de ï¬nition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.Clin Auton Res 2011; 21:69-72; PMID:21431947; http://dx.doi.org/10.1007/s10286-011-0119-5 [50] Review concludes evidence does not support that HPV vaccines cause CRPS or POTS.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Available at: http://www.jsonline.com/news/health/medical-examiner-girls-death-not-caused-by-routine-vaccination-b99376029z1-280058462.html [53] McCarthy NL, Gee J, Sukumaran L, Weintraub E, Duffy J, Khar- banda EO, Baxter R, Irving S, King J, Daley MF, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Obstet Gynecol 2009; 114:1179-88; http://dx.doi.org/10.1097/ AOG.0b013e3181c2ca21 [57] Goss MA, Lievano F, Buchanan KM, Seminack MM, Cunningham ML, Dana A.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Vaccine 2015; 33:3422-8; PMID:25869893; http://dx.doi.org/ 10.1016/j.vaccine.2015.04.014 [58] Moro PL, Zheteyeva Y, Lewis P, Shi J, Yue X, Museru OI, Broder K. Safety of quadrivalent human papillomavirus vaccine (Gardasil) in pregnancy: adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006 â2013.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Vaccine 2015; 33:519-22; PMID:25500173; http://dx.doi.org/10.1016/j.vaccine.2014.11.047 [59] Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA, 3rd, Read JS, Handelsman EL, Nowak B, Sattler CA, Saah A, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
J Acquir Immune De ï¬c Syndr 2010; 55:197-204; PMID:20574412; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"J Infect Dis 2010; 202:1246-53; PMID:20812850;http://dx.doi.org/10.1086/656320 [61] Kojic EM, Kang M, Cespedes MS, Umbleja T, Godfrey C, Allen RT, Firnhaber C, Grinsztejn B, Palefsky JM, Webster-Cyriaque JY, et al.Immunogenicity and safety of the quadrivalent human papillomavi-rus vaccine in HIV-1-infected women.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Clin Infect Dis 2014; 59:127- 35; PMID:24723284; http://dx.doi.org/10.1093/cid/ciu238 [62] Kahn JA, Xu J, Kapogiannis BG, Rudy B, Gonin R, Liu N, Wilson CM, Worrell C, Squires KE.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Vaccine 2014; 32:5657-61; PMID:25149430; http://dx.doi.org/10.1016/j.vaccine.2014.08.011 [64] Toft L, Storgaard M, Muller M, Sehr P, Bonde J, Tolstrup M, Oster- gaard L, Sogaard OS.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"J Infect Dis 2014; 209:1165-73; PMID:24273179; http://dx.doi.org/10.1093/infdis/jit657 [65] Wilcox AJ, Weinberg CR, O âConnor JF, Baird DD, Schlatterer JP, Canï¬eld RE, Armstrong EG, Nisula BC.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"N Engl J Med 1988; 319:189-94; PMID:3393170; http://dx.doi.org/10.1056/NEJM198807283190401 [66] Iskander JK, Miller ER, Chen RT.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Pediatr Infect Dis J 2004; 23:287-94; PMID:15071280; http://dx.doi.org/10.1097/00006454-200404000-00002 [68] Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, et al.",OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Pediatrics2011; 127 Suppl 1:S45-S53; http://dx.doi.org/10.1542/peds.2010- 1722H [69] Lieu TA, Kulldorff M, Davis RL, Lewis EM, Weintraub E, Yih K, Yin R, Brown JS, Platt R. Real-time vaccine safety surveillance for theearly detection of adverse events.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
âAvailable at: http://blogs.fda.gov/fdavoice/index.php/2014/12/another-important- step-in-fdas-journey-towards-enhanced-safety-through-full-scale-act ive-surveillance/ [71] Findlay S. Health Policy Brief: The FDA âs Sentinel Initiative.,Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Avail- able at: http://healthaffairs.org/healthpolicybriefs/brief_pdfs/health policybrief_139.pdf [72] Sentinel Initiative Public Workshop, 2016.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
"Available at: http://www.fda.gov/Bio logicsBloodVaccines/Vaccines /ApprovedProducts/ucm426520.htm [74] Gollust SE, Attanasio L, Dempsey A, Benson AM, Fowler EF.",Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
Womens Health Issues 2013; 23:e143-51; PMID:23557851;http://dx.doi.org/10.1016/j.whi.2013.02.001 [75] Institute of Medicine of the National Academies.,Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/08/cf/khvi-12-06-1168952.PMC4964727.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:e009809corr1.,Non-OADS,/arxiv_data1/oa_pdf/21/e0/bmjopen-2015-009809corr1.PMC4964735.pdf
"3, 740 â748 http://dx.doi.org/10.1080/21645515.2015.1099772",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
Expert Rev Vaccines 2010; 9:1149-76; PMID:20923267; http://dx.doi.org/10.1586/erv.10.115746 V. BLAZEVIC ET AL.,Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Intervirology 2013; 56:141-65; PMID:23594863;http://dx.doi.org/10.1159/000346773 [3] Lavelle L, Gingery M, Phillips M, Gelbart WM, Knobler CM, Cadena-Nava RD, Vega-Acosta JR, Pinedo-Torres LA, Ruiz-Garcia J.Phase diagram of self-assembled viral capsid protein polymorphs.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Phys Chem B 2009; 113:3813-9PMID:19673134; http://dx.doi.org/ 10.1021/jp8079765 [4] Ghosh MK, Deriaud E, Saron MF, Lo-Man R, Henry T, Jiao X, Roy P, Leclerc C. Induction of protective antiviral cytotoxic T cells by a tubular structure capable of carrying large foreign sequences.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Vac- cine 2002; 20:1369-77; PMID:11818155; http://dx.doi.org/10.1016/S0264-410X(01)00467-4 [5] Prasad BV, Wang GJ, Clerx JP, Chiu W. Three-dimensional structure of rotavirus.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Mol Biol 1988; 199:269-75; http://dx.doi.org/10.1016/ 0022-2836(88)90313-0 [6] Estes MK, Crawford SE, Penaranda ME, Petrie BL, Burns JW, Chan WK, Ericson B, Smith GE, Summers MD.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"EMBO J 2001; 20:1498-507; PMID:11285214;http://dx.doi.org/10.1093/emboj/20.7.1498 [10] Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Eur J Immunol 2008; 38:1404-13; PMID:18389478;http://dx.doi.org/10.1002/eji.200737984 [11] Xiang SD, Scholzen A, Minigo G, David C, Apostolopoulos V, Mot- tram PL, Plebanski M. Pathogen recognition and development of particulate vaccines: Does size matter?",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Methods 2006; 40:1-9; http://dx.doi.org/10.1016/j.ymeth.2006.05.016 [12] Hubbell JA, Thomas SN, Swartz MA.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Nature 2009; 462:449-60; PMID:19940915;http://dx.doi.org/10.1038/nature08604 [13] Cubas R, Zhang S, Kwon S, Sevick-Muraca EM, Li M, Chen C, Yao Q. Virus-like particle (VLP) lymphatic traf ï¬cking and immune response generation after immunization by different routes.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"JImmunother 2009; 32:118-28; PMID:19238010; http://dx.doi.org/10.1097/CJI.0b013e31818f13c4 [14] Svensson L, Sheshberadaran H, Vene S, Norrby E, Grandien M, Wadell G. Serum antibody responses to individual viral polypeptidesin human rotavirus infections.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Gen Virol 1987; 68 (Pt 3):643-51;PMID:3029295; http://dx.doi.org/10.1099/0022-1317-68-3-643 [15] Ward RL, McNeal MM.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Infect Dis 2010; 202 Suppl:S101-7; PMID:20684688; http://dx.doi.org/10.1086/653556 [16] Ishida S, Feng N, Tang B, Gilbert JM, Greenberg HB.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Virol 2006; 80:10692-9; http://dx.doi.org/ 10.1128/JVI.00927-06 [18] Garaicoechea L, Olichon A, Marcoppido G, Wigdorovitz A, Mozgo- voj M, Saif L, Surrey T, Parreno V. Llama-derived single-chainantibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrheain mice.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Virol 2008; 82:9753-64; http://dx.doi.org/10.1128/JVI.00436-08 [19] Aiyegbo MS, Sapparapu G, Spiller BW, Eli IM, Williams DR, Kim R, Lee DE, Liu T, Li S, Woods VL, Jr, et al.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"PLoS One 2013; 8: e61101; http://dx.doi.org/10.1371/journal.pone.0061101 [20] Lappalainen S, Pastor AR, Tamminen K, Lopez-Guerrero V, Esqui- vel-Guadarrama F, Palomares LA, Vesikari T, Blazevic V. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Hum Vaccin Immunother 2014;10:2039-47; PMID:25424814; http://dx.doi.org/10.4161/hv.28858 [21] Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Science 1996; 272:104-7; PMID:8600516;http://dx.doi.org/10.1126/science.272.5258.104 [22] Feng N, Lawton JA, Gilbert J, Kuklin N, Vo P, Prasad BV, Greenberg HB.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Clin Invest 2002; 109:1203-13; PMID:11994409; http://dx.doi.org/10.1172/JCI14397 [23] Patel NC, Hertel PM, Estes MK, de la Morena M, Petru AM, Noroski LM, Revell PA, Hanson IC, Paul ME, Rosenblatt HM, et al.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"N Engl J Med 2014; 370:513-9; http://dx.doi.org/10.1056/NEJMoa1311738 [25] Hemming M, Vesikari T. Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
Pediatr Infect Dis J 2012; 31:992-4; http://dx.doi.org/10.1097/INF.,OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"N Engl J Med 2006; 354:23-33; PMID:16394299;http://dx.doi.org/10.1056/NEJMoa052664 [27] Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, et al.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"N Engl J Med 2001; 344:564-72; PMID:11207352; http://dx.doi.org/10.1056/ NEJM200102223440804 [28] Blazevic V, Lappalainen S, Nurminen K, Huhti L, Vesikari T. Noro- virus VLPs and rotavirus VP6 protein as combined vaccine for child-hood gastroenteritis.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Vaccine 2011; 29:8126-33; PMID:21854823; http://dx.doi.org/10.1016/j.vaccine.2011.08.026 [29] Tamminen K, Lappalainen S, Huhti L, Vesikari T, Blazevic V. Triva- lent combination vaccine induces broad heterologous immuneresponses to norovirus and rotavirus in mice.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"PLoS One 2013; 8: e70409; http://dx.doi.org/10.1371/journal.pone.0070409 [30] Glass RI, Parashar UD, Estes MK.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"N Engl J Med 2009; 361:1776-85; PMID:19864676; http://dx.doi.org/10.1056/NEJMra0804575 [31] Kroneman A, Vega E, Vennema H, Vinje J, White PA, Hansman G, Green K, Martella V, Katayama K, Koopmans M. Proposal for auniï¬ed norovirus nomenclature and genotyping Arch Virol 2013; 158:2059-68; PMID:23615870; http://dx.doi.org/10.1007/s00705- 013-1708-5 [32] Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinje J. Geno- typic and epidemiologic trends of norovirus outbreaks in the united states, 2009 to 2013.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
J Clin Microbiol 2014; 52:147-55; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Mol Immunol 1991; 28:269-78; PMID:1850113; http://dx.doi.org/10.1016/0161- 5890(91)90073-S [35] Frenchick PJ, Sabara MI, Ready KF, Babiuk LA.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Vaccine 1992; 10:783-91; http://dx.doi.org/10.1016/0264-410X(92)90514-K [36] Peralta A, Molinari P, Taboga O. Chimeric recombinant rotavirus- like particles as a vehicle for the display of heterologous epitopes.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Virol J 2009; 6:192,422X-6-192; PMID:19891790; http://dx.doi.org/10.1186/1743-422X-6-192 [37] Chen Q, He F, Kwang J, Chan JK, Chen J. GM-CSF and IL-4 stimu- late antibody responses in humanized mice by promoting T, B, and dendritic cell maturation.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Immunol 2012; 189:5223-9; PMID:23089398; http://dx.doi.org/10.4049/jimmunol.1201789 [38] Lappalainen S, Tamminen K, Vesikari T, Blazevic V. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Hum Vaccin Immunother 2013; 9:1991-2001;PMID:23777748; http://dx.doi.org/10.4161/hv.25249 [39] Treanor JJ, Atmar RL, Frey SE, Gormley R, Chen WH, Ferreira J, Goodwin R, Borkowski A, Clemens R, Mendelman PM.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"N Engl J Med 2011; 365:2178-87; PMID:22150036; http://dx.doi.org/10.1056/NEJMoa1101245 [42] Abe T, Takahashi H, Hamazaki H, Miyano-Kurosaki N, Matsuura Y, Takaku H. Baculovirus induces an innate immune response and con- fers protection from lethal in ï¬uenza virus infection in mice.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Immu- nol 2003; 171:1133-9; PMID:12874198; http://dx.doi.org/10.4049/jimmunol.171.3.1133 [43] Hervas-Stubbs S, Rueda P, Lopez L, Leclerc C. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type IIFN.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
J Immunol 2007; 178:2361-9; PMID:17277142; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Virol 2002; 76:12335-43; PMID:12414974; http://dx.doi.org/10.1128/JVI.76.23.12335-12343.2002 [45] Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Ruvoen N, Clement M, Le Pendu J. ABH and lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Biochimie 2001; 83:565-73; http://dx.doi.org/10.1016/S0300-9084(01)01321-9 [46] Hutson AM, Atmar RL, Graham DY, Estes MK.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Infect Dis 2002; 185:1335-7; http://dx.doi.org/10.1086/339883 [47] Reeck A, Kavanagh O, Estes MK, Opekun AR, Gilger MA, Graham DY, Atmar RL.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Infect Dis 2010; 202:1212-8; PMID:20815703; http://dx.doi.org/10.1086/656364 [48] Nurminen K, Blazevic V, Huhti L, Rasanen S, Koho T, Hytonen VP, Vesikari T. Prevalence of norovirus GII-4 antibodies in ï¬nnishchildren.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Infect Dis 2014; 210:1755-62; PMID:24970849; http://dx.doi.org/10.1093/infdis/jiu361 [50] Debbink K, Lindesmith LC, Baric RS.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Clin Infect Dis 2014; 58:1746-52; PMID:24585561; http://dx.doi.org/ 10.1093/cid/ciu120 [51] Atmar RL, Estes MK.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Expert Rev Vaccines 2012; 11:1023-5; http://dx.doi.org/10.1586/ erv.12.78 [52] Choi P, Reiser H. IL-4: Role in disease and regulation of production.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Clin Exp Immunol 1998; 113:317-9; PMID:9737656; http://dx.doi.org/10.1046/j.1365-2249.1998.00690.x [53] Geginat J, Paroni M, Maglie S, Alfen JS, Kastirr I, Gruarin P, De Simone M, Pagani M, Abrignani S. Plasticity of human CD4 T cellsubsets.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Front Immunol 2014; 5:630; PMID:25566245; http://dx.doi.org/10.3389/ ï¬mmu.2014.00630 [54] Esquivel FR, Lopez S, Guitierrez-X L, Arias C. The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response.Arch Virol 2000; 145:813-25; PMID:10893159; http://dx.doi.org/ 10.1007/s007050050674 [55] Ghosh MK, Borca MV, Roy P. Virus-derived tubular structure dis- playing foreign sequences on the surface elicit CD4 Cth cell and pro- tective humoral responses.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
Virology 2002; 302:383-92; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"J Immunol 2004; 173:3148-54; PMID:15322175; http://dx.doi.org/10.4049/jimmunol.173.5.3148 [58] Hoebe K, Janssen E, Beutler B.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Nat Immunol 2004; 5:971-4; PMID:15454919;http://dx.doi.org/10.1038/ni1004-971 [59] Huhti L, Blazevic V, Nurminen K, Koho T, Hytonen VP, Vesikari T. A comparison of methods for puri ï¬cation and concentration of nor- ovirus GII-4 capsid virus-like particles.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Arch Virol 2010; 155:1855-8; PMID:20721592; http://dx.doi.org/10.1007/s00705-010-0768-z [60] Huhti L, Tamminen K, Vesikari T, Blazevic V. Characterization and immunogenicity of norovirus capsid-derived virus-like particlespuriï¬ed by anion exchange chromatography.",Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Arch Virol 2013; 158:933-42; PMID:23229011; http://dx.doi.org/10.1007/s00705-012- 1565-7 [61] Tamminen K, Huhti L, Koho T, Lappalainen S, Hytonen VP, Vesi- kari T, Blazevic V. A comparison of immunogenicity of norovirusGII-4 virus-like particles and P-particles.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
Immunology 2012; 135:89- 99; PMID:22044070; http://dx.doi.org/10.1111/j.1365-2567.2011.,Non-OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"Clin Vaccine Immunol 2015; 22:656-63; PMID:25903355; http://dx.doi.org/10.1128/CVI.00015-15 [63] Uusi-Kerttula H, Tamminen K, Malm M, Vesikari T, Blazevic V. Comparison of human saliva and synthetic histo-blood group anti-gens usage as ligands in norovirus-like particle binding and blockingassays.",OADS,/arxiv_data1/oa_pdf/b9/41/khvi-12-03-1099772.PMC4964741.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part B Volume 22, Number 4, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/ten.teb.2015.0532 322",Non-OADS,/arxiv_data1/oa_pdf/1a/68/ten.teb.2015.0532.PMC4964752.pdf
Available from: http://www.usbjd.org/projects/project_op.cfm?dirID=348.,OADS,/arxiv_data1/oa_pdf/5c/e2/IJOrtho-50-341.PMC4964764.pdf
Available from: http://www.noforg/files/nof/public/content/file/2791/upload/919pdf.,OADS,/arxiv_data1/oa_pdf/0b/37/IJOrtho-50-434.PMC4964778.pdf
Availab le from: http://www.who.int/substance_abuse/ terminology/abuse/en/.,Non-OADS,/arxiv_data1/oa_pdf/0b/37/IJOrtho-50-434.PMC4964778.pdf
Avai lable from: http://www.nice.org.uk/guidance/ta161/ resources/guidance-alendronate-etidronate-risedronate-raloxifene-strontium-ranelate-and-teriparatide-for-thesecondary-prevention-of-osteoporotic-fragility-fractures- in-postmenopausal-women-amended-pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/37/IJOrtho-50-434.PMC4964778.pdf
"7, 1795 â1801 http://dx.doi.org/10.1080/21645515.2015.1134070",Non-OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
After this toxicology study was performed thishigh-dose of virus was used in the randomized Phase II clinicaltrial (http://clinicaltrials.gov/show/NCT00879762) reported byFrey et al.,OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
Expert Rev Vaccines 2008; 7:1225-37;PMID:18844596; http://dx.doi.org/10.1586/14760584.7.8.1225 [2] Russell PK.,Non-OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"Emerg Infect Dis 1999; 5:531-3; PMID:10458959; http://dx.doi.org/10.3201/eid0504.990413 [3] Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrl- ing PB, Hauer J, Layton M, McDade J, Osterholm MT, et al.",OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"Jama 1999; 281:2127-37;PMID:10367824; http://dx.doi.org/10.1001/jama.281.22.2127 [4] Frey SE, Newman FK, Kennedy JS, Sobek V, Ennis FA, Hill H, Yan LK, Chaplin P, Vollmar J, Chaitman BR, et al.",OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"Vaccine 2007; 25:8562- 73; PMID:18036708; http://dx.doi.org/10.1016/j.vaccine.2007.10.017 [5] Metzger W, Mordmueller BG.",Non-OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"J Infect Dis 1970; 122:303-9; PMID:4396189; http://dx.doi.org/10.1093/infdis/122.4.303 [7] Thomas TN, Reef S, Neff L, Sniadack MM, Mootrey GT.",OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"ClinInfect Dis 2008; 46 Suppl 3:S212-20; PMID:18284361; http://dx.doi.org/10.1086/524742 [8] Kemper AR, Davis MM, Freed GL.",OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"Nature 2004; 428:182-5; PMID:15014500; http://dx.doi.org/10.1038/nature02331 [10] Stickl H, Hochstein-Mintzel V, Mayr A, Huber HC, Schafer H, Holz- ner A.",OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
Dtsch Med Wochenschr 1974; 99:2386-92; PMID:4426258; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"Exp Rev Vaccines 2009;8:13-24; PMID:19093767; http://dx.doi.org/10.1586/14760584.8.1.13 [13] Frey SE, Winokur PL, Salata RA, El-Kamary SS, Turley CB, Walter EB, Jr., Hay CM, Newman FK, Hill HR, Zhang Y, et al.",Non-OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"Vaccine 2013; 31:3025-33;PMID:23664987; http://dx.doi.org/10.1016/j.vaccine.2013.04.050 [14] Vollmar J, Arndtz N, Eckl KM, Thomsen T, Petzold B, Mateo L, Schlereth B, Handley A, King L, Hulsemann V, et al.",Non-OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"Vaccine 2006; 24:2065-70; PMID: 16337719; http://dx.doi.org/10.1016/j.vaccine.2005.11.022 [15] von Krempelhuber A, Vollmar J, Pokorny R, Rapp P, Wulff N, Pet- zold B, Handley A, Mateo L, Siersbol H, Kollaritsch H, et al.",Non-OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"Vaccine 2010; 28:1209-16; PMID:19944151; http://dx.doi.org/10.1016/j.vaccine.2009.11.030 [16] Hatch GJ, Graham VA, Bewley KR, Tree JA, Dennis M, Taylor I, Funnell SG, Bate SR, Steeds K, Tipton T, et al.",Non-OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"J Virol 2013;87:7805-15; PMID:23658452; http://dx.doi.org/10.1128/JVI.03481-12 [17] Keckler MS, Carroll DS, Gallardo-Romero NF, Lash RR, Salzer JS, Weiss SL, Patel N, Clemmons CJ, Smith SK, Hutson CL, et al.",OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"J Virol 2011; 85:7683-98; PMID:21632764; http://dx.doi.org/10.1128/JVI.02174-10 [18] Garza NL, Hatkin JM, Livingston V, Nichols DK, Chaplin PJ, Volk- mann A, Fisher D, Nalca A.",OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"Vaccine 2009; 27:5496-504; PMID:19632316; http://dx.doi.org/10.1016/j.vaccine.2009.06.105 [19] Stabenow J, Buller RM, Schriewer J, West C, Sagartz JE, Parker S. A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.",Non-OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"J Virol 2010; 84:3909-20; PMID:20130052; http://dx.doi.org/10.1128/JVI.02012-09 [20] Townsend MB, Keckler MS, Patel N, Davies DH, Felgner P, Damon IK, Karem KL.",OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"J Virol 2013; 87:900-11; PMID:23135728; http://dx.doi.org/10.1128/JVI.02089-12 [21] Frey SE, Winokur PL, Hill H, Goll JB, Chaplin P, Belshe RB.",OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
Vac- cine 2014; 32:2732-9; PMID:24607004; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"Vaccine 2015; 33:5425-31; PMID:26319063; http://dx.doi.org/10.1016/j.vaccine.2015.08.032 [23] Draize JH, Woodard G, Calvery HO.",Non-OADS,/arxiv_data1/oa_pdf/50/6b/khvi-12-07-1134070.PMC4964806.pdf
"7, 1805 â1807 http://dx.doi.org/10.1080/21645515.2016.1143994",Non-OADS,/arxiv_data1/oa_pdf/5c/e0/khvi-12-07-1143994.PMC4964809.pdf
Prog Neurobiol 2010; 91:108-12; PMID:20132860; http://dx.doi.org/10.1016/j.pneurobio.2010.01.008 [2] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/5c/e0/khvi-12-07-1143994.PMC4964809.pdf
1988; http://www.who.int/biologicals/publications/trs/areas/vac cines/jap_encephalitis/WHO_TRS_771_(part2)_A6.pdf?ua D1 [3] World Health Organization.,OADS,/arxiv_data1/oa_pdf/5c/e0/khvi-12-07-1143994.PMC4964809.pdf
"2002; http://www.who.int /biologicals/publications/trs/ areas/vaccines/jap_encephali tis/WHO_TRS_910_A3.pdf?ua D1 [4] Kurane I, Takasaki T. Immunogenicity and protective ef ï¬cacy of the current inactivated Japanese encephalitis vaccine against differentJapanese encephalitis virus stains M. Vaccine 2000; 18:33-5; PMID:10821971; http://dx.doi.org/10.1016/S0264-410X(00)00041-4 [5] Kim JO, Shin JH, Baek SY, Min KI, Min BS, Ryu SR, Kim BK, Kim DK, Ahn MJ, Park M, et al.",OADS,/arxiv_data1/oa_pdf/5c/e0/khvi-12-07-1143994.PMC4964809.pdf
2011; http://law.go.kr/adm RulSc.do?menuId D1&subMenu D1&query D#liBgcolor0 [7] Ministry of Food and Drug Safety.,Non-OADS,/arxiv_data1/oa_pdf/5c/e0/khvi-12-07-1143994.PMC4964809.pdf
"2012; http://www.mfds.go.kr/eng/index.do?nMenuCode D50 [8] Kim DK, Kim HY, Kim JY, Park KB, Han E, Kim J, Ban S, Han S, Park YK, Nam JH.",Non-OADS,/arxiv_data1/oa_pdf/5c/e0/khvi-12-07-1143994.PMC4964809.pdf
"Microbiol Immunol 2012; 56:463-71; PMID:22486472; http://dx.doi.org/10.1111/j.1348-0421.2012.00462.x [9] Butrapet S, Kimura J, Zhou S, Yasui K. Neutralizing mechanism of a monoclonal antibody against Japanese encephalitis virus glycopro- tein E. Am J Trop Med Hyg 1998; 58:389-98; PMID:9574781 [10] Srivastava K, Aira Y, Mori C, Kobayashi Y, Igarashi A. Antigenicity of Japanese encephalitis virus envelope glycoprotein V3 (E) and its cyanogens bromide cleaved fragment examined by monoclonal anti- bodies and Western blotting.",OADS,/arxiv_data1/oa_pdf/5c/e0/khvi-12-07-1143994.PMC4964809.pdf
Arch Virol 1998; 96:97-107; http://dx.doi.org/10.1007/BF01310993 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/e0/khvi-12-07-1143994.PMC4964809.pdf
"7, 1909 â1923 http://dx.doi.org/10.1080/21645515.2016.1151990",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
Evidence-Based Child Heal2013; 8:2076-38; http://dx.doi.org/10.1002/ebch.1948 [2] European Centre for Disease Prevention and Control.,Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Eur J Public Health 2006; 16:85-8; PMID:16446303; http://dx.doi.org/10.1093/eurpub/cki058 [6] Lernout T, Theeten H, Hens N, Braeckman T, Roelants M, Hoppen- brouwers K, Van Damme P. Timeliness of infant vaccination and factors related with delay in Flanders, Belgium.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Vaccine 2014; 32:284-9; PMID:24252698; http://dx.doi.org/10.1016/j.vaccine.2013.10.084 [7] Robert E, Dramaix M, Swennen B. Vaccination Coverage for Infants: Cross-Sectional Studies in Two Regions of Belgium.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"BMC Public Health [Internet] 2013; 13:1.Available from: http://www.biomedcentral.com/1471-2458/13/908 [10] Van Lier A, Van De Kassteele J, De Hoogh P, Drijfhout I, De Melker H. Vaccine uptake determinants in the Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Eur J PublicHealth 2014; 24:304-9; PMID:23531526; http://dx.doi.org/10.1093/ eurpub/ckt042 [11] Bouhamam N, Laporte R, Boutin A, Uters M, Bremond V, Noel G, Rodier P, Minodier P. N. Pr /C19ecarit /C19e, couverture sociale et couverture vaccinale : enqu ^ete chez les enfants consultant aux urgences p/C19ediatriques.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Vaccine 2012; 30:1855-64; PMID:22230590; http://dx.doi.org/10.1016/j.vaccine.2011.12.127 [13] Kriwy P. Similarity of parents and physicians in the decision to vacci- nate children against measles, mumps and rubella.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"BMC Public Health 2012; 12:57; PMID:222643;http://dx.doi.org/10.1186/1471-2458-12-57 [15] Sch â¬onberger K, Ludwig MS, Wildner M, Kalies H. Timely MMR vac- cination in infancy: In ï¬uence of attitudes and medical advice on thewillingness to vaccinate.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Klin Padiatr 2012; 224:437-42; PMID:22821294; http://dx.doi.org/10.1055/s-0032-1321731 [16] Brown K, Fraser G, Ramsay M, Shanley R, Cowley N, van Wijgerden J, Toff P, Falconer M, Hudson M, Green J, et al.",OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
PLoS One 2011; 6:e19381; PMID:21602931; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Vaccine 2011; 26:1700-9;PMID:21185850; http://dx.doi.org/10.1016/j.vaccine.2010.12.030 [18] Coniglio MA, Platania M, Privitera D, Giammanco G, Pignato S. Parents âattitudes and behaviours towards recommended vaccina- tions in Sicily, Italy.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"BMC Public Health 2011; 11:305;PMID:21569424; http://dx.doi.org/10.1186/1471-2458-11-305 [19] Sakou I-I, Tsitsika AK, Papaevangelou V, Tzavela EC, Greydanus DE, Tsolia MN.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Eur J Pediatr 2011;170:1419-26; PMID:21465121; http://dx.doi.org/10.1007/s00431- 011-1456-z [20] Babatsikou F, Vorou R, Vardaki Z, Galani S, Ktenas E, Koutis C. Childhood vaccination uptake and factors affecting this in athens,Greece.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Psychol Health Med 2010; 15:220-30; PMID:20391239; http://dx.doi.org/10.1080/13548501003623963 [23] Jessop LJ, Murrin C, Lotya J, Clarke AT, O âMahony D, Fallon UB, Johnson H, Bury G, Kelleher CC, Murphy AW.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Acta Paediatr Int J Paediatr 2009; 98:1307-12 PMID:19432835; http://dx.doi.org/ 10.1111/j.1651-2227.2009.01331.x [28] Vandermeulen C, Roelants M, Theeten H, Van Damme P, Hoppen- brouwers K. Vaccination coverage and sociodemographic determi- nants of measles-mumps-rubella vaccination in three different age groups.",OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Eur J Pediatr 2008; 167:1161-8; PMID:18204860; http://dx.doi.org/10.1007/s00431-007-0652-3 [29] Mixer RE, Jamrozik K, Newsom D. Ethnicity as a correlate of the uptake of the ï¬rst dose of mumps, measles and rubella vaccine.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Vaccine 2001; 20(Suppl 1):S5-7; discussion S1; PMID:11587800; http://dx.doi.org/10.1016/S0264-410X(01)00307-3 [48] Impicciatore P, Bosetti C, Schiavio S, Pandol ï¬ni C, Bonati M. Moth- ers as active partners in the prevention of childhood diseases: mater- nal factors related to immunization status of preschool children in Italy.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
Vaccine 2013; 31:5687-92; PMID:24120549; http://dx.doi.org/10.1016/j.vaccine.2013.09.056 [53] UNICEF/WHO.,Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
Avail- able from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"dbD pubmed&cmd DRetrieve&dopt DAbstractPlus&list_uids D96742 41352091541817 nnï¬le:///Users/cameronnorman/Library/Applica tion Support/Papers2/Articles/2003/Fishbein/2003 Fishbein.pdf nnpa pers2://publication/uuid/0630; http://dx.doi.org/10.1111/j.1468- 2885.2003.tb00287.x [55] Suarez L, Simpson DM, Smith DR.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Pediatrics 1997; 99:E3; PMID:9113960; http://dx.doi.org/10.1542/peds.99.5.e3 [56] DerSimonian R, Laird N. Meta-analysis in clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
Control Clin Trials 1986; 7:177-88; PMID:3802833; http://dx.doi.org/10.1016/ 0197-2456(86)90046-2 [57] Fleiss JL.,OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Stat Methods Med Res 1993; 2:121-45; PMID:8261254; http://dx.doi.org/10.1177/ 096228029300200202 [58] Higgins JPT, Thompson SG, Deeks JJ, Altman DG.",OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"J Clin Epidemiol 2001;54:1046-55; PMID:11576817; http://dx.doi.org/10.1016/S0895- 4356(01)00377-8 [60] Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-anal- ysis detected by a simple, graphical test.",OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
J Clin Epidemiol 2008; 61:991-6; PMID:18538991; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/04/0e/khvi-12-07-1151990.PMC4964810.pdf
"Human Vaccines & Immunotherapeutics, 12(1):8-19. http://dx.doi.org/10.1080/21645515.2015.1054584Â© 2016 Sylvia Taylor, Martin Ryser, Attila Mihalyi, and Thierry van Effelterre.",Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
"7, 1943 â1946 http://dx.doi.org/10.1080/21645515.2016.1151598",Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
Lancet Infect Dis 2012 Oct; 12(10):781-9; PMID:22920953; http://dx.doi.org/10.1016/S1473- 3099(12)70187-1.,Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
Avail- able from: http://www.gsk-clinicalstudyregister.com/study/109616% 20%28Y7%29#rs.,Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
Exp Rev Vacc 15(3):367-387. http://dx.doi.org/10.1586/ 14760584.2016.1124763.,Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
"Lancet Oncol 2015 Jul; 16(7):775-86; PMID:26071347; http://dx.doi.org/10.1016/S1470-2045(15)00047-9; Epub 2015 Jun 9 [6] Moscicki A-B, Harper D, Naud P, Wheeler C, Blatter M, De Car- valho N, Ferris D, Roteli-Martins C, Teixeira J, Tyring S et al.",OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
Available from: http://www.gsk-clinicalstudyregister.com/ study/104820#rs.,Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
Lancet 2014 Dec 20; 384(9961):2213-27; http://dx.doi.org/10.1016/S0140-6736(14)60920-X.,OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
"Emerg Infect Dis 2016 Jan; 22(1):56-64;PMID:26692336; http://dx.doi.org/10.3201/eid2201.150736 [10] Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, et al.",OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
"N Engl J Med 2015 Feb 19;372(8):711-23; PMID: 25693011; http://dx.doi.org/10.1056/NEJMoa1405044 [11] Di Mario S, Basevi V, Lopalco PL, Balduzzi S, D âAmico R, Magrini N. Are the two human papillomavirus vaccines really similar?",Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
"PMID: 22075171; http://dx.doi.org/10.1016/ S1470-2045(11)70286-8 [14] Lang Kuhs KA, Porras C, Schiller JT, Rodriguez AC, Schiffman M, Gon- z a l e zP ,W a c h o l d e rS ,G h o s hA ,L iY ,L o w yD R ,e ta l .E f f e c to fd i f f e r e n t human papillomavirus serological and DNA criteria on vaccine ef ï¬cacy estimates.",Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
"Hum Vaccin Immunother 2014; 10(7):1781-94; PubMed Central PMCID: PMC4186043;PMID:25424783; http://dx.doi.org/10.4161/hv.28712 [16] GlaxoSmithKline Vaccine HPV-007 Study Group, Romanowski B, de Borba PC, Naud PS, Roteli-Martins CM, De Carvalho NS, Teixeira JC, Aoki F, Ramjattan B, Shier RM, et al.",Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
"Lancet 2009 Dec 12; 374(9706):1975-85; PMID: 19962185; http://dx.doi.org/10.1016/S0140-6736(09)61567-1 [17] Mu ~noz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, et al.",OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
J Natl Cancer Inst 2010 Mar 3; 102(5):325-39; PMID: 20139221; http://dx.doi.org/10.1093/jnci/djp534.,Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
Cancer Epidemiol Biomarkers Prev 2014 Oct;23(10):1997-2008; PMID: 25274978; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
"Epub 2006 Jul 24; http://dx.doi.org/10.1016/j.virol.2006.06.021 [21] Boxus M, Lockman L, Fochesato M, Lorin C, Thomas F, Giannini SL.",OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
Vaccine 2014May 30; 32(26):3232-6; Epub 2014 Apr 13; http://dx.doi.org/ 10.1016/j.vaccine.2014.04.0051946 S. TAYLOR ET AL.,Non-OADS,/arxiv_data1/oa_pdf/76/b3/khvi-12-07-1151598.PMC4964815.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Com- mercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commer-cial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
The identities of DNA sequences were conï¬rmed using NCBI BLAST (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Proc Natl Acad Sci U S A 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/ 10.1073/pnas.95.23.13363 2.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Wildl Dis 1980; 16:89-98; PMID:7373730; http://dx.doi.org/10.7589/0090-3558-16.1.89 5.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Wildl Dis 1982; 18:465-71; PMID:7154220; http://dx.doi.org/10.7589/0090- 3558-18.4.465 6.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
[cited 2015 Aug 6] Avi- alable from: http://www.dnr.illinois.gov/programs/ CWD/Pages/FAQs/aspx.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
[cited 2015Apr 29] Available from: http://www.nwhc.usgs.gov/ disease_information/chronic_wasting_disease/.8.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
[Cited 2015 Aug 6] Available from: https://www.dnr.illinois.gov/programs/CWD/ Documents/CWDAnnualReport20132014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Prion 2008; 2:28-36; PMID:19164895; http://dx.doi.org/10.4161/pri.2.1.6321 11.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Prev Vet Med 2014;113:139-45; PMID:24128754; http://dx.doi.org/ 10.1016/j.prevetmed.2013.09.011 12.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Prev Vet Med 2013; 110:541-8; PMID:23558033; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Mother to offspring transmission of chronic wasting disease in Reevesâ Muntjac deer.Plos One 2013; 8:e71844; http://dx.doi.org/10.1371/ journal.pone.0071844 14.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Prion 2010; 4:275-82; PMID:20948292; http://dx.doi.org/ 10.4161/pri.4.4.13678 15.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Virol 2011; 85:6309-18; PMID:21525361; http://dx.doi.org/ 10.1128/JVI.00425-11 16.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
PLoS Pathog 2006; 2:e32-e; PMID:16617377; http://dx.doi.org/10.1371/jour- nal.ppat.0020032 17.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Prion 2014; 8:92- 9; PMID:24618673; http://dx.doi.org/10.4161/ pri.28467 19.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Recent US case of var- iant Creutzfeldt-Jakob disease - global implications.Emerg Infect Dis J 2015; 21:750; http://dx.doi.org/ 10.3201/eid2105.142017 20.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Virology 2009; 387:235-43; PMID:19269662; http://dx.doi.org/10.1016/j.virol.2009.02.025 21.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Emerg Infect Dis 2009; 15:1366-76; PMID:19788803; http://dx.doi.org/10.3201/eid1509.090253 22.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
"Barria MA, Telling GC, Gambetti P, Mastrianni JA, Soto C. Generation of a new form of human PrP Scin vitro byinterspecies transmission from cervid prions.J Biol Chem 2011; 286:7490-5; PMID:21209079; http://dx.doi.org/10.1074/jbc.M110.198465 23.",OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Cell 1986; 46:503-11; PMID:3015416;http://dx.doi.org/10.1016/0092-8674(86)90875-5 25.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
"White SN, Spraker TR, Reynolds JO, OâRourke K. Association analysis of PRNP gene region with chronic wasting disease in Rocky Mountain elk.BMC Res Notes 2010; 3:7pp.-pp; http://dx.doi.org/ 10.1186/1756-0500-3-314 26.",OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Gen Virol 2006; 87:2109-14;PMID:16760415; http://dx.doi .org/10.1099/vir.0.81615-0 27.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Toxicol Environ Health A 2009; 72:1025-9; http://dx.doi.org/10.1080/ 15287390903084264 29.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Infect GenetEvol 2009; 9:1329-35; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Gen Virol 2004; 85:1339-46; PMID:15105552; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Nature 2015; 522:478-+; PMID:26061765; http://dx.doi.org/ 10.1038/nature14510 32.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Lancet 1991; 337:1441-2; PMID:1675319; http://dx.doi.org/10.1016/0140-6736(91)93128-V 33.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Am J Hum Genet 2005; 76:449- 62; PMID:15700229; http://dx.doi.org/10.1086/428594 35.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Am J Hum Genet 2001; 68:978-89;PMID:11254454; http://dx.doi.org/10.1086/319501 36.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Curr Mol Med 2004; 4:385-96;PMID:15354869; http://dx.doi.org/10.2174/ 1566524043360672 37.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Prev Vet Med 2006; 73:1-16; PMID:16169614; http://dx.doi.org/10.1016/j.prevetmed.2005.08.002 38.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Nature 2009; 461:529-U90;PMID:19741608; http://dx.doi.org/10.1038/nature 08289 40.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Ecol Appl 2012; 22:1050-9; PMID:22645831; http://dx.doi.org/ 10.1890/11-0907.1 41.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Gen Virol 2005; 86:2127-34; PMID:16033959; http://dx.doi.org/ 10.1099/vir.0.81077-0 42.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Virol 2011; 85:9235-8;PMID:21697479; http://dx.doi.org/10.1128/ JVI.00790-11 43.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Wildl Management 2005; 69 :1099-111; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
American Midland Naturalist 2007; 157:212-20; http://dx.doi.org/10.1674/0003-0031(2007)157%5b212:WDDBIA%5d2.0.CO;2 45.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Mammal 2014; 95:646-54; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Mamm Genome 2003; 14:765-77; PMID:14722726; http://dx.doi.org/10.1007/s00335-003-2283-y 48.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Prion 2012; 6:153-62;PMID:22460693; http://dx.doi.org/10.4161/pri.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Hum Mol Genet 2003; 12:205-16; PMID:12554675; http://dx.doi.org/10.1093/hmg/ ddg055 50.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Science 2009; 324:255-8; PMID:19359587; http://dx.doi.org/10.1126/science.1170160 51.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
"Sauna ZE, Kimchi-Sarfaty C. Understanding the con- tribution of synonymous mutations to human disease.Nat Rev Genet 2011; 12:683-91; PMID:21878961; http://dx.doi.org/10.1038/nrg3051 52.",OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Gene2013; 515:249-57; PMID:23266645; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Anim Reprod Sci 2009; 114:157-66; PMID:19028030; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Wildl Management 2001; 65:205-15; http://dx.doi.org/10.2307/3802899 57.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Appl Ecol 2009; 46:457-66; PMID:19536340; http://dx.doi.org/10.1111/j.1365- 2664.2008.01576.x 59.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Management 2003; 181:165-76; http://dx.doi.org/ 10.1016/S0378-1127(03)00130-0 61.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Wildl Management 2012; 76:1420- 30; http://dx.doi.org/10.1002/jwmg.393 62.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Wolf and bear predation on white-tailed deer fawns in northeastern Minnesota.Canadian J Zool-Revue Canadienne De Zoologie 1994; 72:1557-65; http://dx.doi.org/10.1139/z94-207 63.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Population Ecology 2014; 56:327-40; http://dx.doi.org/10.1007/s10144- 013-0427-9 64.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Appl Ecol 2010; 47:1189-98; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
J Wildl Dis2003; 39:576-81; PMID:14567218; http://dx.doi.org/10.7589/0090-3558-39.3.576 66.,OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
Mol Biol Evol 2013; 30:2725-9; PMID:24132122; http://dx.doi.org/10.1093/molbev/ mst197 67.,Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
"Vienna, Austria: R Foundation for Statistical Computing.Available at http://www.R-project.org/ 68.",Non-OADS,/arxiv_data1/oa_pdf/8b/cd/kprn-09-06-1115179.PMC4964855.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
"Currently, 21 states have been affected (http://www.cwd-info.org/index.php/fuseaction/about.map).",Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
J Wildl Dis 1980; 16:89-98; PMID:7373730; http://dx.doi.org/10.7589/0090-3558-16.1.89 2.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Nature 2003; 425:35-6; PMID:12955129; http://dx.doi.org/10.1038/425035a 3.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Emerg Infect Dis 2004; 10: 1003-6; PMID:15207049; http://dx.doi.org/ 10.3201/eid1006.040010 4.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
PLoS One 2009; 4:e4848; PMID:19293928; http://dx.doi.org/10.1371/journal.pone.0004848 5.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
J Wildl Dis 2012; 48:425-34; PMID:22493117; http://dx.doi.org/10.7589/0090- 3558-48.2.425 6.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Science 2006; 314:133-6; PMID:17023660; http://dx.doi.org/10.1126/science.1132661 7.,OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
PLoS Pathog 2006; 2:e32;PMID:16617377; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
PLoS One 2013; 8:e62455; PMID:23671598; http://dx.doi.org/10.1371/journal.pone.0062455 9.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
PLoS Pathog 2006; 2:e26; PMID:16609731; http://dx.doi.org/10.1371/journal.ppat.0020026 10.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
PLoS One 2012; 7:e45774; PMID:23082115; http://dx.doi.org/10.1371/journal.pone.0045774 11.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
J Toxicol Environ Health A 2009;72:1018-24; PMID:19697235; http://dx.doi.org/ 10.1080/15287390903084249 12.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
The Journal of Wildlife Management 2009; 73:655-62; http://dx.doi.org/10.2193/2008-282 13.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Vet Pathol 2010; 47:536-46;PMID:20382822; http://dx.doi.org/10.1177/ 0300985810363702 14.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
JGen Virol 1999; 80 (Pt 10):2757-64; PMID:10573172; http://dx.doi.org/10.1099/0022-1317-80- 10-275715.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
J Gen Virol 2001;82:2327-34; PMID:11562526; http://dx.doi.org/ 10.1099/0022-1317-82-10-2327 16.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Sci- ence 2006; 311:1117; PMID:16439622; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
J Gen Virol 2006; 87:3443-50; PMID:17030881; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Journal of Wildlife Manage- ment 1987; 51:278-85; http://dx.doi.org/10.2307/3801003 20.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Ecol- ogy 1998; 79:1193-208; http://dx.doi.org/10.2307/ 176736 21.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Journal of Wildlife Management 1984; 48:1420-3; http://dx.doi.org/10.2307/3801809 22.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Ecol Lett 2003;6:996-1003; http://dx.doi.org/10.1046/j.1461- 0248.2003.00522.x 23.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Journal of Wildlife Management 1957; 21:424-35;http://dx.doi.org/10.2307/3796675 24.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
J Mammol 1992; 73:337-43; http://dx.doi.org/ 10.2307/1382067 25.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
J Vet Diagn Invest 2002; 14:3-7; PMID:12680636; http://dx.doi.org/10.1177/ 104063870201400102 27.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
J Neurosci2005; 25:7944-9; PMID:16135751; http://dx.doi.org/ 10.1523/JNEUROSCI.2467-05.2005 28.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Neurochem Res 2009; 34:158-68;PMID:18483857; http://dx.doi.org/10.1007/s11064- 008-9741-6 29.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
PLoS One 2009; 4:e7990; PMID:19956732; http://dx.doi.org/10.1371/journal.pone.0007990 30.,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
Journal of Wildlife Management 1988; 52:640-6;http://dx.doi.org/10.2307/3800923CWD PRIONS INFECTIOUS AFTER PASSAGE THROUGH DIGESTIVE SYSTEM OF COYOTES 375,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/kprn-09-05-1086061.PMC4964857.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Genetics 2012; 191:1041-72; PMID:22879407; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Microbiol Mol Biol Rev 2015; 79:1-17;PMID:25631286; http://dx.doi.org/10.1128/ MMBR.00041-14 3.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Brain Res 2012; 1462:61-81; PMID:22445064; http://dx.doi.org/10.1016/j.brainres.2012.01.016 4.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Cell 2013; 154:727-36; PMID:23953108; http://dx.doi.org/10.1016/j.cell.2013.07.038 5.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Yeast prions and human prion- like proteins: sequence features and prediction methods.Cell Mol Life Sci 2014; 71:2047-63; PMID:24390581; http://dx.doi.org/10 .1007/s00018-013-1543-6 6.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Proc Natl Acad Sci U S A 2015; 112:8584-9; PMID:26100899; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Prion 2011; 5:311-6; PMID:22156731; http://dx.doi.org/10.4161/pri.5.4.18304 8.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Mol Cell Biol 2004; 24:7206-13; PMID:15282319; http://dx.doi.org/10.1128/MCB.24.16.7206-7213.2004 9.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
PLoS One2014; 9:e89286; PMID:24586661; http://dx.doi.org/ 10.1371/journal.pone.0089286 13.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Cell 2009; 137:146-58; PMID:19345193; http://dx.doi.org/10.1016/j.cell.2009.02.044 14.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
PLoS ONE 2012; 7:e46458; PMID:23071575; http://dx.doi.org/ 10.1371/journal.pone.0046458 16.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Mol Cell Biol 2015; 35:899-911; http://dx.doi.org/10.1128/MCB.01020-14 17.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
PLoS Biol2004; 2:E86; PMID:15045026; http://dx.doi.org/ 10.1371/journal.pbio.0020086 18.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Nature 2005; 435:773-8; PMID:15944695; http://dx.doi.org/10.1038/nature03680 20.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
J Biol Chem 2003;278:38287-91; PMID:12923185; http://dx.doi.org/ 10.1074/jbc.C300300200 23.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Genetics 2007;176:1557-65; PMID:17507672; http://dx.doi.org/ 10.1534/genetics.107.074153 25.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Nature 1999; 400:573-6; PMID:10448860; http://dx.doi.org/ 10.1038/22919 27.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Br Med Bull 2003; 66:241-54; PMID:14522862; http://dx.doi.org/10.1093/ bmb/66.1.241 28.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
PLoS One 2011; 6:e21953; PMID:21760933; http://dx.doi.org/10.1 371/journal.pone.0021953 29.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
J Struct Biol 2012; 179:279-88; PMID: 21884799; http://dx.doi.org/ 10.1016/j.jsb.2011.08.009 30.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Protein Sci 2000; 9:1203-9; PMID:10892812; http://dx.doi.org/10.1110/ps.9.6.1203 31.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Prion 2013; 7:209-14; PMID:23764835; http://dx.doi.org/10.4161/pri.24628 32.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
The alternative conformations of amyloido- genic proteins and their multi-step assembly pathways.Curr Opin Struct Biol 1998; 8:101-6; PMID:9519302; http://dx.doi.org/10.1 016/S0959-440X(98)80016-X 33.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Nat Meth 2010; 7:237-42; PMID:20154676; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Nat Chem Biol2009; 5:15-22; PMID:19088715; http://dx.doi.org/ 10.1038/nchembio.13136.,OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
Mol Microbiol 2010; 76:1483-99; PMID:20444092; http://dx.doi.org/10.1111/ j.1365-2958.2010.07177.x 37.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kprn-09-05-1111506.PMC4964860.pdf
J Biol Chem 2015; 290(9):5512-22; PMID:25572394; http://dx.doi.org/10.1074/jbc.M114.607507.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
PLoS Pathog 2014; 10: e1004335; PMID:25232824; http://dx.doi.org/ 10.1371/journal.ppat.1004335 2.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Antioxid Redox Signal 2014; 20:1324-63; PMID:23815406; http://dx.doi.org/10.1089/ars.2012.4931 3.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Neurochem Int 2013;62:637-52; PMID:23220386; http://dx.doi.org/ 10.1016/j.neuint.2012.11.015 4.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Front Pharmacol 2014; 5:81; PMID:24795635; http://dx.doi.org/10.3389/fphar.2014.00081 5.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Free Radic Biol Med 2015; 84:322-30; PMID:25862412; http://dx.doi.org/ 10.1016/j.freeradbiomed.2015.03.037 6.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Mol SystBiol 2009; 5:252; PMID:19308092; http://dx.doi.org/ 10.1038/msb.2009.10 7.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Nature 2009; 460:669; PMID:19661875; http://dx.doi.org/10.1038/460669e 8.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
PLoS pathogens 2009; 5:e1000336; PMID:19283067; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Free Radic Biol Med2013; 62:52-64; PMID:23376471; http://dx.doi.org/10.1016/j.freeradbiomed.2013.01.017 10.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Cell Mol Life Sci 2009; 66:3241-61;PMID:19484405; http://dx.doi.org/10.1007/s00018- 009-0051-1 11.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
J Cereb Blood FlowMetab 2015; 35:48-57; PMID:25315861; http://dx.doi.org/10.1038/jcbfm.2014.168 12.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Neuropathol Appl Neurobiol 2012; 38:296-310; PMID:22394291; http://dx.doi.org/ 10.1111/j.1365-2990.2012.01265.x 13.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Neurobiol Dis 2012;45:930-8; PMID:22182691; http://dx.doi.org/ 10.1016/j.nbd.2011.12.012 14.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Biochim Biophys Acta 2015; 1853:1130-44; PMID:25661197; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Blood 2006; 108:1388-94; PMID:16609065; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
J Biol Chem 2010; 285:26729-35; PMID:20522542; http://dx.doi.org/10.1074/jbc.R110.113217 19.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
PLoS One 2009; 4:e6115; PMID:19568430; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Metallomics 2011; 3:206-14; PMID:21264406;http://dx.doi.org/10.1039/c0mt00037j 21.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
J Biol Chem 2015; 290(9):5512-22;PMID:25572394; http://dx.doi.org/10.1074/jbc.M114.607507 23.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Proc Natl Acad Sci U S A 1987;84:3457-61; PMID:3472216; http://dx.doi.org/ 10.1073/pnas.84.10.3457 24.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Prion 2012; 6:317-21; PMID:22575750; http://dx.doi.org/ 10.4161/pri.20196 25.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Prog Neurobiol2011; 93:405-20; PMID:21163327; http://dx.doi.org/ 10.1016/j.pneurobio.2010.12.001 26.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
J Mol Biol2012; 422:556-74; PMID:22687393; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Neurosci Lett 2007; 422:158-63;PMID:17614197; http://dx.doi.org/10.1016/j.neulet.2007.05.061 29.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
J Toxicol Environ Health A 2011; 74:1504- 20; PMID:22043911; http://dx.doi.org/10.1080/15287394.2011.618979 30.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Brain Res Mol Brain Res 2005; 133:266-73;PMID:15710243; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
J Trace Elem Med Biol 2015; 31:267-73;PMID:25716300; http://dx.doi.org/10.1016/j.jtemb.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Available at http://dx.doi.org/10.1016/j.nbd.2015.03.015 34.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Cell Mol Life Sci 2014; 71:1607-22; PMID:24218010; http://dx.doi.org/10.1007/s00018-013-1509-8 35.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
Life sciences 2015; 136:108-19; PMID:26159898; http://dx.doi.org/10.1016/j.lfs.2015.06.026428 Singh et al.,OADS,/arxiv_data1/oa_pdf/b5/09/kprn-09-06-1118602.PMC4964862.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Dev Cell 2011; 21:172- 85; PMID:21763617; http://dx.doi.org/10.1016/j.devcel.2011.06.0162.,OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
J Biochem 2014; 155:345-51; PMID:24711463; http://dx.doi.org/10.1093/jb/mvu026 4.,OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Prion 2011; 5:179-87; PMID:21847013; http://dx.doi.org/ 10.4161/pri.5.3.17230 6.,Non-OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Virus Res 2015; 207:94-105; PMID:25656065; http://dx.doi.org/10.1016/j.virusres.2014.12.032 7.,OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Nature 2013; 495:467-73; PMID:23455423; http://dx.doi.org/10.1038/ nature11922 8.,Non-OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
J Biol Chem 2014;289:1192-202; PMID:24280224; http://dx.doi.org/ 10.1074/jbc.M113.516492 9.,OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Cell 2015; 162:1066-1077; PMID:26317470; http://dx.doi.org/10.1016/j.cell.2015.07.047 10.,OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Genetics 2012; 191:1041-72; PMID:22879407; http://dx.doi.org/10.1534/genetics.111.137760 11.,Non-OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Microbiol Mol Biol Rev 2015; 79:1-17; PMID:25631286; http://dx.doi.org/10.1128/MMBR.00041-14 12.,Non-OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Brain Res 2012; 1462:61-80; PMID:22445064; http://dx.doi.org/10.1016/j.brainres.2012.01.016 15.,OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Biochim Biophys Acta 2013;1834:1-14; PMID:23451353; http://dx.doi.org/ 10.1016/j.bbapap.2012.08.018 16.,OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Protein Sci 2013; 22:693-724; PMID:23553817; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Hum Mol Genet 2000; 9:2009-18; PMID:10942430; http://dx.doi.org/10.1093/hmg/9.13.2009 21.,OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Mol Cell2011; 43:72-84; PMID:21726811; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Biochemistry 2015; 54:4784-94; PMID:26204228; http://dx.doi.org/ 10.1021/acs.biochem.5b00644 23.,Non-OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Cell 2013; 154:134-45; PMID:23791384; http://dx.doi.org/10.1016/j.cell.,OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Frontiers Mol Neuroscience 2014; 7:77; PMID:25324717; http://dx.doi.org/ 10.3389/fnmol.2014.00077 26.,Non-OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Science 2003; 299:1751-3; PMID:12610228; http://dx.doi.org/ 10.1126/science.1080418 27.,Non-OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
PLoS Biol 2006; 4:e417;PMID:17147470; http://dx.doi.org/10.1371/journal.pbio.0040417 28.,Non-OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Ethology Ecol Evolution 2011; 23:262-73; http://dx.doi.org/ 10.1080/03949370.2011.568526 29.,Non-OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
Elife2015; 4:e06807; PMID:26238190; http://dx.doi.org/ 10.7554/eLife.06807346 Malinovska and Alberti,Non-OADS,/arxiv_data1/oa_pdf/68/62/kprn-09-05-1099799.PMC4964863.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Cell 1986; 46:503-11; PMID:3015416;http://dx.doi.org/10.1016/0092-8674(86)90875-5 2.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
J Mol Biol1999; 292:797-817; PMID:10525406; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Embo J 2007; 26:4038-50; PMID:17703189; http://dx.doi.org/10.1038/sj.emboj.7601830 5.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Nature 1999; 400:225-6; PMID:10421360; http://dx.doi.org/10.1038/22241 6.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
J Biol Chem 2005;280:35914-21; PMID:16120605; http://dx.doi.org/ 10.1074/jbc.M507327200 7.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
J Neurosci Res 2008; 86:653-9; PMID: 17896796; http://dx.doi.org/10.1002/jnr.21506 8.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Neurochem 2006; 98:677-89; PMID:16787422; http://dx.doi.org/10.1111/j.1471-4159.2006.03906.x 9.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Embo J 2002; 21:3317-26; PMID:12093733; http://dx.doi.org/ 10.1093/emboj/cdf324 10.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
J Neurochem 2008; 107:218-29;PMID:18691383; http://dx.doi.org/10.1111/j.1471- 4159.2008.05611.x 12.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
J Biol Chem 2011; 286:8901-8; PMID:21257747; http://dx.doi.org/10.1074/jbc.M110.185470 13.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Brain Pathol 2007; 17:174-83; PMID:17388948; http://dx.doi.org/10.1111/j.1750-3639.2007.00061.x 14.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Am J Pathol 2004; 165:227-35; PMID: 15215178; http://dx.doi.org/10.1016/S0002-9440(10)63291-9 15.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
J Neurosci 2005; 25:8967-77; PMID:16192387; http://dx.doi.org/ 10.1523/JNEUROSCI.1115-05.2005 16.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Neurobiol Dis 2005; 20:442-9; PMID:15893468; http://dx.doi.org/ 10.1016/j.nbd.2005.04.002 17.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Neurosci Lett 2004; 372:146-50;PMID:15531106; http://dx.doi.org/10.1016/j.neulet.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Stroke 2006; 37:1296-300; PMID:16574930; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Neuroscience 2005; 136:281-7; PMID:16198494; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Curr Opin Neurobiol 2003; 13:127-32;PMID:12593991; http://dx.doi.org/10.1016/S0959-4388(03)00017-5 23.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Circulation 2015; 131:e29-e322; PMID:25520374; http://dx.doi.org/10.1161/ CIR.0000000000000152 25.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Lancet Neurol 2003; 2:698-701; PMID:14572738; http://dx.doi.org/10.1016/S1474-4422(03)00558-1 26.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
JStroke Cerebrovasc Dis 2014; 23:1753-63; PMID:24957313; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Prion 2013; 8:106-10; http://dx.doi.org/10.4161/pri.27438 29.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
J Neurosci Res 2007; 85:602-11; PMID:17149767; http://dx.doi.org/10.1002/jnr.21142 30.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Gene 2003; 314:89-102; PMID:14527721; http://dx.doi.org/10.1016/ S0378-1119(03)00707-8 31.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
PLoS Pathog 2009; 5:e1000608; PMID:19798432; http://dx.doi.org/10.1371/journal.ppat.1000608 33.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
J Neurosci 2005; 25:10262-72;PMID:16267234; http://dx.doi.org/10.1523/JNEUR- OSCI.2818-05.2005 34.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Transl Stroke Res 2010; 1:184-96; PMID:21792374; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
NeuroRx 2005; 2:396-409; PMID: 16389304; http://dx.doi.org /10.1602/neurorx.2.3.396 36.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Pï¬ugers Arch 2010; 460:525-42; PMID:20229265; http://dx.doi.org/10.1007/s00424-010-0809-1 37.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
J Cell Biol 2008; 181:551-65;PMID:18443219; http://dx.doi.org/10.1083/jcb.20- 0711002 38.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
J Virol 2015; 89:6287-93; PMID:25855735; http://dx.doi.org/10.1128/JVI.03429-14 39.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
J Biol Chem 2003; 278:21732-43;PMID:12663673; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
PLoSPathog 2011; 7:e1002382; PMID:22163178; http://dx.doi.org/10.1371/journal.ppat.1002382 43.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
"J Clin Invest 2014; 124:847-58; PMID:24430187; http://dx.doi.org/10.1172/JCI72241 4 4 .L a uA ,M a y sC E ,G e n o v e s iS ,W e s t a w a yD .R G G Repeats of PrP-like Shadoo Protein Bind Nucleic Acids.Biochemistry 2012; 51:9029-31; PMID:23121093;http://dx.doi.org/10 .1021/bi3013-95w 45.",Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
